<SEC-DOCUMENT>0001091818-21-000099.txt : 20210729
<SEC-HEADER>0001091818-21-000099.hdr.sgml : 20210729
<ACCEPTANCE-DATETIME>20210729144326
ACCESSION NUMBER: 0001091818-21-000099
CONFORMED SUBMISSION TYPE: 10-Q
PUBLIC DOCUMENT COUNT: 36
CONFORMED PERIOD OF REPORT: 20210630
FILED AS OF DATE: 20210729
DATE AS OF CHANGE: 20210729
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOFORCE NANOSCIENCES HOLDINGS, INC.
CENTRAL INDEX KEY: 0001310488
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 852138858
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 10-Q
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51074
FILM NUMBER: 211126692
BUSINESS ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
BUSINESS PHONE: 757-306-6090
MAIL ADDRESS:
STREET 1: 2020 GENERAL BOOTH BLVD
STREET 2: SUITE 230
CITY: VIRGINIA BEACH
STATE: VA
ZIP: 23454
FORMER COMPANY:
FORMER CONFORMED NAME: SILVER RIVER VENTURES, INC.
DATE OF NAME CHANGE: 20041202
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bfnh10q0621.htm
<DESCRIPTION>QUARTERLY REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:i="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:bfnh="http://bioforcenano.com/20210630" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<head>
<title>BIOFORCE NANOSCIENCES HOLDINGS, INC.</title>
<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body style=" ">
<div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember" unitRef="Shares" id="Fact_213" format="ixt:numdotdecimal" decimals="INF" scale="0">2000000</ix:nonFraction>
<ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2021-01-01to2021-06-30" id="Fact_230">0001310488</ix:nonNumeric>
<ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2021-01-01to2021-06-30" id="Fact_231">--12-31</ix:nonNumeric>
<ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2021-01-01to2021-06-30" id="Fact_232">2021</ix:nonNumeric>
<ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2021-01-01to2021-06-30" id="Fact_233">Q2</ix:nonNumeric>
<ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2021-01-01to2021-06-30" id="Fact_234">false</ix:nonNumeric>
<ix:nonNumeric name="dei:DocumentQuarterlyReport" contextRef="From2021-01-01to2021-06-30" id="Fact_2">true</ix:nonNumeric>
<ix:nonNumeric name="dei:DocumentTransitionReport" contextRef="From2021-01-01to2021-06-30" id="Fact_4">false</ix:nonNumeric>
<ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="From2021-01-01to2021-06-30" id="Fact_19">true</ix:nonNumeric>
<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2021-01-01to2021-06-30" id="Fact_20">false</ix:nonNumeric>
<ix:nonNumeric name="dei:EntityShellCompany" contextRef="From2021-01-01to2021-06-30" id="Fact_21">false</ix:nonNumeric>
</ix:hidden>
<ix:references>
<xbrll:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="bfnh-20210630.xsd" xlink:type="simple"></xbrll:schemaRef>
</ix:references>
<ix:resources>
<i:context id="AsOf2020-12-31">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:unit id="USD">
<i:measure>iso4217:USD</i:measure>
</i:unit>
<i:context id="AsOf2021-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2021-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-03-31_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-03-31_us-gaap_PreferredStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-03-31">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2020-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-06-30_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2020-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2019-12-31">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2019-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2019-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2019-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2019-12-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2021-03-31">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2021-03-31</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:unit id="Shares">
<i:measure>i:shares</i:measure>
</i:unit>
<i:context id="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2019-12-31</i:instant>
</i:period>
</i:context>
<i:unit id="USDPShares">
<i:divide>
<i:unitNumerator>
<i:measure>iso4217:USD</i:measure>
</i:unitNumerator>
<i:unitDenominator>
<i:measure>i:shares</i:measure>
</i:unitDenominator>
</i:divide>
</i:unit>
<i:context id="From2021-01-01to2021-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-01-01</i:startDate>
<i:endDate>2021-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2021-04-01to2021-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2021-04-01</i:startDate>
<i:endDate>2021-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-04-01to2020-06-30">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2020-04-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2021-01-01</i:startDate>
<i:endDate>2021-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-04-01to2020-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-04-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2021-04-01to2021-06-30_us-gaap_RetainedEarningsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2021-04-01</i:startDate>
<i:endDate>2021-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="AsOf2021-06-30_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2021-06-30</i:instant>
</i:period>
</i:context>
<i:context id="AsOf2020-12-31_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:instant>2020-12-31</i:instant>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-06-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-05-01to2020-05-06">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2020-05-01</i:startDate>
<i:endDate>2020-05-06</i:endDate>
</i:period>
</i:context>
<i:context id="From2021-01-01to2021-06-30_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2021-01-01</i:startDate>
<i:endDate>2021-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-12-31">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-12-31</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-12-01</i:startDate>
<i:endDate>2020-12-04</i:endDate>
</i:period>
</i:context>
<i:context id="From2020-01-01to2020-06-30_us-gaap_CommonStockMember">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
<i:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</i:segment>
</i:entity>
<i:period>
<i:startDate>2020-01-01</i:startDate>
<i:endDate>2020-06-30</i:endDate>
</i:period>
</i:context>
<i:context id="AsOf2021-07-29">
<i:entity>
<i:identifier scheme="http://www.sec.gov/CIK">0001310488</i:identifier>
</i:entity>
<i:period>
<i:instant>2021-07-29</i:instant>
</i:period>
</i:context>
</ix:resources>
</ix:header>
</div>
<div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">U.S. SECURITIES AND EXCHANGE COMMISSION</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Washington, D.C. 20549</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">FORM </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_1" contextRef="From2021-01-01to2021-06-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="-sec-ix-hidden:Fact_2">[X]</span>  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; ">For the quarterly period ended <ix:nonNumeric id="Fact_3" contextRef="From2021-01-01to2021-06-30" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen">June 30, 2021</ix:nonNumeric>.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="-sec-ix-hidden:Fact_4">[  ]</span>  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Commission file number: </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_5" contextRef="From2021-01-01to2021-06-30" name="dei:EntityFileNumber">000-51074</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><img src="bfnhlogo2019001.jpg" alt="image provided by client" style="width:319.68px; height:149.76px; "/> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:12pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_6" contextRef="From2021-01-01to2021-06-30" name="dei:EntityRegistrantName">BIOFORCE NANOSCIENCES HOLDINGS, INC.</ix:nonNumeric></span> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; ">(Exact name of registrant as specified in its charter)</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:51%; vertical-align:top; border-bottom:1pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_7" contextRef="From2021-01-01to2021-06-30" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></span><span style="font-weight:bold; "></span></p> </td> <td style="width:2%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:37%; vertical-align:top; border-bottom:1pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_8" contextRef="From2021-01-01to2021-06-30" name="dei:EntityTaxIdentificationNumber">74-3078125</ix:nonNumeric></span><span style="font-weight:bold; "></span></p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:51%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(State or Other Jurisdiction of Incorporation or Organization) </p> </td> <td style="width:2%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:37%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(I.R.S. Employer Identification No.) </p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:51%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:6pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:37%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:51%; vertical-align:bottom; border-bottom:1pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_9" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressAddressLine1">2020 General Booth Blvd.</ix:nonNumeric></span><span style="font-weight:bold; ">, </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_10" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressAddressLine2">Unit 230</ix:nonNumeric></span><span style="font-weight:bold; "> </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_11" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressCityOrTown">Virginia Beach</ix:nonNumeric></span><span style="font-weight:bold; ">, </span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_12" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressStateOrProvince">VA</ix:nonNumeric></span><span style="font-weight:bold; "></span></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:37%; vertical-align:bottom; border-bottom:1pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; "><ix:nonNumeric id="Fact_13" contextRef="From2021-01-01to2021-06-30" name="dei:EntityAddressPostalZipCode">23454</ix:nonNumeric></span><span style="font-weight:bold; "></span></p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:51%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Address of Principal Executive Offices) </p> </td> <td style="width:2%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:37%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">(Zip Code) </p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "> </p> </td> <td colspan="3" style="width:90%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:3pt; margin-bottom:0pt; ">Registrant’s telephone number, including area code: <span style="font-weight:bold; "><ix:nonNumeric id="Fact_14" contextRef="From2021-01-01to2021-06-30" name="dei:CityAreaCode">757</ix:nonNumeric></span><span style="font-weight:bold; ">-</span><span style="font-weight:bold; "><ix:nonNumeric id="Fact_15" contextRef="From2021-01-01to2021-06-30" name="dei:LocalPhoneNumber">306-6090</ix:nonNumeric></span><span style="font-weight:bold; "></span></p> </td> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:3pt; margin-bottom:0pt; "><span style="font-weight:bold; "></span></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:-18pt; margin-bottom:0pt; "> </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric id="Fact_16" contextRef="From2021-01-01to2021-06-30" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> [X] No [  ]</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric id="Fact_17" contextRef="From2021-01-01to2021-06-30" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> [X] No [  ]</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:9%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Large accelerated filer [  ] </p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accelerated filer [  ] </p> </td> <td style="width:9%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:9%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><ix:nonNumeric id="Fact_18" contextRef="From2021-01-01to2021-06-30" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen">Non-accelerated filer</ix:nonNumeric> [X] </p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Smaller reporting company <span style="-sec-ix-hidden:Fact_19">[X]</span> </p> </td> <td style="width:9%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:9%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Emerging growth company [  ] </p> </td> <td style="width:38%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-1-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:24pt; margin-bottom:0pt; ">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="-sec-ix-hidden:Fact_20">[  ]</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; ">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <span style="-sec-ix-hidden:Fact_21">[  ]</span> No [X]</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: At July 26, 2021 the registrant had outstanding <ix:nonFraction id="Fact_22" contextRef="AsOf2021-07-29" name="dei:EntityCommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> shares of common stock, par value $0.001 per share. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">TABLE OF CONTENTS</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="80%" cellpadding="0" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td style="width:93%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:8pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> </p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:9pt; margin-bottom:0pt; ">PAGE</p> </td> </tr> </thead> <tbody> <tr class="odd" style=""> <td style="width:93%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="">PART I</span></p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> </p> </td> </tr> <tr class="even" style=""> <td style="width:93%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; text-indent:-62pt !important; padding-left:62pt !important; margin-bottom:0pt; "><span style="">Item 1.</span><span style="padding-left:30.84pt; ">Condensed Consolidated Unaudited Financial Statements</span><span style=""><a href="#d1e349_anchor">​</a></span><span style=""><a href="#d1e349_anchor">​</a></span></p> </td> <td style="width:5%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "><span style="">3</span></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-2-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; " id="d1e337_anchor"><span style="font-weight:bold; ">PART I – FINANCIAL INFORMATION</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; " id="d1e349_anchor"><span style="font-weight:bold; ">ITEM 1. FINANCIAL STATEMENTS</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <tbody> <tr class="odd" style=""> <td colspan="3" style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC.</span><span style="font-weight:bold; "></span></p> </td> </tr> <tr class="even" style=""> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:28%; vertical-align:top; border-bottom:1.5pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:28%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">FINANCIAL REPORTS </p> </td> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:28%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">AT </p> </td> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:34%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:28%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">JUNE 30, 2021 </p> </td> <td style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; margin:auto; "> <thead> <tr class="odd" style=""> <td colspan="2" style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">INDEX TO FINANCIAL STATEMENTS</span></p> </td> </tr> <tr class="even" style=""> <td colspan="2" style="width:100%; vertical-align:top; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "> </p> </td> </tr> </thead> <tbody> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:2pt; margin-bottom:0pt; "><span style="">Condensed Consolidated Balance Sheets at June 30, 2021- Unaudited and December 31, 2020</span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="">4</span></p> </td> </tr> <tr class="even" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:2pt; margin-bottom:0pt; "><span style="">Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2021 and 2020 </span><span style="">- Unaudited</span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="">5</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:2pt; margin-bottom:0pt; "><span style="">Condensed Consolidated Statements of Cash Flows for the Three and Six Months Ended June 30, 2021 and 2020 </span><span style="">- Unaudited</span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="">6</span></p> </td> </tr> <tr class="even" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:2pt; margin-bottom:0pt; "><span style="">Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended June 30, 2021 and </span><span style="">2020– Unaudited</span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="">7</span></p> </td> </tr> <tr class="odd" style=""> <td style="width:90%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:2pt; margin-bottom:0pt; "><span style="">Notes to the Condensed Consolidated Unaudited Financial Statements</span></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:2pt; margin-bottom:0pt; "><span style="">8</span><span style="">-10</span></p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-3-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; " id="d1e436_anchor"><span style="font-weight:bold; ">BioForce Nanosciences Holdings, Inc., and Subsidiary</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="82%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td colspan="7" style="width:100%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">June 30, </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">December 31, </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2021 </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">ASSETS</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Current Assets</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_23" contextRef="AsOf2021-06-30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">27,305</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_24" contextRef="AsOf2020-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid Expenses </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_25" contextRef="AsOf2021-06-30" name="us-gaap:PrepaidExpenseCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">100</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_26" contextRef="AsOf2020-12-31" name="us-gaap:PrepaidExpenseCurrent" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Current Assets</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_27" contextRef="AsOf2021-06-30" name="us-gaap:AssetsCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">27,405</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_28" contextRef="AsOf2020-12-31" name="us-gaap:AssetsCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Assets</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_29" contextRef="AsOf2021-06-30" name="us-gaap:Assets" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">27,405</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_30" contextRef="AsOf2020-12-31" name="us-gaap:Assets" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">LIABILITIES AND STOCKHOLDERS' DEFICIT</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Current Liabilities</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accounts Payable and Accrued Expenses </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_31" contextRef="AsOf2021-06-30" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,032</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_32" contextRef="AsOf2020-12-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">5,090</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued Board of Directors Compensation </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_33" contextRef="AsOf2021-06-30" name="us-gaap:AccruedSalariesCurrentAndNoncurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">539,017</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_34" contextRef="AsOf2020-12-31" name="us-gaap:AccruedSalariesCurrentAndNoncurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">327,517</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Due to Related Parties </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_35" contextRef="AsOf2021-06-30" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">114,658</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_36" contextRef="AsOf2020-12-31" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">67,166</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Current Liabilities</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_37" contextRef="AsOf2021-06-30" name="us-gaap:LiabilitiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">654,707</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_38" contextRef="AsOf2020-12-31" name="us-gaap:LiabilitiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">399,773</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Liabilities</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_39" contextRef="AsOf2021-06-30" name="us-gaap:Liabilities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">654,707</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_40" contextRef="AsOf2020-12-31" name="us-gaap:Liabilities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">399,773</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Stockholders' Deficit</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; ">Common Stock - $<ix:nonFraction id="Fact_42" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_41" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction> Par; <ix:nonFraction id="Fact_44" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_43" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">900,000,000</ix:nonFraction></ix:nonFraction> Shares Authorized, <ix:nonFraction id="Fact_48" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_47" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_46" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_45" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Issued and Outstanding, Respectively​​ </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_49" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_50" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Additional Paid-In-Capital </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_51" contextRef="AsOf2021-06-30" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_52" contextRef="AsOf2020-12-31" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accumulated Deficit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_53" contextRef="AsOf2021-06-30" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,437,701</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_54" contextRef="AsOf2020-12-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,170,307</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Stockholders' Deficit</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_55" contextRef="AsOf2021-06-30" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">627,302</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_56" contextRef="AsOf2020-12-31" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">359,908</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Liabilities and Stockholders' Deficit</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_57" contextRef="AsOf2021-06-30" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">27,405</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_58" contextRef="AsOf2020-12-31" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-4-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; " id="d1e1165_anchor"><span style="font-weight:bold; ">BioForce Nanosciences Holdings, Inc., and Subsidiary</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="82%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td colspan="13" style="width:100%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="padding-left:0pt; "> </span> </p> </td> <td colspan="5" style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Three Months Ended June 30, </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="padding-left:0pt; "> </span> </p> </td> <td colspan="5" style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Six Months Ended June 30, </p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2021 </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2021 </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Sales </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_59" contextRef="From2021-04-01to2021-06-30" name="us-gaap:CostOfRevenue" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_60" contextRef="From2020-04-01to2020-06-30" name="us-gaap:CostOfRevenue" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_61" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CostOfRevenue" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_62" contextRef="From2020-01-01to2020-06-30" name="us-gaap:CostOfRevenue" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cost of Sales </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_63" contextRef="From2021-04-01to2021-06-30" name="us-gaap:Revenues" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_64" contextRef="From2020-04-01to2020-06-30" name="us-gaap:Revenues" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_65" contextRef="From2021-01-01to2021-06-30" name="us-gaap:Revenues" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_66" contextRef="From2020-01-01to2020-06-30" name="us-gaap:Revenues" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Gross Profit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_67" contextRef="From2021-04-01to2021-06-30" name="us-gaap:GrossProfit" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_68" contextRef="From2020-04-01to2020-06-30" name="us-gaap:GrossProfit" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_69" contextRef="From2021-01-01to2021-06-30" name="us-gaap:GrossProfit" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_70" contextRef="From2020-01-01to2020-06-30" name="us-gaap:GrossProfit" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Operating Expenses</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Board of Directors Compensation </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_71" contextRef="From2021-04-01to2021-06-30" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">105,750</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_72" contextRef="From2020-04-01to2020-06-30" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">105,173</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_73" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">211,500</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_74" contextRef="From2020-01-01to2020-06-30" name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,114,863</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">General and Administrative </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_75" contextRef="From2021-04-01to2021-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">16,565</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_76" contextRef="From2020-04-01to2020-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">21,537</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_77" contextRef="From2021-01-01to2021-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">55,894</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_78" contextRef="From2020-01-01to2020-06-30" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">53,205</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Total Expenses</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_79" contextRef="From2021-04-01to2021-06-30" name="us-gaap:OperatingExpenses" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">122,315</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_80" contextRef="From2020-04-01to2020-06-30" name="us-gaap:OperatingExpenses" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">126,710</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_81" contextRef="From2021-01-01to2021-06-30" name="us-gaap:OperatingExpenses" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">267,394</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_82" contextRef="From2020-01-01to2020-06-30" name="us-gaap:OperatingExpenses" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,168,068</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net Loss for the Period</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_83" contextRef="From2021-04-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">122,315</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_84" contextRef="From2020-04-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">126,710</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_85" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">267,394</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_86" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,168,068</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">Weighted Average Number of </span><span style="font-weight:bold; ">Common Shares - Basic and </span><span style="font-weight:bold; ">Diluted</span>​​ </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_87" contextRef="From2021-04-01to2021-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_88" contextRef="From2020-04-01to2020-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,271,755</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_89" contextRef="From2021-01-01to2021-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_90" contextRef="From2020-01-01to2020-06-30" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,271,402</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:32%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">Net Loss for the Period Per </span><span style="font-weight:bold; ">Common Shares - Basic and </span><span style="font-weight:bold; ">Diluted</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_91" contextRef="From2021-04-01to2021-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal" sign="-">0.00</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_92" contextRef="From2020-04-01to2020-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal" sign="-">0.00</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_93" contextRef="From2021-01-01to2021-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal" sign="-">0.01</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_94" contextRef="From2020-01-01to2020-06-30" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal" sign="-">10.36</ix:nonFraction>) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-5-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; " id="d1e1983_anchor"><span style="font-weight:bold; ">BioForce Nanosciences Holdings, Inc., and Subsidiary</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="90%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td colspan="7" style="width:100%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED</span> </p> </td> </tr> <tr class="even" style=""> <td colspan="7" style="width:100%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">For the Six Months Ended June 30, </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2021 </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="2" style="width:15%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">2020 </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash Flows from Operating Activities</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss for the Period </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_95" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">267,394</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_96" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,168,068</ix:nonFraction>) </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Non-Cash Adjustments:</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; ">Common and Preferred Stock Issued for Current Year Board of Directors Compensation​​ </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_97" contextRef="From2021-01-01to2021-06-30" name="bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_98" contextRef="From2020-01-01to2020-06-30" name="bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,000,000</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Changes in Assets and Liabilities:</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Prepaid Expenses </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_99" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">100</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_100" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">3,047</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accounts Payable and Accrued Expenses </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_101" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">4,058</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_102" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">10,248</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Accrued Board of Directors Compensation </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_103" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncreaseDecreaseInAccruedSalaries" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">211,500</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_104" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncreaseDecreaseInAccruedSalaries" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">114,863</ix:nonFraction> </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net Cash Flows Used In Operating Activities</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_105" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">60,052</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_106" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">60,406</ix:nonFraction>) </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash Flows from Investing Activities</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_107" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_108" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash Flows from Financing Activities</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Proceeds from Related Parties </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_109" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,492</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_110" contextRef="From2020-01-01to2020-06-30" name="us-gaap:ProceedsFromRelatedPartyDebt" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,376</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Net Cash Flows Provided by Financing Activities</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_111" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,492</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_112" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,376</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Change in Cash </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_113" contextRef="From2021-01-01to2021-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">12,560</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_114" contextRef="From2020-01-01to2020-06-30" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">13,030</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Cash - Beginning of Period </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_115" contextRef="AsOf2020-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_116" contextRef="AsOf2019-12-31" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">52,895</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash - End of Period</span> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_117" contextRef="AsOf2021-06-30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">27,305</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_118" contextRef="AsOf2020-06-30" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">39,865</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Cash Paid During the Period for:</span> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Interest </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_119" contextRef="From2021-01-01to2021-06-30" name="us-gaap:InterestPaidNet" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_120" contextRef="From2020-01-01to2020-06-30" name="us-gaap:InterestPaidNet" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Income Taxes </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_121" contextRef="From2021-01-01to2021-06-30" name="us-gaap:IncomeTaxesPaidNet" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_122" contextRef="From2020-01-01to2020-06-30" name="us-gaap:IncomeTaxesPaidNet" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">Supplemental Disclosures of Non Cash Investing and Financing Activities:</span>​​ </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="even" style=""> <td style="width:66%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Common Stock Issued to Pay Stock Payable </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_123" contextRef="From2021-01-01to2021-06-30" name="bfnh:CommonStockIssuedToPayAccountsPayableValue" unitRef="USD" xsi:nil="true"></ix:nonFraction>- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:13%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_124" contextRef="From2020-01-01to2020-06-30" name="bfnh:CommonStockIssuedToPayAccountsPayableValue" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,339</ix:nonFraction> </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-6-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; " id="d1e2817_anchor"><span style="font-weight:bold; ">BioForce Nanosciences Holdings, Inc., and Subsidiary</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td colspan="20" style="width:100%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT FOR THE THREE AND SIX MONTHS </span><span style="font-weight:bold; ">ENDED JUNE 30, 2021 AND 2020 - UNAUDITED</span> </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Common Stock </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Preferred Stock - A </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Additional </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Total </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Paid-In </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Accumulated </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Stockholders' </p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Capital </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Deficit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Equity </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - April 1, 2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_125" contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_126" contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">15,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_127" contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,000,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_128" contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">2,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_129" contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,793,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_130" contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,803,110</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_131" contextRef="AsOf2020-03-31" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">7,289</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss for the Period </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_132" contextRef="From2020-04-01to2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">126,710</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_133" contextRef="From2020-04-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">126,710</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - June 30, 2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_134" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_135" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">15,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_136" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,000,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_137" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">2,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_138" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,793,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_139" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,929,820</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_140" contextRef="AsOf2020-06-30" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">119,421</ix:nonFraction>) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Common Stock </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Preferred Stock - A </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Additional </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Total </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Paid-In </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Accumulated </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Stockholders' </p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Capital </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Deficit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Equity </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - April 1, 2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_141" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_142" contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_143" contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_144" contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,315,386</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_145" contextRef="AsOf2021-03-31" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">504,987</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss for the Period </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_146" contextRef="From2021-04-01to2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">122,315</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_147" contextRef="From2021-04-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">122,315</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - June 30, 2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_148" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_149" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_150" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_151" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,437,701</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_152" contextRef="AsOf2021-06-30" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">627,302</ix:nonFraction>) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Common Stock </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Preferred Stock - A </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Additional </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Total </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Paid-In </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Accumulated </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Stockholders' </p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Capital </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Deficit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Equity </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - January 1, 2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_153" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,270,588</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_154" contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">15,271</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_155" contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">793,789</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_156" contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">761,752</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_157" contextRef="AsOf2019-12-31" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,308</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; ">Common Stock Issued for Product Payment - Stock Payable </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_158" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="bfnh:CommonStockIssuedToPayAccountsPayableShares" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,167</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_159" contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember" name="bfnh:CommonStockIssuedToPayAccountsPayable" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_160" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="bfnh:CommonStockIssuedToPayAccountsPayable" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,338</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_161" contextRef="From2020-01-01to2020-06-30" name="bfnh:CommonStockIssuedToPayAccountsPayable" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,339</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; text-indent:-12pt !important; padding-left:12pt !important; margin-bottom:0pt; ">Preferred Shares Issued for Services </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_162" contextRef="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,000,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_163" contextRef="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">2,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_164" contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">157,998,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_165" contextRef="From2020-01-01to2020-06-30" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,000,000</ix:nonFraction> </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss for the Period </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_166" contextRef="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,168,068</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_167" contextRef="From2020-01-01to2020-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,168,068</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - June 30, 2020</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_168" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">15,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_169" contextRef="AsOf2020-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">15,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_170" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,000,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_171" contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">2,000</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_172" contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,793,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_173" contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">158,929,820</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_174" contextRef="AsOf2020-06-30" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">119,421</ix:nonFraction>) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> <div>
<table width="100%" cellpadding="0" style="border-spacing:0; border-bottom:0.7pt solid #000000; margin:auto; "> <tbody> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Common Stock </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Preferred Stock - A </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Additional </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Total </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:17%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td colspan="4" style="width:16%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">$ 0.001 Par </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Paid-In </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Accumulated </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Stockholders' </p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Shares </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Amount </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Capital </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Deficit </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; ">Equity </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - January 1, 2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_175" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_176" contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_177" contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_178" contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,170,307</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_179" contextRef="AsOf2020-12-31" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">359,908</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">Net Loss for the Period </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:1%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_180" contextRef="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">267,394</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; border-bottom:0.7pt solid #000000; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_181" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NetIncomeLoss" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">267,394</ix:nonFraction>) </p> </td> </tr> <tr class="even" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">  </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-bottom:0pt; "></p> </td> </tr> <tr class="odd" style=""> <td style="width:26%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Balance - June 30, 2021</span> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_182" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:6%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_183" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,272</ix:nonFraction> </p> </td> <td style="width:1%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:8%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:4%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">- </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:10%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; "><ix:nonFraction id="Fact_184" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">158,781,127</ix:nonFraction> </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:11%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_185" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">159,437,701</ix:nonFraction>) </p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </td> <td style="width:2%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:0pt; ">$ </p> </td> <td style="width:9%; vertical-align:bottom; ">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:right; margin-top:0pt; margin-bottom:0pt; ">(<ix:nonFraction id="Fact_186" contextRef="AsOf2021-06-30" name="us-gaap:StockholdersEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal" sign="-">627,302</ix:nonFraction>) </p> </td> </tr> </tbody> </table> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-7-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:36pt; margin-bottom:0pt; " id="d1e5294_anchor"><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC., AND SUBSIDIARY</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO THE CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</span><span style="font-weight:bold; "></span></p> <hr style="border-top:2.5pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/> <ix:nonNumeric id="Fact_189" contextRef="From2021-01-01to2021-06-30" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 1 – Organization & Description of Business</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company was incorporated in the State of Nevada on December 10, 1999 as Silver River Ventures, Inc. On February 24, 2006, the Company completed the acquisition of BioForce Nanosciences Holdings Inc. (“BioForce”), a Delaware corporation, and changed the corporate name at that time. On May 6, 2020, the Company purchased <ix:nonFraction id="Fact_187" contextRef="From2020-05-01to2020-05-06" name="bfnh:BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> shares of Element Acquisition Corporation for $<ix:nonFraction id="Fact_188" contextRef="From2020-05-01to2020-05-06" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,000</ix:nonFraction> which then became a wholly owned subsidiary. The Company on October 15, 2020 changed the name of its wholly-owned subsidiary Element Acquisition Corporation, a Wyoming corporation, to BioForce Nanosciences Holdings, Inc, a Wyoming corporation. The Company’s mission is to become a leading provider of vitamin, mineral and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_197" contextRef="From2021-01-01to2021-06-30" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies</span></p> <ix:nonNumeric id="Fact_190" contextRef="From2021-01-01to2021-06-30" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Basis of Presentation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The accompanying condensed consolidated balance sheet has been derived from the December 31, 2020 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2021 and 2020, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2021, are not necessarily indicative of the results of operations expected for the year ending December 31, 2021. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_191" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ConsolidationPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Principles of Consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Bioforce Nanosciences Holdings, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_192" contextRef="From2021-01-01to2021-06-30" name="us-gaap:UseOfEstimates" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_193" contextRef="From2021-01-01to2021-06-30" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Earnings (Loss) per Share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. </p></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-8-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; "><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC., AND SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO THE CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</span></p> <hr style="border-top:2.5pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies - continued</span></p> <ix:nonNumeric id="Fact_194" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Stock-Based Compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, <span style="font-style:italic; ">Compensation—Stock Compensation,</span> which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_195" contextRef="From2021-01-01to2021-06-30" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Fair Value of Financial Instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_196" contextRef="From2021-01-01to2021-06-30" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Revenue Recognition</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company implemented ASC 606, <span style="font-style:italic; ">Revenue from Contracts with Customers</span>. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. </p></ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric id="Fact_198" contextRef="From2021-01-01to2021-06-30" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 3 – Recently Issued Accounting Standards</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements, including the new lease standard. The Company does not have any leases and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_199" contextRef="From2021-01-01to2021-06-30" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 4 – Going Concern</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">While the Company is attempting to continue operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes that the actions presently being taken to further implement the Company’s business plan; to expand sales with a dynamic marketing campaign and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. During the three and six months ended June 30, 2021 due to lack of revenues the officers of the Company paid for all expenses through loans to the Company. This allowed the Company to continue as a going concern. </p></ix:nonNumeric>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "></p> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-9-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div><div style="page-break-after:always;"></div> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; "><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC., AND SUBSIDIARY</span><span style="font-weight:bold; "></span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO THE CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</span><span style="font-weight:bold; "></span></p> <hr style="border-top:2.5pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/> <ix:nonNumeric id="Fact_204" contextRef="From2021-01-01to2021-06-30" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5 – Related Party Transactions</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company’s Director, Secretary and Acting CFO, Richard Kaiser, is the operator of Yes International, a full-service investor relations firm. He handles duties of the Company regarding his officer capacities as the Secretary and Acting CFO, but also provides investor relations services through Yes International for the Company at no charge.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the six months ended June 30, 2021 and 2020, two board of directors paid expenses of the Company in the amount of $<ix:nonFraction id="Fact_200" contextRef="From2021-01-01to2021-06-30_custom_TwoBoardOfDirectorsMember" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">47,492</ix:nonFraction> and $<ix:nonFraction id="Fact_201" contextRef="From2020-01-01to2020-06-30_custom_TwoBoardOfDirectorsMember" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">13,772</ix:nonFraction>, respectively. Due to related parties was $<ix:nonFraction id="Fact_202" contextRef="AsOf2021-06-30_custom_TwoBoardOfDirectorsMember" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">114,658</ix:nonFraction> and $<ix:nonFraction id="Fact_203" contextRef="AsOf2020-12-31_custom_TwoBoardOfDirectorsMember" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">67,166</ix:nonFraction> at June 30, 2021 and December 31, 2020, respectively. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_228" contextRef="From2021-01-01to2021-06-30" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 6 – Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Preferred Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Preferred stock consists of 100,000,000 shares authorized at $<ix:nonFraction id="Fact_206" contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_205" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction> par value. <ix:nonFraction id="Fact_208" contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_207" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction> of these preferred shares have been separately allocated to Series A Preferred. Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock. At December 31, 2020 and 2019 there were -<ix:nonFraction id="Fact_212" contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_211" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_210" contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_209" contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" name="us-gaap:PreferredStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>- Series A Preferred shares issued and outstanding. On June 30, 2020, the Company issued <span style="-sec-ix-hidden:Fact_213">two</span> million shares of Series A preferred stock as compensation for their two board members. The preferred shares were valued at $<ix:nonFraction id="Fact_214" contextRef="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" decimals="-6" scale="6" format="ixt:numdotdecimal">158</ix:nonFraction> million based on the market price of the Company’s common stock of $<ix:nonFraction id="Fact_215" contextRef="AsOf2021-06-30" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal">0.79</ix:nonFraction> on the measurement date, given such preferred stock can be converted into 100 shares of common stock and has dividend and voting rights as though converted into common stock. On December 4, 2020, the two board of directors returned these <ix:nonFraction id="Fact_216" contextRef="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember" name="bfnh:NumberOfReturnedAndCancelledShares" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">2,000,000</ix:nonFraction> shares to be retired. In exchange the Company issued <ix:nonFraction id="Fact_217" contextRef="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">14,000,000</ix:nonFraction> common shares.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Common Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Common stock consists of <ix:nonFraction id="Fact_219" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_218" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">900,000,000</ix:nonFraction></ix:nonFraction> shares authorized at $<ix:nonFraction id="Fact_221" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_220" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction> par value. On November 25, 2019, the board of directors approved a 5 to 1 reverse split. At June 30, 2021 and December 31, 2020 there were <ix:nonFraction id="Fact_225" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_224" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesIssued" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_223" contextRef="AsOf2021-06-30" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction id="Fact_222" contextRef="AsOf2020-12-31" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">29,271,755</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued <ix:nonFraction id="Fact_226" contextRef="From2020-01-01to2020-12-31" name="us-gaap:ConversionOfStockSharesIssued1" unitRef="Shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,167</ix:nonFraction> shares of common stock in exchange for product payment that was recorded in stock payable in the amount of $<ix:nonFraction id="Fact_227" contextRef="From2020-01-01to2020-12-31" name="us-gaap:ProceedsFromOtherEquity" unitRef="USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,339</ix:nonFraction> at December 31, 2019. The fair value of the shares issued was based on the market price of the Company’s common stock on the measurement date. </p></ix:nonNumeric> <ix:nonNumeric id="Fact_229" contextRef="From2021-01-01to2021-06-30" name="us-gaap:ConcentrationRiskDisclosureTextBlock" escape="true">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 7 – Risks and Uncertainties</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Coronavirus Impact (COVID-19)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Due to the recent outbreak of the coronavirus reported in many countries worldwide, local and federal governments have issued travel advisories, canceled large scale public events and closed schools. In addition, companies have begun to cancel conferences and travel plans and require employees to work from home. Global financial markets have also experienced extreme volatility and disruptions to capital and credit markets.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We are unable to predict the impact of the coronavirus on our operations at this time. Adverse events such as health-related concerns about working in our offices, the inability to travel, potential impact on our business partners and customers, and other matters affecting the general work and business environment could harm our business and delay the implementation of our business strategy. The adverse events may also adversely impact our ability to raise capital or to continue as a going concern. We continue to monitor the recent outbreak of the coronavirus on our operations.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:24pt; margin-bottom:0pt; ">  </p></ix:nonNumeric> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-10-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "></p> </div> </div> </div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit10-1.htm
<DESCRIPTION>CONSULTING CONTRACT RSDL ENTERPRISES-APRIL 16, 2021
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY style="color: rgb(0, 0, 0); line-height: 12pt; font-family: Times New Roman; font-size: 10pt;">
<P style="margin: 0pt; line-height: 13pt; font-size: 11pt;"><FONT color="#000000"
face="Times New Roman"><B>Exhibit 10.1</B></FONT></P>
<P align="center"
style="margin: 0pt; line-height: 13pt; font-size: 11pt;"><B>CONSULTING
AGREEMENT</B></P>
<P style="margin: 0pt; line-height: 13pt; font-size: 11pt;">BioForce
NanoSciences Holdings, Inc.
desires to have services provided by Aldo Dalla-Vecchia.</P>
<P style="margin: 0pt;"> </P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;">Therefore, the parties agree as follows:
</P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>1.
DESCRIPTION OF SERVICES. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">Beginning on
April 16, 2021, Aldo Dalla-Vecchia will provide
the following services (collectively, the "Services"):
General Consulting for Management </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>2.
PERFORMANCE OF SERVICES. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">The manner in which the Services are to be performed and
the specific hours to be worked by Aldo Dalla-Vecchia shall be determined by Aldo Dalla-Vecchia.
BioForce NanoSciences Holdings, Inc. will rely on Aldo</P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Dalla-Vecchia to work as many hours as may be
reasonably necessary to fulfill Aldo Dalla-Vecchia's obligations
under</P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">this Agreement.
</P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>3.
PAYMENT. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">BioForce
NanoSciences Holdings, Inc.
will pay a fee to Aldo Dalla-Vecchia for the Services in the
amount of $2,250 per month for a total of
$4,500.00. This fee shall be payable in a lump-sum upon within
48 hours upon signing agreement. </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>4.
NEW PROJECT APPROVAL. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">Aldo Dalla-Vecchia and BioForce
NanoSciences Holdings, Inc. recognize that
Aldo Dalla-Vecchia's Services will include working on various projects for Bravo Multinational Inc.
Aldo Dalla-Vecchia shall obtain the approval of BioForce
NanoSciences Holdings, Inc. prior to the
commencement of a new project. </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>5.
TERM/TERMINATION. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">This Agreement shall terminate automatically on June
16, 2021 at 5:30PM ET. </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>6.
RELATIONSHIP OF PARTIES. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">It is understood by the parties that Aldo Dalla-Vecchia is an
independent contractor with respect to Bravo Multinational Inc, and not an employee of BioForce
NanoSciences Holdings, Inc. BioForce NanoSciences Holdings, Inc.
will not provide fringe benefits, including health
insurance benefits, paid vacation, or any other employee benefit, for the benefit of Aldo
Dalla-Vecchia. </P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>7.
INDEMNIFICATION. </B></P>
<P
style="margin: 0pt 0pt 7.35pt; line-height: 13.85pt; font-size: 11pt;">Aldo Dalla-Vecchia agrees to indemnify and hold harmless BioForce
NanoSciences Holdings, Inc.
from all claims, losses, expenses, fees including attorney fees, costs, and
Judgments that may be asserted against BioForce
NanoSciences Holdings, Inc.
that result from the acts or
omissions of Aldo Dalla-Vecchia, Aldo Dalla-Vecchia's employees, if any, and Aldo
Dalla-Vecchia's agents. </P>
<P align="justify" style="margin: 0pt;"> </P>
<P align="center" style="margin: 0pt;">-1-</P>
<P style="margin: 0pt; page-break-before: always;"></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>8.
RETURN OF RECORDS. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Upon termination of this Agreement, Aldo Dalla-Vecchia shall
deliver all records, notes, data, memoranda, models, and equipment of any nature that are in Aldo
Dalla-Vecchia's possession or under Aldo Dalla-Vecchia's control and that BioForce
NanoSciences Holdings, Inc.
's property or relate to BioForce NanoSciences
Holdings, Inc.’s business. </P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>9.
NOTICES. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">All notices required or permitted under this Agreement shall be in writing and shall
be deemed delivered when delivered in person or deposited in the United States mail, postage
prepaid, addressed as follows: </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>IF for Bravo Multinational Inc:
</B></P>
<P style="margin: 0pt; line-height: 13pt; font-size: 11pt;">BioForce
NanoSciences Holdings, Inc.</P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;">Richard Kaiser</P>
<P style="margin: 0pt; line-height: 13pt; font-size: 11pt;">Secretary </P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;">2020 General Booth Blvd Suite 230
Virginia Beach, Virginia 23454 </P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>IF for Aldo Dalla-Vecchia:</B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"> RSDL Enterprises,3700 Colchester Road
Lansing, Michigan 48906</P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"> Such address may be changed from time to time by either party by providing written notice to the
other in the manner set forth above. </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>10.
ENTIRE AGREEMENT. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">This Agreement contains the entire agreement of the parties and
there are no other promises or conditions in any other Agreement(s )whether oral or written. This
Agreement supersedes any prior written or oral agreements between the </P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">parties. </P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>11.
AMENDMENT. </B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;">This Agreement may be modified or amended if the amendment is made in
writing and is signed by both parties. </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>12.
SEVERABILITY. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">If any provision of this Agreement shall be held to be invalid or
unenforceable for any reason, the remaining
provisions shall continue to be valid and enforceable. If
a court finds that any provision of this
Agreement is invalid or unenforceable, but that by limiting
such provision it would become valid and
enforceable, then such provision shall be deemed to be
written, construed, and enforced as so limited.
</P>
<P align="justify" style="margin: 0pt;"> </P>
<P align="center" style="margin: 0pt;">-2-</P>
<P style="margin: 0pt; page-break-before: always;"></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>13.
WAIVER OF CONTRACTUAL RIGHT. </B></P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt; page-break-before: always;">The failure of either party to enforce any provision
of this Agreement shall not be construed as a waiver or limitation of that party's right to
subsequently enforce and compel strict compliance with every provision of this Agreement.
</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt; page-break-before: always;"> </P>
<P style="margin-top: 0pt; margin-bottom: 7.35pt;"><B>14. APPLICABLE
LAW.</B></P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"> This Agreement shall be governed by the laws of the State of Virginia.
</P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>15.
INTERRUPTION OF SERVICE. </B></P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Either party shall be excused from any delay or failure in
performance required hereunder if caused by reason of any occurrence or contingency beyond its
reasonable control, including, but not limited to, acts of God, </P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">acts of war, fire, insurrection, laws
proclamations, edits, ordinances or regulations, strikes, lock-outs or other serious labor disputes,
riots, earthquakes, floods, explosions or other acts of nature. The obligations and
rights of the party
so excused shall be extended on a day-to-day basis for the time period equal to the period of such
excusable interruption. When such events have abated, the parties' respective obligations hereunder
shall resume. In the event the interruption of the excused party's obligations continues for a period in
excess of thirty (30) days, either party shall have the right to terminate this Agreement upon ten (10)
days' prior written notice to the other party.
</P>
<P style="margin: 0pt;"> </P>
<P style="line-height: 13.85pt; font-size: 11pt; margin-top: 0pt; margin-bottom: 7.35pt;"><B>16.
ASSIGNMENT. </B></P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;">Aldo Dalla-Vecchia agrees that it will not assign, sell, transfer, delegate or
otherwise dispose of any rights or obligations under this Agreement without the prior written
consent of Bravo Multinational Inc. Any purported assignment,</P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;"> transfer, or delegation shall be null
and void. Nothing in this Agreement shall prevent the consolidation
of BioForce NanoSciences Holdings, Inc.
with, or its merger into, any other corporation, or the sale by
BioForce NanoSciences Holdings, Inc. of all or
substantially all of its properties or assets, or
the assignment by BioForce NanoSciences Holdings, Inc.
of this Ageement and the performance of
its obligations hereunder to
any successor in interest or any
Affiliated Company. Subject to the foregoing, this Agreement
shall be binding upon and shall inure
to the benefit of the parties and their respective heirs, legal representatives,successors, and
permitted assigns, and shall not benefit any person or </P>
<P
style="margin: 0pt; line-height: 13pt; font-size: 11pt;">entity other than those enumerated above.
</P>
<P style="margin: 0pt;"> </P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">This Agreement shall be signed on behalf of BioForce
NanoSciences Holdings, Inc.by
Richard Kasier, Secretary and on behalf of Aldo Dalla-Vecchia by Aldo Dalla-Vecchia, Principal
, RSDL RSDI Enterprises and effective as of </P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">the date first above written.
</P>
<P style="margin: 0pt;"> </P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;"><B>This Consulting Agreement is executed and agreed to by:</B></P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;"> </P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">/s/ Richard
Kaiser</P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">____________________________</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Richard
Kaiser</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">BioForce
NanoSciences Holdings, Inc.</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Date: April 16,
2021</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;"> </P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">/s/ Aldo
Dalla-Vecchia</P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">________________________</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">Aldo
Dalla-Vecchia</P>
<P
style="margin: 0pt; line-height: 13.85pt; font-size: 11pt;">RSDL Enterprises
</P>
<P style="margin: 0pt; line-height: 13.85pt; font-size: 11pt; page-break-before: always;">Date:
April 16, 2021</P>
<P align="center" style="margin: 0pt; line-height: 13.85pt; font-size: 11pt; page-break-before: always;">-3-</P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>exhibit31-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY style="color: rgb(0, 0, 0); line-height: 12pt; font-family: Times New Roman; font-size: 10pt;">
<P style="margin: 0pt 0pt 9.15pt;"><B>Exhibit 31.1</B></P>
<P align="center" style="margin: 0pt 0pt 9.15pt;"><FONT
face="Times New Roman"><B>CHIEF EXECUTIVE OFFICER</B></FONT></P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">I, Merle Ferguson, hereby
certify that:</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(1) I have reviewed this
quarterly report on Form 10-Q of Bioforce Nanosciences Holdings, Inc..;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(2) Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(3) Based on my knowledge,
the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(4) The registrant's other
certifying officers and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(a) Designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
report is being prepared;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(b) Designed such internal
control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(c) Evaluated the
effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(d) Disclosed in this report
any change in the registrant’s internal control over financial reporting that
occurred during the registrant’s most recent fiscal quarter (the registrant’s
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(5) The registrant's other
certifying officers and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the
equivalent functions):</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(a) All significant
deficiencies in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial information; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(b) Any fraud, whether or not
material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.</P>
<TABLE style="font-size: 10pt;" cellspacing="0">
<TR>
<TD width="139"></TD>
<TD width="139"></TD></TR>
<TR>
<TD width="186"> </TD>
<TD width="186"> </TD></TR>
<TR>
<TD width="186" valign="top">
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">Dated:July 29,
2021</P></TD>
<TD width="186" valign="top">
<P style="margin: 0pt;"><I><U>/s/Merle Ferguson</U></I></P>
<P style="margin: 0pt;">Merle Ferguson</P>
<P style="margin: 0pt;">Chief Executive Officer</P></TD></TR></TABLE>
<P align="justify" style="margin: 0pt;"> </P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>exhibit31-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY style="color: rgb(0, 0, 0); line-height: 12pt; font-family: Times New Roman; font-size: 10pt;">
<P style="margin: 0pt 0pt 9.15pt;"><B>Exhibit 31.2</B></P>
<P align="center" style="margin: 0pt 0pt 9.15pt;"><FONT
face="Times New Roman"><B>CHIEF FINANCIAL OFFICER</B></FONT></P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">I, Richard Kaiser, hereby
certify that:</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(1) I have reviewed this
quarterly report on Form 10-Q of BioForce Nanosciences Holdings, Inc..;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(2) Based on my knowledge,
this report does not contain any untrue statement of a material fact or omit to
state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(3) Based on my knowledge,
the financial statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(4) The registrant's other
certifying officers and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(a) Designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to
the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
report is being prepared;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(b) Designed such internal
control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles;</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(c) Evaluated the
effectiveness of the registrant's disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(d) Disclosed in this report
any change in the registrant’s internal control over financial reporting that
occurred during the registrant’s most recent fiscal quarter (the registrant’s
fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(5) The registrant's other
certifying officers and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the
equivalent functions):</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(a) All significant
deficiencies in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial information; and</P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">(b) Any fraud, whether or not
material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.</P>
<TABLE style="font-size: 10pt;" cellspacing="0">
<TR>
<TD width="135"></TD>
<TD width="166"></TD></TR>
<TR>
<TD width="180"> </TD>
<TD width="222"> </TD></TR>
<TR>
<TD width="180">
<P style="margin: 0pt; font-size: 8pt;"> </P></TD>
<TD width="222">
<P style="margin: 0pt; font-size: 8pt;"> </P></TD></TR>
<TR>
<TD width="180" valign="top">
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">Dated: July 29,
2021</P></TD>
<TD width="222" valign="top">
<P style="margin: 0pt;"><I><U>/s/Richard Kaiser</U></I></P>
<P style="margin: 0pt;">Richard Kaiser</P>
<P style="margin: 0pt;">Acting Chief Financial
Officer</P></TD></TR></TABLE>
<P align="justify" style="margin: 0pt;"> </P>
<P align="center" style="margin: 0pt;"><BR></P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>exhibit32-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY style="color: rgb(0, 0, 0); line-height: 12pt; font-family: Times New Roman; font-size: 10pt;">
<P style="margin: 0pt; page-break-before: always;"></P>
<P style="margin: 0pt 0pt 9.15pt;"><B>Exhibit 32.1</B></P>
<P align="center" style="margin: 0pt; line-height: 13pt; font-size: 11pt;"><FONT
face="Times New Roman"><B>CERTIFICATION PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002</B></FONT></P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">Pursuant to section 906 of the Sarbanes-Oxley Act of
2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), the undersigned officers of Bioforce Nanosciences Holdings,
Inc., a Nevada corporation (the "Company"), do hereby certify, to the best of
their knowledge, that:</P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">1. The Quarterly Report on Form
10-Q for the period ending June 30, 2021 (the "Report") of the Company complies
in all material respects with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and</P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">2. The information contained in
the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company. </P>
<P style="margin-top: 0pt; margin-bottom: 3.05pt;"> </P>
<TABLE style="font-size: 10pt;" cellspacing="0">
<TR>
<TD width="135"></TD>
<TD width="144"></TD></TR>
<TR>
<TD width="180" valign="top">
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">Dated: August__ ,
2021</P></TD>
<TD width="192" valign="top">
<P style="margin: 0pt;"><I><U>/s/Merle Ferguson</U></I></P>
<P style="margin: 0pt;">Merle Ferguson</P>
<P style="margin: 0pt;">Chief Executive
Officer</P></TD></TR></TABLE>
<P style="margin: 0pt;"> </P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>exhibit32-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY style="color: rgb(0, 0, 0); line-height: 12pt; font-family: Times New Roman; font-size: 10pt;">
<P style="margin: 0pt; page-break-before: always;"></P>
<P style="margin: 0pt;"><B>Exhibit 32.2</B></P>
<P align="center"
style="margin: 0pt; line-height: 13pt; font-size: 11pt;"><B>CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">Pursuant to section 906 of the Sarbanes-Oxley Act of
2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), the undersigned officers of Bioforce Nanosciences Holdings, Inc.,
a Nevada corporation (the "Company"), do hereby certify, to the best of their
knowledge, that:</P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">1. The Quarterly Report on Form
10-Q for the period ending June 30, 2021 (the "Report") of the Company complies
in all material respects with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and</P>
<P style="margin: 0pt;"> </P>
<P style="margin: 0pt;">2. The information contained in
the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company. </P>
<P style="margin: 0pt;"> </P>
<TABLE style="font-size: 10pt;" cellspacing="0">
<TR>
<TD width="135"></TD>
<TD width="166"></TD></TR>
<TR>
<TD width="180" valign="top">
<P style="margin-top: 0pt; margin-bottom: 3.05pt;">Dated:July 29, 2021
</P></TD>
<TD width="222" valign="top">
<P style="margin: 0pt;"><I><U>/s/Richard Kaiser</U></I></P>
<P style="margin: 0pt;">Richard Kaiser</P>
<P style="margin: 0pt;">Acting Chief Financial
Officer</P></TD></TR></TABLE>
<P align="center" style="margin: 0pt;"> </P></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>bfnh-20210630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<schema attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" targetNamespace="http://bioforcenano.com/20210630" xmlns:bfnh="http://bioforcenano.com/20210630">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="bfnh-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bfnh-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bfnh-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:linkbaseRef xlink:type="simple" xlink:href="bfnh-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
<link:roleType roleURI="http://bioforcenano.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
<link:definition>00010 - Document - Document and Entity Information</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited" id="CondensedConsolidatedBalanceSheets-Unaudited">
<link:definition>00020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical" id="CondensedConsolidatedBalanceSheets-UnauditedParenthetical">
<link:definition>00030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited" id="CondensedConsolidatedStatementsOfOperations-Unaudited">
<link:definition>00040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited" id="CondensedConsolidatedStatementsOfCashFlows-Unaudited">
<link:definition>00050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited" id="CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited">
<link:definition>00060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/OrganizationDescriptionOfBusiness" id="OrganizationDescriptionOfBusiness">
<link:definition>00070 - Disclosure - Organization & Description of Business</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>00080 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/RecentlyIssuedAccountingStandards" id="RecentlyIssuedAccountingStandards">
<link:definition>00090 - Disclosure - Recently Issued Accounting Standards</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/GoingConcern" id="GoingConcern">
<link:definition>00100 - Disclosure - Going Concern</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>00110 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/Stock" id="Stock">
<link:definition>00120 - Disclosure - Stock</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/RisksAndUncertainties" id="RisksAndUncertainties">
<link:definition>00130 - Disclosure - Risks and Uncertainties</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>00140 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>00150 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails" id="OrganizationDescriptionOfBusinessDetails">
<link:definition>00160 - Disclosure - Organization & Description of Business (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
<link:definition>00170 - Disclosure - Related Party Transactions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://bioforcenano.com/role/StockDetails" id="StockDetails">
<link:definition>00180 - Disclosure - Stock (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
</link:roleType>
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
<import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd"/>
<import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd"/>
<import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
<import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd"/>
<element name="DocumentAndEntityInformationAbstract" id="bfnh_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<element name="StockPayableCurrent" id="bfnh_StockPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="instant" xbrli:balance="credit"/>
<element name="CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" id="bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
<element name="CommonStockIssuedToPayAccountsPayableValue" id="bfnh_CommonStockIssuedToPayAccountsPayableValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
<element name="CapitalContributionDirectors" id="bfnh_CapitalContributionDirectors" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="credit"/>
<element name="CommonStockIssuedToPayAccountsPayable" id="bfnh_CommonStockIssuedToPayAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
<element name="CommonStockIssuedToPayAccountsPayableShares" id="bfnh_CommonStockIssuedToPayAccountsPayableShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<element name="GoingConcernAbstract" id="bfnh_GoingConcernAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
<element name="BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" id="bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<element name="TwoBoardOfDirectorsMember" id="bfnh_TwoBoardOfDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
<element name="GainLossOnLiabilitySettlement" id="bfnh_GainLossOnLiabilitySettlement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration" xbrli:balance="debit"/>
<element name="NumberOfReturnedAndCancelledShares" id="bfnh_NumberOfReturnedAndCancelledShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>bfnh-20210630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedBalanceSheets-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfOperations-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfCashFlows-Unaudited"/>
<calculationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Assets" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="locator_us-gaap_PrepaidExpenseCurrent" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_Liabilities" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_Liabilities" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="3" weight="1"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_StockPayableCurrent" xlink:label="locator_bfnh_StockPayableCurrent"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="locator_bfnh_StockPayableCurrent" use="optional" priority="0" order="4" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="3" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="locator_us-gaap_PreferredStockValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_PreferredStockValue" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" priority="0" order="3" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="4" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="locator_us-gaap_GrossProfit"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_us-gaap_GrossProfit" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="locator_us-gaap_Revenues"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GrossProfit" xlink:to="locator_us-gaap_Revenues" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="locator_us-gaap_CostOfRevenue"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_GrossProfit" xlink:to="locator_us-gaap_CostOfRevenue" use="optional" priority="0" order="2" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="2" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="2" weight="1"/>
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" priority="0" order="3" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" priority="0" order="4" weight="-1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="5" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="6" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedSalaries"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedSalaries" use="optional" priority="0" order="7" weight="1"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xlink:label="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" use="optional" priority="0" order="8" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="2" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="3" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="locator_us-gaap_ProceedsFromRelatedPartyDebt"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromRelatedPartyDebt" use="optional" priority="0" order="1" weight="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="locator_us-gaap_ProceedsFromContributedCapital"/>
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="locator_us-gaap_ProceedsFromContributedCapital" use="optional" priority="0" order="2" weight="1"/>
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>bfnh-20210630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedBalanceSheets-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedBalanceSheets-UnauditedParenthetical"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="bfnh-20210630.xsd#RelatedPartyTransactionsDetails"/>
<roleRef roleURI="http://bioforcenano.com/role/StockDetails" xlink:type="simple" xlink:href="bfnh-20210630.xsd#StockDetails"/>
<definitionLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AssetsAbstract" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrentAbstract" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseCurrent" use="optional" priority="0" order="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="4"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_Assets" use="optional" priority="0" order="5"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="0" order="6"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="0" order="7"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" use="optional" priority="0" order="8"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent" use="optional" priority="0" order="9"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_StockPayableCurrent" xlink:label="locator_bfnh_StockPayableCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_bfnh_StockPayableCurrent" use="optional" priority="0" order="11"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="12"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_Liabilities" use="optional" priority="0" order="13"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="21"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="14"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" use="optional" priority="0" order="15"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="locator_us-gaap_PreferredStockValue"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_PreferredStockValue" use="optional" priority="0" order="16"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="17"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" priority="0" order="18"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="19"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="0" order="21"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain_cf4863df-9d30-eef8-7b72-f12bc1754945_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain_cf4863df-9d30-eef8-7b72-f12bc1754945_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="21"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain_309c8e20-d9e2-8e10-c17c-f298d3ebcde9_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain_309c8e20-d9e2-8e10-c17c-f298d3ebcde9_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CapitalContributionDirectors" xlink:label="locator_bfnh_CapitalContributionDirectors"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CapitalContributionDirectors" use="optional" priority="0" order="3"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayable" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CommonStockIssuedToPayAccountsPayable" use="optional" priority="0" order="4"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayableShares" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares" use="optional" priority="0" order="5"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" use="optional" priority="0" order="6"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" use="optional" priority="0" order="7"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="8"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="locator_us-gaap_PreferredStockMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_PreferredStockMember" use="optional" priority="0" order="11"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="21"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_EquityComponentDomain" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="31"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain_aa9fe2ba-74e9-c87a-666d-5ba9c2b6b005_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain_aa9fe2ba-74e9-c87a-666d-5ba9c2b6b005_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_TwoBoardOfDirectorsMember" xlink:label="locator_bfnh_TwoBoardOfDirectorsMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_bfnh_TwoBoardOfDirectorsMember" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain_a2b3bd44-ad53-4921-68b8-2c2c32e12cfb_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain_a2b3bd44-ad53-4921-68b8-2c2c32e12cfb_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/StockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="locator_us-gaap_ClassOfStockLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="locator_us-gaap_PreferredStockSharesAuthorized"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesAuthorized" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesIssued" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="locator_us-gaap_PreferredStockSharesOutstanding"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesOutstanding" use="optional" priority="0" order="3"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="4"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="5"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="6"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="7"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="locator_us-gaap_ConversionOfStockSharesIssued1"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_ConversionOfStockSharesIssued1" use="optional" priority="0" order="8"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromOtherEquity" use="optional" priority="0" order="9"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="locator_us-gaap_ScheduleOfStockByClassTable"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_ScheduleOfStockByClassTable" use="optional" priority="0" order="10" xbrldt:contextElement="segment" xbrldt:closed="true"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="31"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_TwoBoardOfDirectorsMember" xlink:label="locator_bfnh_TwoBoardOfDirectorsMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_bfnh_TwoBoardOfDirectorsMember" use="optional" priority="0" order="51"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_GainLossOnLiabilitySettlement" xlink:label="locator_bfnh_GainLossOnLiabilitySettlement"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_bfnh_GainLossOnLiabilitySettlement" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" use="optional" priority="0" order="11"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" use="optional" priority="0" order="12"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_SharesIssuedPricePerShare" use="optional" priority="0" order="13"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_NumberOfReturnedAndCancelledShares" xlink:label="locator_bfnh_NumberOfReturnedAndCancelledShares"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_bfnh_NumberOfReturnedAndCancelledShares" use="optional" priority="0" order="14"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="15"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain_8a05e204-277c-cf05-f183-f3a98668f9f8_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain_8a05e204-277c-cf05-f183-f3a98668f9f8_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain_e4bcb519-3181-c838-fde0-b6a671cf197b_default"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain_e4bcb519-3181-c838-fde0-b6a671cf197b_default" use="optional" priority="0" order="30" xbrldt:contextElement="segment"/>
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>bfnh-20210630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"/>
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_DocumentAndEntityInformationAbstract" xlink:label="locator_bfnh_DocumentAndEntityInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_DocumentAndEntityInformationAbstract" xml:lang="en-US">Document And Entity Information</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="label_bfnh_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCentralIndexKey" xlink:to="label_dei_EntityCentralIndexKey"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_CurrentFiscalYearEndDate" xlink:to="label_dei_CurrentFiscalYearEndDate"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalYearFocus" xlink:to="label_dei_DocumentFiscalYearFocus"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentFiscalPeriodFocus" xlink:to="label_dei_DocumentFiscalPeriodFocus"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_AmendmentFlag" xlink:to="label_dei_AmendmentFlag"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentType" xlink:to="label_dei_DocumentType"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="locator_dei_DocumentQuarterlyReport"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentQuarterlyReport" xml:lang="en-US">Document Quarterly Report</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentQuarterlyReport" xlink:to="label_dei_DocumentQuarterlyReport"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="locator_dei_DocumentTransitionReport"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentTransitionReport" xml:lang="en-US">Document Transition Report</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentTransitionReport" xlink:to="label_dei_DocumentTransitionReport"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_DocumentPeriodEndDate" xlink:to="label_dei_DocumentPeriodEndDate"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityFileNumber" xml:lang="en-US">Entity File Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityFileNumber" xlink:to="label_dei_EntityFileNumber"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityRegistrantName" xlink:to="label_dei_EntityRegistrantName"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation State or Country Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityIncorporationStateCountryCode" xlink:to="label_dei_EntityIncorporationStateCountryCode"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="locator_dei_EntityTaxIdentificationNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityTaxIdentificationNumber" xlink:to="label_dei_EntityTaxIdentificationNumber"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine1" xlink:to="label_dei_EntityAddressAddressLine1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressAddressLine2" xml:lang="en-US">Entity Address, Address Line Two</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressAddressLine2" xlink:to="label_dei_EntityAddressAddressLine2"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressCityOrTown" xlink:to="label_dei_EntityAddressCityOrTown"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="locator_dei_EntityAddressStateOrProvince"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressStateOrProvince" xlink:to="label_dei_EntityAddressStateOrProvince"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityAddressPostalZipCode" xlink:to="label_dei_EntityAddressPostalZipCode"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="locator_dei_CityAreaCode"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_CityAreaCode" xlink:to="label_dei_CityAreaCode"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="locator_dei_LocalPhoneNumber"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_LocalPhoneNumber" xlink:to="label_dei_LocalPhoneNumber"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="locator_dei_Security12bTitle"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_Security12bTitle" xml:lang="en-US">Title of 12(b) Security</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_Security12bTitle" xlink:to="label_dei_Security12bTitle"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="locator_dei_TradingSymbol"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_TradingSymbol" xlink:to="label_dei_TradingSymbol"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="locator_dei_SecurityExchangeName"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_SecurityExchangeName" xml:lang="en-US">Name of Exchange on which Security is Registered</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_SecurityExchangeName" xlink:to="label_dei_SecurityExchangeName"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="locator_dei_EntityCurrentReportingStatus"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCurrentReportingStatus" xml:lang="en-US">Entity Current Reporting Status</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCurrentReportingStatus" xlink:to="label_dei_EntityCurrentReportingStatus"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="locator_dei_EntityInteractiveDataCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityInteractiveDataCurrent" xml:lang="en-US">Entity Interactive Data Current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityInteractiveDataCurrent" xlink:to="label_dei_EntityInteractiveDataCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="locator_dei_EntityFilerCategory"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityFilerCategory" xlink:to="label_dei_EntityFilerCategory"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="locator_dei_EntitySmallBusiness"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntitySmallBusiness" xlink:to="label_dei_EntitySmallBusiness"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="locator_dei_EntityEmergingGrowthCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityEmergingGrowthCompany" xlink:to="label_dei_EntityEmergingGrowthCompany"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="locator_dei_EntityShellCompany"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityShellCompany" xml:lang="en-US">Entity Shell Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityShellCompany" xlink:to="label_dei_EntityShellCompany"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="locator_dei_EntityCommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_dei_EntityCommonStockSharesOutstanding" xlink:to="label_dei_EntityCommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementTable" xlink:to="label_us-gaap_StatementTable"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="label_us-gaap_StatementClassOfStockAxis"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SeriesAPreferredStockMember" xml:lang="en-US">Series A Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SeriesAPreferredStockMember" xlink:to="label_us-gaap_SeriesAPreferredStockMember"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="label_us-gaap_StatementLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsAbstract" xml:lang="en-US">ASSETS</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="label_us-gaap_AssetsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="label_us-gaap_AssetsCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash - Beginning of Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash - End of Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PrepaidExpenseCurrent" xlink:to="label_us-gaap_PrepaidExpenseCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Total Current Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AssetsCurrent" xlink:to="label_us-gaap_AssetsCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Assets" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Assets" xlink:to="label_us-gaap_Assets"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Current Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="label_us-gaap_LiabilitiesCurrentAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xml:lang="en-US">Accounts Payable and Accrued Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="label_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccruedSalariesCurrentAndNoncurrent" xml:lang="en-US">Accrued Board of Directors Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:to="label_us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Due to Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Due to related parties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_DueToRelatedPartiesCurrent" xlink:to="label_us-gaap_DueToRelatedPartiesCurrent"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_StockPayableCurrent" xlink:label="locator_bfnh_StockPayableCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_StockPayableCurrent" xml:lang="en-US">Stock Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_StockPayableCurrent" xml:lang="en-US">Stock Payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_StockPayableCurrent" xlink:to="label_bfnh_StockPayableCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total Current Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesCurrent" xlink:to="label_us-gaap_LiabilitiesCurrent"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_Liabilities" xml:lang="en-US">Total Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Liabilities" xlink:to="label_us-gaap_Liabilities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies (Note 8)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommitmentsAndContingencies" xlink:to="label_us-gaap_CommitmentsAndContingencies"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US">Stockholders' Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="label_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="locator_us-gaap_PreferredStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock - $0.001 Par; 90,000,000 Shares Authorized, -0- Issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockValue" xlink:to="label_us-gaap_PreferredStockValue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock - $0.001 Par; 900,000,000 Shares Authorized, 29,271,755 Issued and Outstanding, Respectively</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockValue" xlink:to="label_us-gaap_CommonStockValue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapitalCommonStock" xml:lang="en-US">Additional Paid-In-Capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="label_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="label_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Total Stockholders' Deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Beginning balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Ending balance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquity" xlink:to="label_us-gaap_StockholdersEquity"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total Liabilities and Stockholders' Deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="label_us-gaap_LiabilitiesAndStockholdersEquity"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, par value (in Dollars per Share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="label_us-gaap_CommonStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, shares authorized (in Shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesAuthorized" xlink:to="label_us-gaap_CommonStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, shares issued (in Shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesIssued" xlink:to="label_us-gaap_CommonStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, shares outstanding (in Shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Beginning balance, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="label_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Ending balance, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockSharesOutstanding" xlink:to="label_us-gaap_CommonStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="label_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="locator_us-gaap_Revenues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_Revenues" xml:lang="en-US">Sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_Revenues" xlink:to="label_us-gaap_Revenues"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="locator_us-gaap_CostOfRevenue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CostOfRevenue" xml:lang="en-US">Cost of Sales</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CostOfRevenue" xlink:to="label_us-gaap_CostOfRevenue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="locator_us-gaap_GrossProfit"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GrossProfit" xml:lang="en-US">Gross Profit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GrossProfit" xlink:to="label_us-gaap_GrossProfit"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpensesAbstract" xml:lang="en-US">Operating Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpensesAbstract" xlink:to="label_us-gaap_OperatingExpensesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xml:lang="en-US">Board of Directors Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:to="label_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_GeneralAndAdministrativeExpense" xlink:to="label_us-gaap_GeneralAndAdministrativeExpense"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Total Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OperatingExpenses" xml:lang="en-US">Operating Expenses [Default Label]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OperatingExpenses" xlink:to="label_us-gaap_OperatingExpenses"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Loss for the Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Loss for the Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetIncomeLoss" xlink:to="label_us-gaap_NetIncomeLoss"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number of Common Shares - Basic and Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="label_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net Loss for the Period Per Common Shares - Basic and Diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="label_us-gaap_EarningsPerShareBasicAndDiluted"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="label_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash Flows from Operating Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Non-Cash Adjustments:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xml:lang="en-US">Common Stock Issued for Product Payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="label_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensation" xml:lang="en-US">Preferred Stock Issued for Current Year Board of Directors Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensation" xlink:to="label_us-gaap_ShareBasedCompensation"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xlink:label="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xml:lang="en-US">Common and Preferred Stock Issued for Current Year Board of Directors Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xml:lang="en-US">Common and Preferred Stock Issued for Current Year Board of Directors Compensation.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xlink:to="label_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Changes in Assets and Liabilities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Accounts Receivable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="label_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Accounts Payable and Accrued Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="label_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedSalaries"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_IncreaseDecreaseInAccruedSalaries" xml:lang="en-US">Accrued Board of Directors Compensation</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncreaseDecreaseInAccruedSalaries" xml:lang="en-US">Increase (Decrease) in Accrued Salaries</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="label_us-gaap_IncreaseDecreaseInAccruedSalaries"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Flows Used In Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Cash Flows from Investing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash Flows from Financing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="locator_us-gaap_ProceedsFromRelatedPartyDebt"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US">Proceeds from Related Parties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="label_us-gaap_ProceedsFromRelatedPartyDebt"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="locator_us-gaap_ProceedsFromContributedCapital"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromContributedCapital" xml:lang="en-US">Capital Contributions from Directors</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromContributedCapital" xlink:to="label_us-gaap_ProceedsFromContributedCapital"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Flows Provided by Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="label_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xml:lang="en-US">Net Change in Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="label_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="locator_us-gaap_SupplementalCashFlowInformationAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SupplementalCashFlowInformationAbstract" xml:lang="en-US">Cash Paid During the Period for:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="label_us-gaap_SupplementalCashFlowInformationAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="locator_us-gaap_InterestPaidNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_InterestPaidNet" xml:lang="en-US">Interest</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_InterestPaidNet" xlink:to="label_us-gaap_InterestPaidNet"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="locator_us-gaap_IncomeTaxesPaidNet"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_IncomeTaxesPaidNet" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_IncomeTaxesPaidNet" xlink:to="label_us-gaap_IncomeTaxesPaidNet"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Supplemental Disclosures of Non Cash Investing and Financing Activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="label_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayableValue" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayableValue"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayableValue" xml:lang="en-US">Common Stock Issued to Pay Stock Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayableValue" xml:lang="en-US">Common Stock Issued to Pay Accounts Payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_CommonStockIssuedToPayAccountsPayableValue" xlink:to="label_bfnh_CommonStockIssuedToPayAccountsPayableValue"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="label_us-gaap_StatementEquityComponentsAxis"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CommonStockMember" xlink:to="label_us-gaap_CommonStockMember"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="locator_us-gaap_PreferredStockMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockMember" xml:lang="en-US">Preferred Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockMember" xlink:to="label_us-gaap_PreferredStockMember"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-In Capital [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdditionalPaidInCapitalMember" xlink:to="label_us-gaap_AdditionalPaidInCapitalMember"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RetainedEarningsMember" xlink:to="label_us-gaap_RetainedEarningsMember"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CapitalContributionDirectors" xlink:label="locator_bfnh_CapitalContributionDirectors"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_CapitalContributionDirectors" xml:lang="en-US">Capital Contributions - Directors</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_CapitalContributionDirectors" xml:lang="en-US">Capital Contribution - Directors.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_CapitalContributionDirectors" xlink:to="label_bfnh_CapitalContributionDirectors"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayable" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayable" xml:lang="en-US">Common Stock Issued for Product Payment - Stock Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayable" xml:lang="en-US">Common stock issued to pay accounts payable.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_CommonStockIssuedToPayAccountsPayable" xlink:to="label_bfnh_CommonStockIssuedToPayAccountsPayable"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayableShares" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayableShares" xml:lang="en-US">Common Stock Issued for Product Payment - Stock Payable, shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_CommonStockIssuedToPayAccountsPayableShares" xml:lang="en-US">Common Stock Issued in Exchange for Product Payment, shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares" xlink:to="label_bfnh_CommonStockIssuedToPayAccountsPayableShares"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xml:lang="en-US">Preferred Shares Issued for Services</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xml:lang="en-US">Preferred Shares Issued for Services, shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="label_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="locator_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xml:lang="en-US">Organization & Description of Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="label_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="label_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SignificantAccountingPoliciesTextBlock" xml:lang="en-US">Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="label_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="locator_us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="label_us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="locator_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xml:lang="en-US">Recently Issued Accounting Standards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="label_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_GoingConcernAbstract" xlink:label="locator_bfnh_GoingConcernAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_GoingConcernAbstract" xml:lang="en-US">Going Concern [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_GoingConcernAbstract" xlink:to="label_bfnh_GoingConcernAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="locator_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xml:lang="en-US">Going Concern</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="label_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="label_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="label_us-gaap_StockholdersEquityNoteAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="locator_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stock</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="locator_us-gaap_RisksAndUncertaintiesAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RisksAndUncertaintiesAbstract" xml:lang="en-US">Risks and Uncertainties [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="label_us-gaap_RisksAndUncertaintiesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="locator_us-gaap_ConcentrationRiskDisclosureTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConcentrationRiskDisclosureTextBlock" xml:lang="en-US">Risks and Uncertainties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="label_us-gaap_ConcentrationRiskDisclosureTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="locator_us-gaap_SubsequentEventsAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SubsequentEventsAbstract" xlink:to="label_us-gaap_SubsequentEventsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="locator_us-gaap_SubsequentEventsTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SubsequentEventsTextBlock" xlink:to="label_us-gaap_SubsequentEventsTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="label_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="locator_us-gaap_ConsolidationPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principles of Consolidation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConsolidationPolicyTextBlock" xlink:to="label_us-gaap_ConsolidationPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="locator_us-gaap_UseOfEstimates"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_UseOfEstimates" xlink:to="label_us-gaap_UseOfEstimates"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="label_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings (Loss) per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="label_us-gaap_EarningsPerSharePolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xml:lang="en-US">Stock-Based Compensation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="label_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="locator_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="label_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="locator_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xml:lang="en-US">Revenue Recognition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="label_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="locator_us-gaap_BusinessCombinationDescriptionAbstract"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_BusinessCombinationDescriptionAbstract" xml:lang="en-US">Business Combination, Description [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_BusinessCombinationDescriptionAbstract" xlink:to="label_us-gaap_BusinessCombinationDescriptionAbstract"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" xlink:label="locator_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" xml:lang="en-US">Number of shares purchased</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" xml:lang="en-US">Number of shares purchased.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" xlink:to="label_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="locator_us-gaap_PaymentsToAcquireBusinessesGross"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PaymentsToAcquireBusinessesGross" xml:lang="en-US">Payment to acquire subsidiary</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="label_us-gaap_PaymentsToAcquireBusinessesGross"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="label_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party Transactions By Related Party [Axis]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="label_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_TwoBoardOfDirectorsMember" xlink:label="locator_bfnh_TwoBoardOfDirectorsMember"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_TwoBoardOfDirectorsMember" xml:lang="en-US">Two board of directors [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_TwoBoardOfDirectorsMember" xml:lang="en-US">Two board of directors [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_TwoBoardOfDirectorsMember" xlink:to="label_bfnh_TwoBoardOfDirectorsMember"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="label_us-gaap_RelatedPartyTransactionLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="label_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xml:lang="en-US">Additional paid in capital contributed</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="label_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="locator_us-gaap_ScheduleOfStockByClassTable"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="label_us-gaap_ScheduleOfStockByClassTable"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="locator_us-gaap_ClassOfStockLineItems"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="label_us-gaap_ClassOfStockLineItems"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, par value</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="label_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="locator_us-gaap_PreferredStockSharesAuthorized"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, shares authorized (in Shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockSharesAuthorized" xlink:to="label_us-gaap_PreferredStockSharesAuthorized"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, issued (in Shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockSharesIssued" xlink:to="label_us-gaap_PreferredStockSharesIssued"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="locator_us-gaap_PreferredStockSharesOutstanding"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, outstanding (in Shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_PreferredStockSharesOutstanding" xlink:to="label_us-gaap_PreferredStockSharesOutstanding"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="locator_us-gaap_ConversionOfStockSharesIssued1"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ConversionOfStockSharesIssued1" xml:lang="en-US">Shares issued in exchange for product payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ConversionOfStockSharesIssued1" xlink:to="label_us-gaap_ConversionOfStockSharesIssued1"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_ProceedsFromOtherEquity" xml:lang="en-US">Proceeds from exchange for product payment</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_ProceedsFromOtherEquity" xlink:to="label_us-gaap_ProceedsFromOtherEquity"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_GainLossOnLiabilitySettlement" xlink:label="locator_bfnh_GainLossOnLiabilitySettlement"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_GainLossOnLiabilitySettlement" xml:lang="en-US">Loss on Liability Settlement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_GainLossOnLiabilitySettlement" xml:lang="en-US">Loss on liability settlement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_GainLossOnLiabilitySettlement" xlink:to="label_bfnh_GainLossOnLiabilitySettlement"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Common stock per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_SharesIssuedPricePerShare" xlink:to="label_us-gaap_SharesIssuedPricePerShare"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_NumberOfReturnedAndCancelledShares" xlink:label="locator_bfnh_NumberOfReturnedAndCancelledShares"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_bfnh_NumberOfReturnedAndCancelledShares" xml:lang="en-US">Number of returned and cancelled shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="label_bfnh_NumberOfReturnedAndCancelledShares" xml:lang="en-US">Number Of Returned And Cancelled Shares.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_bfnh_NumberOfReturnedAndCancelledShares" xlink:to="label_bfnh_NumberOfReturnedAndCancelledShares"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Number of shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="label_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>bfnh-20210630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<!-- XBRL Document Created with XML Edge from P3 Data Systems -->
<roleRef roleURI="http://bioforcenano.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="bfnh-20210630.xsd#DocumentAndEntityInformation"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedBalanceSheets-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedBalanceSheets-UnauditedParenthetical"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfOperations-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfCashFlows-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited" xlink:type="simple" xlink:href="bfnh-20210630.xsd#CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"/>
<roleRef roleURI="http://bioforcenano.com/role/OrganizationDescriptionOfBusiness" xlink:type="simple" xlink:href="bfnh-20210630.xsd#OrganizationDescriptionOfBusiness"/>
<roleRef roleURI="http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="simple" xlink:href="bfnh-20210630.xsd#SummaryOfSignificantAccountingPolicies"/>
<roleRef roleURI="http://bioforcenano.com/role/RecentlyIssuedAccountingStandards" xlink:type="simple" xlink:href="bfnh-20210630.xsd#RecentlyIssuedAccountingStandards"/>
<roleRef roleURI="http://bioforcenano.com/role/GoingConcern" xlink:type="simple" xlink:href="bfnh-20210630.xsd#GoingConcern"/>
<roleRef roleURI="http://bioforcenano.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="bfnh-20210630.xsd#RelatedPartyTransactions"/>
<roleRef roleURI="http://bioforcenano.com/role/Stock" xlink:type="simple" xlink:href="bfnh-20210630.xsd#Stock"/>
<roleRef roleURI="http://bioforcenano.com/role/RisksAndUncertainties" xlink:type="simple" xlink:href="bfnh-20210630.xsd#RisksAndUncertainties"/>
<roleRef roleURI="http://bioforcenano.com/role/SubsequentEvents" xlink:type="simple" xlink:href="bfnh-20210630.xsd#SubsequentEvents"/>
<roleRef roleURI="http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="bfnh-20210630.xsd#SummaryOfSignificantAccountingPoliciesPolicies"/>
<roleRef roleURI="http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails" xlink:type="simple" xlink:href="bfnh-20210630.xsd#OrganizationDescriptionOfBusinessDetails"/>
<roleRef roleURI="http://bioforcenano.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="bfnh-20210630.xsd#RelatedPartyTransactionsDetails"/>
<roleRef roleURI="http://bioforcenano.com/role/StockDetails" xlink:type="simple" xlink:href="bfnh-20210630.xsd#StockDetails"/>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/DocumentAndEntityInformation">
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_DocumentAndEntityInformationAbstract" xlink:label="locator_bfnh_DocumentAndEntityInformationAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="locator_dei_EntityCentralIndexKey"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityCentralIndexKey" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="locator_dei_CurrentFiscalYearEndDate"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_CurrentFiscalYearEndDate" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="locator_dei_DocumentFiscalYearFocus"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentFiscalYearFocus" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="locator_dei_DocumentFiscalPeriodFocus"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentFiscalPeriodFocus" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="locator_dei_AmendmentFlag"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_AmendmentFlag" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="locator_dei_DocumentType"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentType" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="locator_dei_DocumentQuarterlyReport"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentQuarterlyReport" use="optional" priority="0" order="70"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="locator_dei_DocumentTransitionReport"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentTransitionReport" use="optional" priority="0" order="80"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="locator_dei_DocumentPeriodEndDate"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_DocumentPeriodEndDate" use="optional" priority="0" order="90"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="locator_dei_EntityFileNumber"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityFileNumber" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="locator_dei_EntityRegistrantName"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityRegistrantName" use="optional" priority="0" order="110"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="locator_dei_EntityIncorporationStateCountryCode"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityIncorporationStateCountryCode" use="optional" priority="0" order="120"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="locator_dei_EntityTaxIdentificationNumber"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityTaxIdentificationNumber" use="optional" priority="0" order="130"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="locator_dei_EntityAddressAddressLine1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressAddressLine1" use="optional" priority="0" order="140"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="locator_dei_EntityAddressAddressLine2"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressAddressLine2" use="optional" priority="0" order="150"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="locator_dei_EntityAddressCityOrTown"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressCityOrTown" use="optional" priority="0" order="160"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="locator_dei_EntityAddressStateOrProvince"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressStateOrProvince" use="optional" priority="0" order="170"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="locator_dei_EntityAddressPostalZipCode"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityAddressPostalZipCode" use="optional" priority="0" order="180"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="locator_dei_CityAreaCode"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_CityAreaCode" use="optional" priority="0" order="190"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="locator_dei_LocalPhoneNumber"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_LocalPhoneNumber" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="locator_dei_Security12bTitle"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_Security12bTitle" use="optional" priority="0" order="210"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="locator_dei_TradingSymbol"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_TradingSymbol" use="optional" priority="0" order="220"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="locator_dei_SecurityExchangeName"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_SecurityExchangeName" use="optional" priority="0" order="230"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="locator_dei_EntityCurrentReportingStatus"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityCurrentReportingStatus" use="optional" priority="0" order="240"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="locator_dei_EntityInteractiveDataCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityInteractiveDataCurrent" use="optional" priority="0" order="250"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="locator_dei_EntityFilerCategory"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityFilerCategory" use="optional" priority="0" order="260"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="locator_dei_EntitySmallBusiness"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntitySmallBusiness" use="optional" priority="0" order="270"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="locator_dei_EntityEmergingGrowthCompany"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityEmergingGrowthCompany" use="optional" priority="0" order="280"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="locator_dei_EntityShellCompany"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityShellCompany" use="optional" priority="0" order="290"/>
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="locator_dei_EntityCommonStockSharesOutstanding"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_DocumentAndEntityInformationAbstract" xlink:to="locator_dei_EntityCommonStockSharesOutstanding" use="optional" priority="0" order="300"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="locator_us-gaap_AssetsAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_AssetsAbstract" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="locator_us-gaap_AssetsCurrentAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrentAbstract" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="locator_us-gaap_PrepaidExpenseCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsCurrentAbstract" xlink:to="locator_us-gaap_PrepaidExpenseCurrent" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="locator_us-gaap_AssetsCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_AssetsCurrent" use="optional" priority="0" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="locator_us-gaap_Assets"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AssetsAbstract" xlink:to="locator_us-gaap_Assets" use="optional" priority="0" order="50" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="locator_us-gaap_LiabilitiesCurrentAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrentAbstract" use="optional" priority="0" order="70"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" use="optional" priority="0" order="80"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:label="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_AccruedSalariesCurrentAndNoncurrent" use="optional" priority="0" order="90"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_StockPayableCurrent" xlink:label="locator_bfnh_StockPayableCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesCurrentAbstract" xlink:to="locator_bfnh_StockPayableCurrent" use="optional" priority="0" order="110"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="locator_us-gaap_LiabilitiesCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_LiabilitiesCurrent" use="optional" priority="0" order="120" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="locator_us-gaap_Liabilities"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="locator_us-gaap_Liabilities" use="optional" priority="0" order="130" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="locator_us-gaap_CommitmentsAndContingencies"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommitmentsAndContingencies" use="optional" priority="0" order="140"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" use="optional" priority="0" order="150"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="locator_us-gaap_PreferredStockValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_PreferredStockValue" use="optional" priority="0" order="160"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="locator_us-gaap_CommonStockValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_CommonStockValue" use="optional" priority="0" order="170"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="locator_us-gaap_AdditionalPaidInCapitalCommonStock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_AdditionalPaidInCapitalCommonStock" use="optional" priority="0" order="180"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="locator_us-gaap_RetainedEarningsAccumulatedDeficit"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" priority="0" order="190"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="200" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="locator_us-gaap_LiabilitiesAndStockholdersEquity"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_LiabilitiesAndStockholdersEquity" use="optional" priority="0" order="210" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="locator_us-gaap_StatementOfFinancialPositionAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="30"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="locator_us-gaap_IncomeStatementAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="locator_us-gaap_Revenues"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_Revenues" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="locator_us-gaap_CostOfRevenue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_CostOfRevenue" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="locator_us-gaap_GrossProfit"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_GrossProfit" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="locator_us-gaap_OperatingExpensesAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_OperatingExpensesAbstract" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="locator_us-gaap_GeneralAndAdministrativeExpense"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_GeneralAndAdministrativeExpense" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="locator_us-gaap_OperatingExpenses"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_OperatingExpenses" use="optional" priority="0" order="60" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" use="optional" priority="0" order="80"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="locator_us-gaap_EarningsPerShareBasicAndDiluted"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncomeStatementAbstract" xlink:to="locator_us-gaap_EarningsPerShareBasicAndDiluted" use="optional" priority="0" order="90"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="locator_us-gaap_StatementOfCashFlowsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="locator_us-gaap_ShareBasedCompensation"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensation" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" xlink:label="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsReceivable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsReceivable" use="optional" priority="0" order="70" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="locator_us-gaap_IncreaseDecreaseInPrepaidExpense"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" priority="0" order="80" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" use="optional" priority="0" order="90" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:label="locator_us-gaap_IncreaseDecreaseInAccruedSalaries"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="locator_us-gaap_IncreaseDecreaseInAccruedSalaries" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" priority="0" order="110" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" priority="0" order="120"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" priority="0" order="130"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="locator_us-gaap_ProceedsFromRelatedPartyDebt"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromRelatedPartyDebt" use="optional" priority="0" order="140"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital" xlink:label="locator_us-gaap_ProceedsFromContributedCapital"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="locator_us-gaap_ProceedsFromContributedCapital" use="optional" priority="0" order="150"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" priority="0" order="160" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" use="optional" priority="0" order="170" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" priority="0" order="180" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_b18ece3e-8a90-47a9-6e25-5eb483347131"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsAtCarryingValue_b18ece3e-8a90-47a9-6e25-5eb483347131" use="optional" priority="0" order="190" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="locator_us-gaap_SupplementalCashFlowInformationAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_SupplementalCashFlowInformationAbstract" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="locator_us-gaap_InterestPaidNet"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="locator_us-gaap_InterestPaidNet" use="optional" priority="0" order="210"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="locator_us-gaap_IncomeTaxesPaidNet"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="locator_us-gaap_IncomeTaxesPaidNet" use="optional" priority="0" order="220"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfCashFlowsAbstract" xlink:to="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" use="optional" priority="0" order="230"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayableValue" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayableValue"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="locator_bfnh_CommonStockIssuedToPayAccountsPayableValue" use="optional" priority="0" order="240"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="locator_us-gaap_StatementOfStockholdersEquityAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="locator_us-gaap_StatementTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="locator_us-gaap_StatementTable" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="locator_us-gaap_StatementEquityComponentsAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementEquityComponentsAxis" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="locator_us-gaap_CommonStockMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_CommonStockMember" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="locator_us-gaap_PreferredStockMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_PreferredStockMember" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="locator_us-gaap_AdditionalPaidInCapitalMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_AdditionalPaidInCapitalMember" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="locator_us-gaap_RetainedEarningsMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_RetainedEarningsMember" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="locator_us-gaap_EquityComponentDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementEquityComponentsAxis" xlink:to="locator_us-gaap_EquityComponentDomain" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="locator_us-gaap_StatementLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementTable" xlink:to="locator_us-gaap_StatementLineItems" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="20" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CapitalContributionDirectors" xlink:label="locator_bfnh_CapitalContributionDirectors"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CapitalContributionDirectors" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayable" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CommonStockIssuedToPayAccountsPayable" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_CommonStockIssuedToPayAccountsPayableShares" xlink:label="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_bfnh_CommonStockIssuedToPayAccountsPayableShares" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" use="optional" priority="0" order="70"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="locator_us-gaap_NetIncomeLoss"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_NetIncomeLoss" use="optional" priority="0" order="80"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="locator_us-gaap_StockholdersEquity_7b389854-f870-df75-7ac7-ba0264bde96e"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_StockholdersEquity_7b389854-f870-df75-7ac7-ba0264bde96e" use="optional" priority="0" order="90" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding_2c1426bf-6552-c628-3873-e5efcbf7c006"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding_2c1426bf-6552-c628-3873-e5efcbf7c006" use="optional" priority="0" order="100" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/OrganizationDescriptionOfBusiness">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="locator_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="locator_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="locator_us-gaap_SignificantAccountingPoliciesTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_SignificantAccountingPoliciesTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/RecentlyIssuedAccountingStandards">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:label="locator_us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="locator_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="locator_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/GoingConcern">
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_GoingConcernAbstract" xlink:label="locator_bfnh_GoingConcernAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="locator_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_bfnh_GoingConcernAbstract" xlink:to="locator_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/Stock">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="locator_us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_StockholdersEquityNoteDisclosureTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/RisksAndUncertainties">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="locator_us-gaap_RisksAndUncertaintiesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="locator_us-gaap_ConcentrationRiskDisclosureTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="locator_us-gaap_ConcentrationRiskDisclosureTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="locator_us-gaap_SubsequentEventsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="locator_us-gaap_SubsequentEventsTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_SubsequentEventsAbstract" xlink:to="locator_us-gaap_SubsequentEventsTextBlock" use="optional" priority="0" order="0"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="locator_us-gaap_AccountingPoliciesAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="locator_us-gaap_ConsolidationPolicyTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ConsolidationPolicyTextBlock" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="locator_us-gaap_UseOfEstimates"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_UseOfEstimates" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_CashAndCashEquivalentsPolicyTextBlock" use="optional" priority="0" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="locator_us-gaap_EarningsPerSharePolicyTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_EarningsPerSharePolicyTextBlock" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="locator_us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_FairValueOfFinancialInstrumentsPolicy" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="locator_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_AccountingPoliciesAbstract" xlink:to="locator_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" use="optional" priority="0" order="70"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDescriptionAbstract" xlink:label="locator_us-gaap_BusinessCombinationDescriptionAbstract"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" xlink:label="locator_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_BusinessCombinationDescriptionAbstract" xlink:to="locator_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="locator_us-gaap_PaymentsToAcquireBusinessesGross"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_BusinessCombinationDescriptionAbstract" xlink:to="locator_us-gaap_PaymentsToAcquireBusinessesGross" use="optional" priority="0" order="10"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/RelatedPartyTransactionsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="locator_us-gaap_RelatedPartyTransactionsAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_TwoBoardOfDirectorsMember" xlink:label="locator_bfnh_TwoBoardOfDirectorsMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_bfnh_TwoBoardOfDirectorsMember" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="locator_us-gaap_RelatedPartyTransactionLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="locator_us-gaap_RelatedPartyTransactionLineItems" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="locator_us-gaap_DueToRelatedPartiesCurrent"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_DueToRelatedPartiesCurrent" use="optional" priority="0" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:label="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionLineItems" xlink:to="locator_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" use="optional" priority="0" order="20"/>
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://bioforcenano.com/role/StockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="locator_us-gaap_StockholdersEquityNoteAbstract"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="locator_us-gaap_ScheduleOfStockByClassTable"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StockholdersEquityNoteAbstract" xlink:to="locator_us-gaap_ScheduleOfStockByClassTable" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="locator_us-gaap_StatementClassOfStockAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="locator_us-gaap_StatementClassOfStockAxis" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="locator_us-gaap_ClassOfStockDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_StatementClassOfStockAxis" xlink:to="locator_us-gaap_ClassOfStockDomain" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="locator_us-gaap_SeriesAPreferredStockMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockDomain" xlink:to="locator_us-gaap_SeriesAPreferredStockMember" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="locator_us-gaap_RelatedPartyDomain"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="locator_us-gaap_RelatedPartyDomain" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_TwoBoardOfDirectorsMember" xlink:label="locator_bfnh_TwoBoardOfDirectorsMember"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_RelatedPartyDomain" xlink:to="locator_bfnh_TwoBoardOfDirectorsMember" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="locator_us-gaap_ClassOfStockLineItems"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ScheduleOfStockByClassTable" xlink:to="locator_us-gaap_ClassOfStockLineItems" use="optional" priority="0" order="200"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_PreferredStockParOrStatedValuePerShare"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockParOrStatedValuePerShare" use="optional" priority="0" order="0"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="locator_us-gaap_PreferredStockSharesAuthorized"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesAuthorized" use="optional" priority="0" order="10"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="locator_us-gaap_PreferredStockSharesIssued"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesIssued" use="optional" priority="0" order="20"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="locator_us-gaap_PreferredStockSharesOutstanding"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_PreferredStockSharesOutstanding" use="optional" priority="0" order="30"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="locator_us-gaap_CommonStockParOrStatedValuePerShare"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockParOrStatedValuePerShare" use="optional" priority="0" order="40"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="locator_us-gaap_CommonStockSharesAuthorized"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesAuthorized" use="optional" priority="0" order="50"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="locator_us-gaap_CommonStockSharesIssued"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesIssued" use="optional" priority="0" order="60"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="locator_us-gaap_CommonStockSharesOutstanding"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_CommonStockSharesOutstanding" use="optional" priority="0" order="70"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="locator_us-gaap_ConversionOfStockSharesIssued1"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_ConversionOfStockSharesIssued1" use="optional" priority="0" order="80"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="locator_us-gaap_ProceedsFromOtherEquity"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_ProceedsFromOtherEquity" use="optional" priority="0" order="90"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_GainLossOnLiabilitySettlement" xlink:label="locator_bfnh_GainLossOnLiabilitySettlement"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_bfnh_GainLossOnLiabilitySettlement" use="optional" priority="0" order="100"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" use="optional" priority="0" order="110"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" use="optional" priority="0" order="120"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="locator_us-gaap_SharesIssuedPricePerShare"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_SharesIssuedPricePerShare" use="optional" priority="0" order="130"/>
<loc xlink:type="locator" xlink:href="bfnh-20210630.xsd#bfnh_NumberOfReturnedAndCancelledShares" xlink:label="locator_bfnh_NumberOfReturnedAndCancelledShares"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_bfnh_NumberOfReturnedAndCancelledShares" use="optional" priority="0" order="140"/>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="locator_us-gaap_ClassOfStockLineItems" xlink:to="locator_us-gaap_StockIssuedDuringPeriodSharesNewIssues" use="optional" priority="0" order="150"/>
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>bfnhlogo2019001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bfnhlogo2019001.jpg
M_]C_X 02D9)1@ ! 0$ 9 !D #_VP!# (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P@ 1" #0 ;P# 1$ A$! Q$!_\0
M'0 ! $% 0$! D!!08'" 0" __$ !L! 0 # 0$! 0
M !! 4# @8'_]H # ,! (0 Q 'OM"8IXE,5*2_&?'P6GM7MO6MY
M?2V]Z_X3XM/;C8>]:]UK.M-O#M7OQG-+2L_OE^73CG.5L7+GV]'GUL[*V+AX
MZU\S7T^ID ?F\_FC%;.5^/KGB5O.O'*W@M[#^YZ??OI\>CE[
M\/3E]SUI,^B)MG3GDU&]G&?H62SQ_.>63U-+&;F?X?7G86=K:\T\E'O;63K^
MWG8^Y #\XC M#YW-J&[@.AAYM1VL%OY.74M/!M3*R"G9UQI8
M>1U;V+7:EXY>\?L>,TS]']_$Y!QN5ABMNCF-/1LW:M8+%?8>;K8/H9GX>_&P
MLO6U-M8>2TKNS<W7JE,U$169 Q&SD7WA?Q>SGW[E>QRQ2O]:UB
M=VAE5/0P31R\XS]/6&MB9/4ZZGVLC?'SOU%JZU?1XZ7KA;PR[G7ZM<KZG&K-
M',J>AC%JK:NE?8N=KZQV,6Z\+&6T;VJ=C#V+EZ^;TM&OGTF*RK,@
M # +WSV=T/H,"O8F<4]?7&AC9;4TL9MT/UCI<N';#;M#8-#3U#MX&[,'Z*R]
M*7FZ<;CRMVKMQ_)YNG*SC_>IZ_/7TQ[Q_O3R#C<M'7C:NG#,JFAA5S/N'GM=
M.?O"+N?L/-U\VH:%?:J0 !@]K$OW'0YA[TN?J^CZ(]V?KQR+A9QF
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MBJ/TF9)^E?#K^;QOE[>&HH#U$[)>B(@YY +B;D* "'3G2KTW;QH9*7T%OCV
M+W/F3+ZGX6V]:D:_R/Z-;8FOJ'CWW7]G\!MCWSX<^5^VT]5M4B1L7IQD@^F^
M-QNU0YXR]SD;Y_ZN@/LG6,E, N8'Y^^G+>?MQT2'U,_I"5?;^<Z+Q]SB?GVC
MPF:( G*,S(B#GD V,3;E0"A1YM43!/,^ 'V277,C?/6K#3G_06Q-8"5'4P=
ME=N<:>7M:/Y6*0&S"9/O4NW#OQU'2-#U-(@?9.L9*8#=^?\ CU[Y9S]R.B9%
M4_M[B8>[E;NS]2.\X32!GQ-V?H1$'/(!L<FV*@%$43:T03)\ *G:!(ZB"9-
MJ )G(;B(B9<[@&S":N%)CC8C22!]DZQDIA-O#\WOSROG[T='H!]'29\'.QYP
M5),3LLH1$'/(!=SHX D6,N()3P &=F"&4DW9!@6H F<-Q$1!SP ?1^P/@_(
M ^R=8R4QOOFXQ:SN7L_?CMCH*B5! 5,_)##K ^BA$0<\@ $SQLL@E/ =O
MG$!4E^(E2U $SAN(B(.> ?9.L9*?@YZEU?F>7J.WP'PO@ "I="1X[+*
M$1!SR 3/&RR"4\ !+61,GYG<QQ:6H F<-Q$1!SP #[)UC)3\T:[O?.
M\7Q;X9I; 'Z$MQDIP(<Q@'J)E3;Q$0<\@&1G:H *':9?R"4\ !,F1\'.9L@P
MPM0!,X;B(B#G@ R8[2!IPYJ /LG6,E/F(PRYB<)^XXBH[H'Z$X9FYJXA2 !W
M^=_$1!SR ;&)MRH *%K()3P $R9I(C9 !,X;B(B#G@ V839%#C,C. /LG6,
ME*>5LZU8W]/YWC7)^L ^R<0S<UH0F [R)"R(@YY -C$VY4 M1!*> F3,M
M(0S\P "9PW$1$'/ !LPFR!QD1G 'V3K&2GS'FD^H]K63P;5U@/LF(,H(^3E(
M $BYW*1$G/(!L8FW*@ %J()3P $R9NDAQ-(@ $SAN(B(.> #9A-D#C(C. /L
MG6,E$1\RX91'2] #WDTQL@B(.>0#8Q-N5 +402G@ )DS=)P21]% 3.&
MXB(@YX -F$V0.,B,X ^R=8R4%#AJ$<\@ /:2/G:10B(.>0#8Q-N5 +402
MG@ )DS=1K A4/@ $SAN(B(.> #9A-D#C(C. /LG6,E$$QRLGC( ^S;)UV;
M>*E".PTZ 9F2A%0 "W$4IY "28V@?)%T8@ "2TV21V&G #-R3\H<T'$(!]$J
MY?0#'C%#+R^ P N)EP* J#\RV'P7H H5 !X#W'T4 *%2A4LP+R"S%Y,<,A/H
M%"H!:RZ H#Z .23+#%C89YS4AOXP8Q8R4N!]'Z&WSD4RTR MI\&0'E,=+^>T
MR$P$\I<3]B_F)EK/HZL..2WFWSQ&N#/3 C-C(RQ%T,#.M#]#F0])^9?S>!Z
M#G(R,P RH\Y[#9AITUZ;L+68V7@W@8N<X'ZEZ-B&)E#T&%&R"[&ISTFY34!L
M<U,7<P\[%--'P>4\I8C(3#S.#-33![RQ&SC>QH$RLTF;*,\,[ !0%2@!4H 5
M* J"A4H 5 * %2@ *E"AJ\RXR,\YZ "I0%0
M #_Q S$ ! P,# @0#!P4! % P0& (' 0@0&#<1(#4V$A0S
M$Q46%R4P,2$C0$%0)__: @! 0 !!0+3C7^>?F4ZU=64\DK >JK/!J6KC(PI
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MN_[_ /_$ #@1 $$ 0$ @@%! (# $ @,$!1$2(1,B,4$R4080%" C
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M<!L?W<H#_P!OO__$ #<1 $# @,& P@! @< $ @,$$042(1 3(C%!
M42 C8105,D!"4'&!,R21,#1#4F* H?_: @! @$!/P&UMG-:';D/0+(>C5'2
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MT9UU56TV#ONS>2C=E<%B!X&_=KZ[)),T8'W:W_<#_\0 4! 0," @,*" L%
M!P,% 0 @$#! %$1(3(3$&$!0@(C)!47%S-4)A<G24L=$5(S S@9&2H;+!
MPB124Y.S%C1 0V*BT@=0@B5%56/P8/_: @! 0 &/P+C?.!]=<\/KK(]*: N
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M6H"I4\U\#VQ4:<(,<Q]"]M>!K9]H_?7@:V?:/WUX&MGVC]]6VZOM-LNS6\Y
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M422!9A>:$L>O5O73S6OZ8\1J)%;5V0^64 QPS+7@%W^>U_RKP"[_ #VO^5>
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MJN*QSPU5N:<PP^,<3ZD1/D@E0I#L9]M<4-LL%ZZ"T7U6F+@>J.]S1D+^ZO\
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MK)>M5Z=X%<; U:7,&*8Y5Z__ . __\0 *A ! (! P,$ @(# 0$ 0 1
M(3%!41 @87&!H?"1T3"Q0,'A\5#_V@ ( 0$ 3\AR.BBUVA+ ="4<OIE?_7F
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M!,;$5EBZI)FX:?XYDL,>.)_2":BX(/H.KPF2V\)9%B+PRRA?FYU'YGESBW<
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M#4]^U?\ ?W ?_T^@:-.=GR@_A$&OF::6-N7%^4U=GEQI+3^/@QCF"OJ93Z'
MEVD8',96[(Z/@EU3ECQ*@V'SC-H0S;@ JYZ[^,B9\5KS&KH0=FE4";&/(9D
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M(4V1[/B.NTGCQAJ)O*_]<1 'YAB:?EU[,=@PN46]T6!%\:/HH59J54U*Z/\
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M51BJWCXG+$ 6*7;S5TS (PQV!5,TO8#*W>$)X%$1Y+A!>UI$*S::5RXF4E!
M-#'B_M6L UX5-0Z2LBEH%<7S, -<.XFH+R$TEZ ;A["KK&U>J9NY*4Y@,J]Y
MD?5X@UBJZP<Q1UJ#GS!LO.S,A4U>WIL59FG,-+%RA * %QZ0"VG +,I5%:0
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M 801PDI$C8 ;WA?F!!9!E[:C*]>EGWL:XG#*E=:_^W__V@ , P$ @ #
M$)=N10<M\SA#7.<@ )?\,!=T,^^(7[7 &:>
ML:U,)9X!)E5O?* )M U0L3*^,?K(3]XOP )=GW^QW
MQI]T4=;S8'0 !JT)WR;$U!WD?0W'>!S, ! '&GZ4]? )3T
M,.R_?/\ QM "0 2 GTA:(R('#365=FRD-M:9P#+C #:@=L,B2" ;
M:@ /8<86$;7Z@ !2 !4@ " "0 L '"@9K(9([ O@0T6B"2 &6 ".
M%2!(0".W #/ 3& 02 "222 ""0 "" 20 B@.0 2 0 ""
M !P@ 202 " 0 "" "]@ "2" " "0 2 22 "" "20
M R@ 00 22 "0 " "2" "" "" !4 "0 " "0 "2 "" 0 "P
M " 2 22 "0 "2 "" 0 U@ " " "0 "20 "" 0 #
M2 2 "0 "0 "" 0 !$2222" "22 022"220 20"222 " 20 2222
M2220 0"" 0222 022 "002 " 0 02 "2"2200 "22"0 "00" 00 20" "
M 00" 2 " " 22 2"2"2"2220""2 "2"220200202
M #_Q J$0$ @(! P,$ @,! 0 ! !$A,4%187&!D:$0($!0
ML<'1X? P@/_: @! P$!/Q H<D6;9@!:EK&B)6E%)F$&4'O-X0\\QFBQ#&2'
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M6MSIK/RE>L#&)^8Z$H7_ ["I'IRC:_SO!"PS>&82[*/5=SIQ46P'E17K^SF
M95NG+@CQ8T#?!FH!UY@,'0QNYZ;L.T!*1M89:JP\1 S&^8?CL;I^9G+HBLZ3
M^5Q!H")FUZ=(K\/'F*>DO$V$E#I?/I ISR+RP;06YP0?@#)R\JQ6.Q") [96
M87I ]X2"U<MMX(6:DYX8EJ%U(NH$?,S$ ] 1*KO<GF$WBO*)+RZ<,,]G,L1
MN.TS3C3E ^*GF7YWY_ZW'+74Y.[!\?FMDILY@0S^.$&YVL-3.DJVNX;6HFK
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MW_;$7ANL3$:*_E_;(H,<VXBT(!73;^V(+)1^V/W-?_)__\0 *A$! (" 0(%
M! (# 0 0 1(3%!46$0('&!D4!0H<&QT3#A\(#_V@ ( 0(! 3\01@0E
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MS'$AO3'XE!P7C*7^9E$CWE0@7!;CF4Z8B8?HA8Y8=$=E&,H8*26,0$NJ9@!
MC2Y=-D>3XMY4=P#4HNV-(NV2'3!J7>(5MERM# BYN.)G!+!N!F :ED)+(-['
MQ,D+5%/Q )@T._>7#9F#4?H@M>IJ^Z6IA,S+EC" ;EIC<$VBUB(6SR3/A1,>
M :U,2W$%/ Z;8KL7[/XB(D+M7ZQ*"#7A>/ A,A<\>\6KM\_SHB2_?8=K&(B-
MUUB+A!E3UG<E^0)9*Z1+8D2O-ZPE$.D6'Q!XF$?* @YQ[S??=<':59=X)8Z_
MSM<Q_)<4PC%EKR@H$"B]X, ]%9^8JJZQPN(!7,&K@-7 O/:H*VC 5+J*Z? J
M\PA;<$-F!DCU86'7:57F&X?Q)KX[I 2V8 @H]^G\,WCKN:0Q+_SW%31.QYE:
M0:'4O.2#*!@LRA@@BE*Y:W1&.]FKP#U@O$CBK?,3++@UN95OFJ^PGH"'/BFQ
M#;XIB%KOS%Q4XKZ"O"_-;=^#F"A7DH@5J7Y#&I6;CX*I3YNB%3@>C-'U\;AR
MF7+]Q4>J<GA+9=?&N*CQ1%Q7W',8!7T_=T%MXB"-J%8<A]VH29O9B7 [Q\?=
MM%RU$!<[_=N"%+<O9R+]W!47[P:^[!_Y0__$ "H0 0$ @(!! (# 0$ @,
M $1 "$Q05$0(&%Q@? PD:% P;'A4-'Q_]H " $! $_$-.-S8;8F%&EP"\/
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MWYN4GB8"GCG-]\X4M*N5C4.1S0G*]_>!WE93<QY.&$ =II#$JP0N5,3B(
MX7@0>?0F^\4QRVNMXQP94E<J=X-&TYRCQAS\?>5/K+OGSCBBA@N8$I67#XX[
MAJ@MJ+7#&RDWI^65-*8EWO- Q5\S-L0$E:<Q.(WH.,T9@L25 0M $,5QTT&
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M.!" =B*3O"/*VJ&_ZPCTP"OP&"<XZ2=,8^,>?3]1Y/7,1%N7A[3!W 3IV_\
MV8OI!ZP,N\%21[\Z8?JQ1*SNO!#D<L7:F9B?YJU=Q,=6[Z"C'T:UF\DX4GH3
MF[N+< _HP0/OVSM1GSL[Q7_ ,^PB?/6%=(X![=1AQQO IOC/,K26@[9&CHP
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M6*\FML$)\U@@@9,\5\0^P(!0#V*8DW6.@4':X4W);]0>U5-(.$LY37R&ED-
MH.4PQ>G(R-S#_P ST CY,=L2="0"HKD1[S<+S?;.4Q!C36:-N+!=,YO97KUY
M3J9JY^[*ZQ-.G/NJC!<5YY2:)5"/0ZN&(XQO-F^XKI#1Q(U(TG-[%"??\6]\
M3V!09W'(7C%K"CZ5RON38&1LK]>S]1Y/7,*G."%GCVCH_"W)%"7QM_EIKV*>
M)M\Z9XH>G0:'17C/(3N>HQUE;^<LQIE:' "G*<XM#[]L[S4S#:]^SG 'X]]4
M8Q-L9>O-N=#ZWG+!C@SC7\6]^WINCD7#/8+]1Y/7,TY<XIP$4DEV/F8;_:TB
M'XGL_;>3/WWCZ<:)VB ^0GW[=I@0VJ:GDSP<>V=^W\YR?Y*HQCMF'9NH&[3D
MWCHD'LD [$1$?^/>_."_4>3US*9_>/Y,$1,G @_E"_GV$Q #*];,)>R44U":
M1UC+HAFT=P##MP0>VEUP'B0A 0,*KUHPH]--*]8-PR^7M3OV_G.3_)5&,7:O
M!D*PP Z& E+XVW_Q[WYP7ZCR>N;@QY]9\06][$_O^(5Z_.17,K7.XJ@KH[AA
M_BUP3(2=:9K1@T)W[9W[?SG)_DJC&(,=]8_X!453:K!A'7.+3MXY_P"+>_."
M_4>3V9G^-:A'#K7_ "#Q5Z 5T.(19DTW$*A0-MIDSI]^V=^W\YR?Y*HQBFJ6
MX?9WB8R\!P>\9]Z,%I$Z1ZZ_XM[\X+]1Y/;FMCI<S1!2N.)_!BQ8L6+%B,SY
M<!VA5#X%QX U[&\K$E62\ZK^O8'J'I@$DCB.6_1;^MXKPS.V8"$V;E]F+%B,
M9:EJT+^@,=7YX]JPP@*;@4@=%4WB7S2-2COP?9BQ8@;3:' 6=0X7#9@L02(4
M3ZQD:/WFQ)ITBI-)[,6+$CDD^CFE&*[!I[]&-R5U+2$?)[,6+$)V=J--L =!
M7!IG]_"O+8FE0'?0^S%BQ*-@W\N"OF],P&F(4T^Q_P#8"0JSRSHQZ";5('^8
M/. @B O2))]Y#WQD.2/?VB1*J!CYQITX#6HG17RF0L\XBMM\9R<[?.1:=8@.
M<3O=3K);BL'JCT *XR=4SL0G($3XPDA-CJ<@F._C.6(&><A.G!\X<>,"_?C)
MLR Q(8[$<ZASPDODY39K/\RZR?.1_6L G^8@/OCYP("_WB&)4,/E:8QF8H(1
MVP4O(8Q>\:J(>9,/C#*"%$X3'ASC*>CE@.V"EYC@4[Q>?(D"B)>)'EPTH!G0
M=B847)G.(&3;O)#!%&?.!Y8V=&SD#W"+R)B1G;Q\X@9WB+#)WE6T>O8H73$H
MZ@C@%!SA]>90D5[)$./$6!]7 V4W$3@XP>A$*H_HPIX(Y44@'!(,D:Y&:VNA
MF><07V:79(8' B>=R042:T')0-&;3ZU1(6Y*(36&R%PP&@C*Z^)4^FW5^!56
MAYQ]+&#" "2E.,@W8-Z+]EF,@70B2O\ *R52&+IGSCA.#C_IADQ+626LKP**
MAB.%G$Z!.1'3\Y)U[6D<"V05/Q=91=;&D@J D4ZPVM$M<;"(6M+ S$895U^D
MM(4BMZE:X_K;KM@1V5)LZC-K8IK.DP&^*PA8K*F(U!NX.UI].JZ+2 BT-6X/
MF=\Z+@HQ74Q"/.C% G2'*?%&/R8B! #CHN'G35X35JU WQE--]5?>!$@VPF]
M7O#%"GX,E K&1<\*18""K#5%IL-7;3$%((S2.]'6#CYM $((@YVY8&AN<GDQ
MJRLQRVC?,.C VI5X3N\JAHFSK ;(C=:)&&M$U;E</HWZHM/2HV1Q/-/@P6_.
M*L[ND0'4*0#>[99NDYV!*4NC'+VS&12*$LA90;RC."GU]$ 'Q,5W DQ6.331
M.W* /A*9RIE$* ;2Y,R]=8V0*AM.$BJ\%%5.QSAK",XB">.RF3W8N3,LMHC&
ME"[FDQJ"K4C:3(5T,K!:L6=ASCE5(Y: H6@%B.WV 3J8CLD%B&\4X)U@%(S5
M:D)-XDHX9@0Y-.K-&<2G89C":&WAWB[T52#A1"7.@9HNMRH0N4.J>&&Z0):6
MH6,(.$P?KI0EHD&BLNL'<6!<?XPV15AB#)SDH'LIS9X*XX_+#\>"F'DB7#5>
M,?%Z\!**!T9)PTJ!=YX"#C 8A^1G+ J#:8CRNOVJ& !$H(Y7H?7L QM3!N8>
M *-A%3\P0H'&2(%U\IH\,%Q=.BAZS1SR, [-](0MT.0H[ECCHS!-BQ>1-:PF
M4P1MH8!@BO#:/%Z1)R@ VAY89BG"$URO8C>;VC31AIUFX:(=R8HL>G8UD^ (
M<B;N#-SUW;022G.)QK4<@&6CM!\Y.63]C!&B5V$HW+T5<1)K,",AP:V+$ZC8
M\ZQ4!N^=1JV/-&B&Z(J4P=_#\Q[IP(9=*F.UQ(G[4%;E!P[Y\UIKU YEU<WV
M-W8!.D-"[:'+1H6_HE#HJ"DWBA*J6 @'4%+G0^YVO/%YP<CA8X ^)!2((4=2
MAWPF&LUK1J0T@FVL\FT6)H:J;'MSD"7:80L"H]!#DF5N>124/M SPW ,C5Q-
M0FPF387!@._JQ"9C'52+FY3MPX0:,M'VF0]_7UBCY8H"P:NH\+QO+$?WHRS1
MJ*;R>C98-(PI(GE,F2^<<52</!*[U\3KU?/EB"&EU[4.!&S>0R=ZYR?&!.C>
M!,0]9&3)DF(7(\9/C #A#DVS>1K7&3XP)^<D)@ P)D>, 9$F34](9"WSB%R,
MFIDG63;,Z?&1,C &0SHPJQJ"B/)EAHRB(;A]Q7O'<B0L6W"O*R8:X8X?"IH\
2F\2]9,/C60Q+D9-W_P#-?__9
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>bfnh10q0621_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
xmlns="http://www.xbrl.org/2003/instance"
xmlns:bfnh="http://bioforcenano.com/20210630"
xmlns:dei="http://xbrl.sec.gov/dei/2021"
xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
xmlns:link="http://www.xbrl.org/2003/linkbase"
xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
xmlns:xlink="http://www.w3.org/1999/xlink"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<link:schemaRef xlink:href="bfnh-20210630.xsd" xlink:type="simple"/>
<context id="AsOf2020-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="AsOf2021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2021-06-30</instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-06-30</instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-06-30</instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-06-30</instant>
</period>
</context>
<context id="AsOf2020-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-03-31</instant>
</period>
</context>
<context id="AsOf2020-03-31_us-gaap_PreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-03-31</instant>
</period>
</context>
<context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-03-31</instant>
</period>
</context>
<context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-03-31</instant>
</period>
</context>
<context id="AsOf2020-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2020-03-31</instant>
</period>
</context>
<context id="AsOf2020-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-06-30</instant>
</period>
</context>
<context id="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-06-30</instant>
</period>
</context>
<context id="AsOf2020-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-06-30</instant>
</period>
</context>
<context id="AsOf2020-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2020-06-30</instant>
</period>
</context>
<context id="AsOf2020-06-30_us-gaap_PreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-06-30</instant>
</period>
</context>
<context id="AsOf2019-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2019-12-31</instant>
</period>
</context>
<context id="AsOf2019-12-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2019-12-31</instant>
</period>
</context>
<context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2019-12-31</instant>
</period>
</context>
<context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2019-12-31</instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-03-31</instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-03-31</instant>
</period>
</context>
<context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-03-31</instant>
</period>
</context>
<context id="AsOf2021-03-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2021-03-31</instant>
</period>
</context>
<context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2019-12-31</instant>
</period>
</context>
<context id="From2021-01-01to2021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2021-01-01</startDate>
<endDate>2021-06-30</endDate>
</period>
</context>
<context id="From2020-01-01to2020-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2021-04-01to2021-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2021-04-01</startDate>
<endDate>2021-06-30</endDate>
</period>
</context>
<context id="From2020-04-01to2020-06-30">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2020-04-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2021-01-01</startDate>
<endDate>2021-06-30</endDate>
</period>
</context>
<context id="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2020-04-01to2020-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-04-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2021-04-01to2021-06-30_us-gaap_RetainedEarningsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2021-04-01</startDate>
<endDate>2021-06-30</endDate>
</period>
</context>
<context id="AsOf2021-06-30_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2021-06-30</instant>
</period>
</context>
<context id="AsOf2020-12-31_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<instant>2020-12-31</instant>
</period>
</context>
<context id="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-06-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2020-05-01to2020-05-06">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2020-05-01</startDate>
<endDate>2020-05-06</endDate>
</period>
</context>
<context id="From2021-01-01to2021-06-30_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2021-01-01</startDate>
<endDate>2021-06-30</endDate>
</period>
</context>
<context id="From2020-01-01to2020-06-30_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="From2020-01-01to2020-12-31">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-12-31</endDate>
</period>
</context>
<context id="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">bfnh:TwoBoardOfDirectorsMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-12-01</startDate>
<endDate>2020-12-04</endDate>
</period>
</context>
<context id="From2020-01-01to2020-06-30_us-gaap_CommonStockMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate>2020-01-01</startDate>
<endDate>2020-06-30</endDate>
</period>
</context>
<context id="AsOf2021-07-29">
<entity>
<identifier scheme="http://www.sec.gov/CIK">0001310488</identifier>
</entity>
<period>
<instant>2021-07-29</instant>
</period>
</context>
<unit id="USD">
<measure>iso4217:USD</measure>
</unit>
<unit id="Shares">
<measure>shares</measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure>iso4217:USD</measure>
</unitNumerator>
<unitDenominator>
<measure>shares</measure>
</unitDenominator>
</divide>
</unit>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
contextRef="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember"
decimals="INF"
id="Fact_213"
unitRef="Shares">2000000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-06-30" id="Fact_230">0001310488</dei:EntityCentralIndexKey>
<dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-06-30" id="Fact_231">--12-31</dei:CurrentFiscalYearEndDate>
<dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-06-30" id="Fact_232">2021</dei:DocumentFiscalYearFocus>
<dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-06-30" id="Fact_233">Q2</dei:DocumentFiscalPeriodFocus>
<dei:AmendmentFlag contextRef="From2021-01-01to2021-06-30" id="Fact_234">false</dei:AmendmentFlag>
<dei:DocumentQuarterlyReport contextRef="From2021-01-01to2021-06-30" id="Fact_2">true</dei:DocumentQuarterlyReport>
<dei:DocumentTransitionReport contextRef="From2021-01-01to2021-06-30" id="Fact_4">false</dei:DocumentTransitionReport>
<dei:EntitySmallBusiness contextRef="From2021-01-01to2021-06-30" id="Fact_19">true</dei:EntitySmallBusiness>
<dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-06-30" id="Fact_20">false</dei:EntityEmergingGrowthCompany>
<dei:EntityShellCompany contextRef="From2021-01-01to2021-06-30" id="Fact_21">false</dei:EntityShellCompany>
<dei:DocumentType contextRef="From2021-01-01to2021-06-30" id="Fact_1">10-Q</dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-06-30" id="Fact_3">2021-06-30</dei:DocumentPeriodEndDate>
<dei:EntityFileNumber contextRef="From2021-01-01to2021-06-30" id="Fact_5">000-51074</dei:EntityFileNumber>
<dei:EntityRegistrantName contextRef="From2021-01-01to2021-06-30" id="Fact_6">BIOFORCE NANOSCIENCES HOLDINGS, INC.</dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-06-30" id="Fact_7">NV</dei:EntityIncorporationStateCountryCode>
<dei:EntityTaxIdentificationNumber contextRef="From2021-01-01to2021-06-30" id="Fact_8">74-3078125</dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-06-30" id="Fact_9">2020 General Booth Blvd.</dei:EntityAddressAddressLine1>
<dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-06-30" id="Fact_10">Unit 230</dei:EntityAddressAddressLine2>
<dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-06-30" id="Fact_11">Virginia Beach</dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="From2021-01-01to2021-06-30" id="Fact_12">VA</dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="From2021-01-01to2021-06-30" id="Fact_13">23454</dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="From2021-01-01to2021-06-30" id="Fact_14">757</dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="From2021-01-01to2021-06-30" id="Fact_15">306-6090</dei:LocalPhoneNumber>
<dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-06-30" id="Fact_16">Yes</dei:EntityCurrentReportingStatus>
<dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-06-30" id="Fact_17">Yes</dei:EntityInteractiveDataCurrent>
<dei:EntityFilerCategory contextRef="From2021-01-01to2021-06-30" id="Fact_18">Non-accelerated Filer</dei:EntityFilerCategory>
<dei:EntityCommonStockSharesOutstanding
contextRef="AsOf2021-07-29"
decimals="INF"
id="Fact_22"
unitRef="Shares">29271755</dei:EntityCommonStockSharesOutstanding>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_23"
unitRef="USD">27305</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_24"
unitRef="USD">39865</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:PrepaidExpenseCurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_25"
unitRef="USD">100</us-gaap:PrepaidExpenseCurrent>
<us-gaap:PrepaidExpenseCurrent
contextRef="AsOf2020-12-31"
id="Fact_26"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:AssetsCurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_27"
unitRef="USD">27405</us-gaap:AssetsCurrent>
<us-gaap:AssetsCurrent
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_28"
unitRef="USD">39865</us-gaap:AssetsCurrent>
<us-gaap:Assets
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_29"
unitRef="USD">27405</us-gaap:Assets>
<us-gaap:Assets
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_30"
unitRef="USD">39865</us-gaap:Assets>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_31"
unitRef="USD">1032</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_32"
unitRef="USD">5090</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
<us-gaap:AccruedSalariesCurrentAndNoncurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_33"
unitRef="USD">539017</us-gaap:AccruedSalariesCurrentAndNoncurrent>
<us-gaap:AccruedSalariesCurrentAndNoncurrent
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_34"
unitRef="USD">327517</us-gaap:AccruedSalariesCurrentAndNoncurrent>
<us-gaap:DueToRelatedPartiesCurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_35"
unitRef="USD">114658</us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_36"
unitRef="USD">67166</us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:LiabilitiesCurrent
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_37"
unitRef="USD">654707</us-gaap:LiabilitiesCurrent>
<us-gaap:LiabilitiesCurrent
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_38"
unitRef="USD">399773</us-gaap:LiabilitiesCurrent>
<us-gaap:Liabilities
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_39"
unitRef="USD">654707</us-gaap:Liabilities>
<us-gaap:Liabilities
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_40"
unitRef="USD">399773</us-gaap:Liabilities>
<us-gaap:CommonStockParOrStatedValuePerShare
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_42"
unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_41"
unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesAuthorized
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_44"
unitRef="Shares">900000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_43"
unitRef="Shares">900000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_48"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesIssued
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_47"
unitRef="Shares">29271755</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_46"
unitRef="Shares">29271755</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_45"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockValue
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_49"
unitRef="USD">29272</us-gaap:CommonStockValue>
<us-gaap:CommonStockValue
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_50"
unitRef="USD">29272</us-gaap:CommonStockValue>
<us-gaap:AdditionalPaidInCapitalCommonStock
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_51"
unitRef="USD">158781127</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:AdditionalPaidInCapitalCommonStock
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_52"
unitRef="USD">158781127</us-gaap:AdditionalPaidInCapitalCommonStock>
<us-gaap:RetainedEarningsAccumulatedDeficit
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_53"
unitRef="USD">-159437701</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:RetainedEarningsAccumulatedDeficit
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_54"
unitRef="USD">-159170307</us-gaap:RetainedEarningsAccumulatedDeficit>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_55"
unitRef="USD">-627302</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_56"
unitRef="USD">-359908</us-gaap:StockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_57"
unitRef="USD">27405</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:LiabilitiesAndStockholdersEquity
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_58"
unitRef="USD">39865</us-gaap:LiabilitiesAndStockholdersEquity>
<us-gaap:CostOfRevenue
contextRef="From2021-04-01to2021-06-30"
id="Fact_59"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:CostOfRevenue
contextRef="From2020-04-01to2020-06-30"
id="Fact_60"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:CostOfRevenue
contextRef="From2021-01-01to2021-06-30"
id="Fact_61"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:CostOfRevenue
contextRef="From2020-01-01to2020-06-30"
id="Fact_62"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:Revenues
contextRef="From2021-04-01to2021-06-30"
id="Fact_63"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:Revenues
contextRef="From2020-04-01to2020-06-30"
id="Fact_64"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:Revenues
contextRef="From2021-01-01to2021-06-30"
id="Fact_65"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:Revenues
contextRef="From2020-01-01to2020-06-30"
id="Fact_66"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:GrossProfit
contextRef="From2021-04-01to2021-06-30"
id="Fact_67"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:GrossProfit
contextRef="From2020-04-01to2020-06-30"
id="Fact_68"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:GrossProfit
contextRef="From2021-01-01to2021-06-30"
id="Fact_69"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:GrossProfit
contextRef="From2020-01-01to2020-06-30"
id="Fact_70"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold
contextRef="From2021-04-01to2021-06-30"
decimals="0"
id="Fact_71"
unitRef="USD">105750</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
<us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold
contextRef="From2020-04-01to2020-06-30"
decimals="0"
id="Fact_72"
unitRef="USD">105173</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
<us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_73"
unitRef="USD">211500</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
<us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_74"
unitRef="USD">158114863</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
<us-gaap:GeneralAndAdministrativeExpense
contextRef="From2021-04-01to2021-06-30"
decimals="0"
id="Fact_75"
unitRef="USD">16565</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense
contextRef="From2020-04-01to2020-06-30"
decimals="0"
id="Fact_76"
unitRef="USD">21537</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_77"
unitRef="USD">55894</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:GeneralAndAdministrativeExpense
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_78"
unitRef="USD">53205</us-gaap:GeneralAndAdministrativeExpense>
<us-gaap:OperatingExpenses
contextRef="From2021-04-01to2021-06-30"
decimals="0"
id="Fact_79"
unitRef="USD">122315</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses
contextRef="From2020-04-01to2020-06-30"
decimals="0"
id="Fact_80"
unitRef="USD">126710</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_81"
unitRef="USD">267394</us-gaap:OperatingExpenses>
<us-gaap:OperatingExpenses
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_82"
unitRef="USD">158168068</us-gaap:OperatingExpenses>
<us-gaap:NetIncomeLoss
contextRef="From2021-04-01to2021-06-30"
decimals="0"
id="Fact_83"
unitRef="USD">-122315</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2020-04-01to2020-06-30"
decimals="0"
id="Fact_84"
unitRef="USD">-126710</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_85"
unitRef="USD">-267394</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_86"
unitRef="USD">-158168068</us-gaap:NetIncomeLoss>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
contextRef="From2021-04-01to2021-06-30"
decimals="INF"
id="Fact_87"
unitRef="Shares">29271755</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
contextRef="From2020-04-01to2020-06-30"
decimals="INF"
id="Fact_88"
unitRef="Shares">15271755</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
contextRef="From2021-01-01to2021-06-30"
decimals="INF"
id="Fact_89"
unitRef="Shares">29271755</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
contextRef="From2020-01-01to2020-06-30"
decimals="INF"
id="Fact_90"
unitRef="Shares">15271402</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted
contextRef="From2021-04-01to2021-06-30"
decimals="INF"
id="Fact_91"
unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted
contextRef="From2020-04-01to2020-06-30"
decimals="INF"
id="Fact_92"
unitRef="USDPShares">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted
contextRef="From2021-01-01to2021-06-30"
decimals="INF"
id="Fact_93"
unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:EarningsPerShareBasicAndDiluted
contextRef="From2020-01-01to2020-06-30"
decimals="INF"
id="Fact_94"
unitRef="USDPShares">-10.36</us-gaap:EarningsPerShareBasicAndDiluted>
<us-gaap:NetIncomeLoss
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_95"
unitRef="USD">-267394</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_96"
unitRef="USD">-158168068</us-gaap:NetIncomeLoss>
<bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation
contextRef="From2021-01-01to2021-06-30"
id="Fact_97"
unitRef="USD"
xsi:nil="true"/>
<bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_98"
unitRef="USD">158000000</bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation>
<us-gaap:IncreaseDecreaseInPrepaidExpense
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_99"
unitRef="USD">100</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInPrepaidExpense
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_100"
unitRef="USD">-3047</us-gaap:IncreaseDecreaseInPrepaidExpense>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_101"
unitRef="USD">-4058</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_102"
unitRef="USD">-10248</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
<us-gaap:IncreaseDecreaseInAccruedSalaries
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_103"
unitRef="USD">211500</us-gaap:IncreaseDecreaseInAccruedSalaries>
<us-gaap:IncreaseDecreaseInAccruedSalaries
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_104"
unitRef="USD">114863</us-gaap:IncreaseDecreaseInAccruedSalaries>
<us-gaap:NetCashProvidedByUsedInOperatingActivities
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_105"
unitRef="USD">-60052</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInOperatingActivities
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_106"
unitRef="USD">-60406</us-gaap:NetCashProvidedByUsedInOperatingActivities>
<us-gaap:NetCashProvidedByUsedInInvestingActivities
contextRef="From2021-01-01to2021-06-30"
id="Fact_107"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:NetCashProvidedByUsedInInvestingActivities
contextRef="From2020-01-01to2020-06-30"
id="Fact_108"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:ProceedsFromRelatedPartyDebt
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_109"
unitRef="USD">47492</us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:ProceedsFromRelatedPartyDebt
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_110"
unitRef="USD">47376</us-gaap:ProceedsFromRelatedPartyDebt>
<us-gaap:NetCashProvidedByUsedInFinancingActivities
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_111"
unitRef="USD">47492</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:NetCashProvidedByUsedInFinancingActivities
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_112"
unitRef="USD">47376</us-gaap:NetCashProvidedByUsedInFinancingActivities>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_113"
unitRef="USD">-12560</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_114"
unitRef="USD">-13030</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_115"
unitRef="USD">39865</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2019-12-31"
decimals="0"
id="Fact_116"
unitRef="USD">52895</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_117"
unitRef="USD">27305</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:CashAndCashEquivalentsAtCarryingValue
contextRef="AsOf2020-06-30"
decimals="0"
id="Fact_118"
unitRef="USD">39865</us-gaap:CashAndCashEquivalentsAtCarryingValue>
<us-gaap:InterestPaidNet
contextRef="From2021-01-01to2021-06-30"
id="Fact_119"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:InterestPaidNet
contextRef="From2020-01-01to2020-06-30"
id="Fact_120"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:IncomeTaxesPaidNet
contextRef="From2021-01-01to2021-06-30"
id="Fact_121"
unitRef="USD"
xsi:nil="true"/>
<us-gaap:IncomeTaxesPaidNet
contextRef="From2020-01-01to2020-06-30"
id="Fact_122"
unitRef="USD"
xsi:nil="true"/>
<bfnh:CommonStockIssuedToPayAccountsPayableValue
contextRef="From2021-01-01to2021-06-30"
id="Fact_123"
unitRef="USD"
xsi:nil="true"/>
<bfnh:CommonStockIssuedToPayAccountsPayableValue
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_124"
unitRef="USD">1339</bfnh:CommonStockIssuedToPayAccountsPayableValue>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-03-31_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_125"
unitRef="Shares">15271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-03-31_us-gaap_CommonStockMember"
decimals="0"
id="Fact_126"
unitRef="USD">15272</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember"
decimals="INF"
id="Fact_127"
unitRef="Shares">2000000</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember"
decimals="0"
id="Fact_128"
unitRef="USD">2000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_129"
unitRef="USD">158793127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_130"
unitRef="USD">-158803110</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-03-31"
decimals="0"
id="Fact_131"
unitRef="USD">7289</us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss
contextRef="From2020-04-01to2020-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_132"
unitRef="USD">-126710</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2020-04-01to2020-06-30"
decimals="0"
id="Fact_133"
unitRef="USD">-126710</us-gaap:NetIncomeLoss>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_134"
unitRef="Shares">15271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
decimals="0"
id="Fact_135"
unitRef="USD">15272</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
decimals="INF"
id="Fact_136"
unitRef="Shares">2000000</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
decimals="0"
id="Fact_137"
unitRef="USD">2000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_138"
unitRef="USD">158793127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_139"
unitRef="USD">-158929820</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30"
decimals="0"
id="Fact_140"
unitRef="USD">-119421</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_141"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-03-31_us-gaap_CommonStockMember"
decimals="0"
id="Fact_142"
unitRef="USD">29272</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_143"
unitRef="USD">158781127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_144"
unitRef="USD">-159315386</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-03-31"
decimals="0"
id="Fact_145"
unitRef="USD">-504987</us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss
contextRef="From2021-04-01to2021-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_146"
unitRef="USD">-122315</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2021-04-01to2021-06-30"
decimals="0"
id="Fact_147"
unitRef="USD">-122315</us-gaap:NetIncomeLoss>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_148"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
decimals="0"
id="Fact_149"
unitRef="USD">29272</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_150"
unitRef="USD">158781127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_151"
unitRef="USD">-159437701</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_152"
unitRef="USD">-627302</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_153"
unitRef="Shares">15270588</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2019-12-31_us-gaap_CommonStockMember"
decimals="0"
id="Fact_154"
unitRef="USD">15271</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_155"
unitRef="USD">793789</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_156"
unitRef="USD">-761752</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2019-12-31"
decimals="0"
id="Fact_157"
unitRef="USD">47308</us-gaap:StockholdersEquity>
<bfnh:CommonStockIssuedToPayAccountsPayableShares
contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_158"
unitRef="Shares">1167</bfnh:CommonStockIssuedToPayAccountsPayableShares>
<bfnh:CommonStockIssuedToPayAccountsPayable
contextRef="From2020-01-01to2020-06-30_us-gaap_CommonStockMember"
decimals="0"
id="Fact_159"
unitRef="USD">1</bfnh:CommonStockIssuedToPayAccountsPayable>
<bfnh:CommonStockIssuedToPayAccountsPayable
contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_160"
unitRef="USD">1338</bfnh:CommonStockIssuedToPayAccountsPayable>
<bfnh:CommonStockIssuedToPayAccountsPayable
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_161"
unitRef="USD">1339</bfnh:CommonStockIssuedToPayAccountsPayable>
<us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
contextRef="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember"
decimals="INF"
id="Fact_162"
unitRef="Shares">2000000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices
contextRef="From2020-01-01to2020-06-30_us-gaap_PreferredStockMember"
decimals="0"
id="Fact_163"
unitRef="USD">2000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices
contextRef="From2020-01-01to2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_164"
unitRef="USD">157998000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_165"
unitRef="USD">158000000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:NetIncomeLoss
contextRef="From2020-01-01to2020-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_166"
unitRef="USD">-158168068</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2020-01-01to2020-06-30"
decimals="0"
id="Fact_167"
unitRef="USD">-158168068</us-gaap:NetIncomeLoss>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_168"
unitRef="Shares">15271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_CommonStockMember"
decimals="0"
id="Fact_169"
unitRef="USD">15272</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
decimals="INF"
id="Fact_170"
unitRef="Shares">2000000</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_PreferredStockMember"
decimals="0"
id="Fact_171"
unitRef="USD">2000</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_172"
unitRef="USD">158793127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_173"
unitRef="USD">-158929820</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-06-30"
decimals="0"
id="Fact_174"
unitRef="USD">-119421</us-gaap:StockholdersEquity>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_175"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-12-31_us-gaap_CommonStockMember"
decimals="0"
id="Fact_176"
unitRef="USD">29272</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_177"
unitRef="USD">158781127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_178"
unitRef="USD">-159170307</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2020-12-31"
decimals="0"
id="Fact_179"
unitRef="USD">-359908</us-gaap:StockholdersEquity>
<us-gaap:NetIncomeLoss
contextRef="From2021-01-01to2021-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_180"
unitRef="USD">-267394</us-gaap:NetIncomeLoss>
<us-gaap:NetIncomeLoss
contextRef="From2021-01-01to2021-06-30"
decimals="0"
id="Fact_181"
unitRef="USD">-267394</us-gaap:NetIncomeLoss>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
decimals="INF"
id="Fact_182"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
decimals="0"
id="Fact_183"
unitRef="USD">29272</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
decimals="0"
id="Fact_184"
unitRef="USD">158781127</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
decimals="0"
id="Fact_185"
unitRef="USD">-159437701</us-gaap:StockholdersEquity>
<us-gaap:StockholdersEquity
contextRef="AsOf2021-06-30"
decimals="0"
id="Fact_186"
unitRef="USD">-627302</us-gaap:StockholdersEquity>
<us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_189">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 1 – Organization &amp; Description of Business</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company was incorporated in the State of Nevada on December 10, 1999 as Silver River Ventures, Inc. On February 24, 2006, the Company completed the acquisition of BioForce Nanosciences Holdings Inc. (“BioForce”), a Delaware corporation, and changed the corporate name at that time. On May 6, 2020, the Company purchased 100,000 shares of Element Acquisition Corporation for $1,000 which then became a wholly owned subsidiary. The Company on October 15, 2020 changed the name of its wholly-owned subsidiary Element Acquisition Corporation, a Wyoming corporation, to BioForce Nanosciences Holdings, Inc, a Wyoming corporation. The Company’s mission is to become a leading provider of vitamin, mineral and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. </p></us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
<bfnh:BusinessAcquisitionEquityInterestsPurchasedNumberOfShares
contextRef="From2020-05-01to2020-05-06"
decimals="INF"
id="Fact_187"
unitRef="Shares">100000</bfnh:BusinessAcquisitionEquityInterestsPurchasedNumberOfShares>
<us-gaap:PaymentsToAcquireBusinessesGross
contextRef="From2020-05-01to2020-05-06"
decimals="0"
id="Fact_188"
unitRef="USD">1000</us-gaap:PaymentsToAcquireBusinessesGross>
<us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_197">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Basis of Presentation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The accompanying condensed consolidated balance sheet has been derived from the December 31, 2020 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2021 and 2020, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2021, are not necessarily indicative of the results of operations expected for the year ending December 31, 2021. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Principles of Consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Bioforce Nanosciences Holdings, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Earnings (Loss) per Share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-8-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; "><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC., AND SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO THE CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</span></p> <hr style="border-top:2.5pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies - continued</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Stock-Based Compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, <span style="font-style:italic; ">Compensation—Stock Compensation,</span> which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Fair Value of Financial Instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Revenue Recognition</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company implemented ASC 606, <span style="font-style:italic; ">Revenue from Contracts with Customers</span>. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. </p></us-gaap:SignificantAccountingPoliciesTextBlock>
<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_190">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Basis of Presentation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The accompanying condensed consolidated balance sheet has been derived from the December 31, 2020 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2021 and 2020, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2021, are not necessarily indicative of the results of operations expected for the year ending December 31, 2021. </p></us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
<us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_191">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Principles of Consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Bioforce Nanosciences Holdings, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. </p></us-gaap:ConsolidationPolicyTextBlock>
<us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-06-30" id="Fact_192">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p></us-gaap:UseOfEstimates>
<us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_193">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Earnings (Loss) per Share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. </p></us-gaap:EarningsPerSharePolicyTextBlock>
<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-06-30" id="Fact_194">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Stock-Based Compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, <span style="font-style:italic; ">Compensation—Stock Compensation,</span> which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. </p></us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2021-01-01to2021-06-30" id="Fact_195">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Fair Value of Financial Instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. </p></us-gaap:FairValueOfFinancialInstrumentsPolicy>
<us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_196">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Revenue Recognition</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company implemented ASC 606, <span style="font-style:italic; ">Revenue from Contracts with Customers</span>. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. </p></us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
<us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_198">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 3 – Recently Issued Accounting Standards</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements, including the new lease standard. The Company does not have any leases and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. </p></us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
<us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_199">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 4 – Going Concern</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">While the Company is attempting to continue operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes that the actions presently being taken to further implement the Company’s business plan; to expand sales with a dynamic marketing campaign and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. During the three and six months ended June 30, 2021 due to lack of revenues the officers of the Company paid for all expenses through loans to the Company. This allowed the Company to continue as a going concern. </p></us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
<us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_204">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5 – Related Party Transactions</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company’s Director, Secretary and Acting CFO, Richard Kaiser, is the operator of Yes International, a full-service investor relations firm. He handles duties of the Company regarding his officer capacities as the Secretary and Acting CFO, but also provides investor relations services through Yes International for the Company at no charge.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the six months ended June 30, 2021 and 2020, two board of directors paid expenses of the Company in the amount of $47,492 and $13,772, respectively. Due to related parties was $114,658 and $67,166 at June 30, 2021 and December 31, 2020, respectively. </p></us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
contextRef="From2021-01-01to2021-06-30_custom_TwoBoardOfDirectorsMember"
decimals="0"
id="Fact_200"
unitRef="USD">47492</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
contextRef="From2020-01-01to2020-06-30_custom_TwoBoardOfDirectorsMember"
decimals="0"
id="Fact_201"
unitRef="USD">13772</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
<us-gaap:DueToRelatedPartiesCurrent
contextRef="AsOf2021-06-30_custom_TwoBoardOfDirectorsMember"
decimals="0"
id="Fact_202"
unitRef="USD">114658</us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:DueToRelatedPartiesCurrent
contextRef="AsOf2020-12-31_custom_TwoBoardOfDirectorsMember"
decimals="0"
id="Fact_203"
unitRef="USD">67166</us-gaap:DueToRelatedPartiesCurrent>
<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_228">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 6 – Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Preferred Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Preferred stock consists of 100,000,000 shares authorized at $0.001 par value. 10,000,000 of these preferred shares have been separately allocated to Series A Preferred. Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock. At December 31, 2020 and 2019 there were -0- Series A Preferred shares issued and outstanding. On June 30, 2020, the Company issued <span style="-sec-ix-hidden:Fact_213">two</span> million shares of Series A preferred stock as compensation for their two board members. The preferred shares were valued at $158 million based on the market price of the Company’s common stock of $0.79 on the measurement date, given such preferred stock can be converted into 100 shares of common stock and has dividend and voting rights as though converted into common stock. On December 4, 2020, the two board of directors returned these 2,000,000 shares to be retired. In exchange the Company issued 14,000,000 common shares.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Common Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Common stock consists of 900,000,000 shares authorized at $0.001 par value. On November 25, 2019, the board of directors approved a 5 to 1 reverse split. At June 30, 2021 and December 31, 2020 there were 29,271,755 shares issued and outstanding, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued 1,167 shares of common stock in exchange for product payment that was recorded in stock payable in the amount of $1,339 at December 31, 2019. The fair value of the shares issued was based on the market price of the Company’s common stock on the measurement date. </p></us-gaap:StockholdersEquityNoteDisclosureTextBlock>
<us-gaap:PreferredStockParOrStatedValuePerShare
contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_206"
unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockParOrStatedValuePerShare
contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_205"
unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
<us-gaap:PreferredStockSharesAuthorized
contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_208"
unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesAuthorized
contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_207"
unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
<us-gaap:PreferredStockSharesIssued
contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_212"
unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesIssued
contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_211"
unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
<us-gaap:PreferredStockSharesOutstanding
contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_210"
unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:PreferredStockSharesOutstanding
contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember"
decimals="INF"
id="Fact_209"
unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
<us-gaap:StockIssuedDuringPeriodValueIssuedForServices
contextRef="From2020-06-01to2020-06-30_custom_TwoBoardOfDirectorsMember"
decimals="-6"
id="Fact_214"
unitRef="USD">158000000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
<us-gaap:SharesIssuedPricePerShare
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_215"
unitRef="USDPShares">0.79</us-gaap:SharesIssuedPricePerShare>
<bfnh:NumberOfReturnedAndCancelledShares
contextRef="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember"
decimals="INF"
id="Fact_216"
unitRef="Shares">2000000</bfnh:NumberOfReturnedAndCancelledShares>
<us-gaap:StockIssuedDuringPeriodSharesNewIssues
contextRef="From2020-12-01to2020-12-04_custom_TwoBoardOfDirectorsMember"
decimals="INF"
id="Fact_217"
unitRef="Shares">14000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
<us-gaap:CommonStockSharesAuthorized
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_219"
unitRef="Shares">900000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockSharesAuthorized
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_218"
unitRef="Shares">900000000</us-gaap:CommonStockSharesAuthorized>
<us-gaap:CommonStockParOrStatedValuePerShare
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_221"
unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockParOrStatedValuePerShare
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_220"
unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
<us-gaap:CommonStockSharesIssued
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_225"
unitRef="Shares">29271755</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesIssued
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_224"
unitRef="Shares">29271755</us-gaap:CommonStockSharesIssued>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2021-06-30"
decimals="INF"
id="Fact_223"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:CommonStockSharesOutstanding
contextRef="AsOf2020-12-31"
decimals="INF"
id="Fact_222"
unitRef="Shares">29271755</us-gaap:CommonStockSharesOutstanding>
<us-gaap:ConversionOfStockSharesIssued1
contextRef="From2020-01-01to2020-12-31"
decimals="INF"
id="Fact_226"
unitRef="Shares">1167</us-gaap:ConversionOfStockSharesIssued1>
<us-gaap:ProceedsFromOtherEquity
contextRef="From2020-01-01to2020-12-31"
decimals="0"
id="Fact_227"
unitRef="USD">1339</us-gaap:ProceedsFromOtherEquity>
<us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2021-01-01to2021-06-30" id="Fact_229">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 7 – Risks and Uncertainties</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Coronavirus Impact (COVID-19)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Due to the recent outbreak of the coronavirus reported in many countries worldwide, local and federal governments have issued travel advisories, canceled large scale public events and closed schools. In addition, companies have begun to cancel conferences and travel plans and require employees to work from home. Global financial markets have also experienced extreme volatility and disruptions to capital and credit markets.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We are unable to predict the impact of the coronavirus on our operations at this time. Adverse events such as health-related concerns about working in our offices, the inability to travel, potential impact on our business partners and customers, and other matters affecting the general work and business environment could harm our business and delay the implementation of our business strategy. The adverse events may also adversely impact our ability to raise capital or to continue as a going concern. We continue to monitor the recent outbreak of the coronavirus on our operations.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:24pt; margin-bottom:0pt; ">  </p></us-gaap:ConcentrationRiskDisclosureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660023899080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jul. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001310488<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30, 2021<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51074<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BIOFORCE NANOSCIENCES HOLDINGS, INC.<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-3078125<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2020 General Booth Blvd.<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Unit 230<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Virginia Beach<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23454<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">757<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">306-6090<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660023883672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 27,305<span></span>
</td>
<td class="nump">$ 39,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expenses</a></td>
<td class="nump">100<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">27,405<span></span>
</td>
<td class="nump">39,865<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">27,405<span></span>
</td>
<td class="nump">39,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">5,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrentAndNoncurrent', window );">Accrued Board of Directors Compensation</a></td>
<td class="nump">539,017<span></span>
</td>
<td class="nump">327,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to Related Parties</a></td>
<td class="nump">114,658<span></span>
</td>
<td class="nump">67,166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">654,707<span></span>
</td>
<td class="nump">399,773<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">654,707<span></span>
</td>
<td class="nump">399,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Deficit</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock - $0.001 Par; 900,000,000 Shares Authorized, 29,271,755 Issued and Outstanding, Respectively</a></td>
<td class="nump">29,272<span></span>
</td>
<td class="nump">29,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid-In-Capital</a></td>
<td class="nump">158,781,127<span></span>
</td>
<td class="nump">158,781,127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">(159,437,701)<span></span>
</td>
<td class="num">(159,170,307)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Deficit</a></td>
<td class="num">(627,302)<span></span>
</td>
<td class="num">(359,908)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Deficit</a></td>
<td class="nump">$ 27,405<span></span>
</td>
<td class="nump">$ 39,865<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660143131960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value (in Dollars per Share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized (in Shares)</a></td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued (in Shares)</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding (in Shares)</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660023755880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of Sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold', window );">Board of Directors Compensation</a></td>
<td class="nump">105,750<span></span>
</td>
<td class="nump">105,173<span></span>
</td>
<td class="nump">211,500<span></span>
</td>
<td class="nump">158,114,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
<td class="nump">16,565<span></span>
</td>
<td class="nump">21,537<span></span>
</td>
<td class="nump">55,894<span></span>
</td>
<td class="nump">53,205<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Expenses</a></td>
<td class="nump">122,315<span></span>
</td>
<td class="nump">126,710<span></span>
</td>
<td class="nump">267,394<span></span>
</td>
<td class="nump">158,168,068<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="num">$ (122,315)<span></span>
</td>
<td class="num">$ (126,710)<span></span>
</td>
<td class="num">$ (267,394)<span></span>
</td>
<td class="num">$ (158,168,068)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted Average Number of Common Shares - Basic and Diluted</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">15,271,755<span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">15,271,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net Loss for the Period Per Common Shares - Basic and Diluted</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (10.36)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660023866664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="num">$ (267,394)<span></span>
</td>
<td class="num">$ (158,168,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Non-Cash Adjustments:</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation', window );">Common and Preferred Stock Issued for Current Year Board of Directors Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Assets and Liabilities:</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid Expenses</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">3,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="num">(4,058)<span></span>
</td>
<td class="num">(10,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued Board of Directors Compensation</a></td>
<td class="nump">211,500<span></span>
</td>
<td class="nump">114,863<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Flows Used In Operating Activities</a></td>
<td class="num">(60,052)<span></span>
</td>
<td class="num">(60,406)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash Flows from Investing Activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from Related Parties</a></td>
<td class="nump">47,492<span></span>
</td>
<td class="nump">47,376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Flows Provided by Financing Activities</a></td>
<td class="nump">47,492<span></span>
</td>
<td class="nump">47,376<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="num">(12,560)<span></span>
</td>
<td class="num">(13,030)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash - Beginning of Period</a></td>
<td class="nump">39,865<span></span>
</td>
<td class="nump">52,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash - End of Period</a></td>
<td class="nump">27,305<span></span>
</td>
<td class="nump">39,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash Paid During the Period for:</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental Disclosures of Non Cash Investing and Financing Activities:</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_CommonStockIssuedToPayAccountsPayableValue', window );">Common Stock Issued to Pay Stock Payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common and Preferred Stock Issued for Current Year Board of Directors Compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_CommonStockIssuedToPayAccountsPayableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Issued to Pay Accounts Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_CommonStockIssuedToPayAccountsPayableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660027553096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 15,271<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 793,789<span></span>
</td>
<td class="num">$ (761,752)<span></span>
</td>
<td class="nump">$ 47,308<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2019</a></td>
<td class="nump">15,270,588<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_CommonStockIssuedToPayAccountsPayable', window );">Common Stock Issued for Product Payment - Stock Payable</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,338<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_CommonStockIssuedToPayAccountsPayableShares', window );">Common Stock Issued for Product Payment - Stock Payable, shares</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Preferred Shares Issued for Services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">157,998,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Preferred Shares Issued for Services, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(158,168,068)<span></span>
</td>
<td class="num">(158,168,068)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">$ 15,272<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">158,793,127<span></span>
</td>
<td class="num">(158,929,820)<span></span>
</td>
<td class="num">(119,421)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="nump">15,271,755<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 15,272<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">158,793,127<span></span>
</td>
<td class="num">(158,803,110)<span></span>
</td>
<td class="nump">7,289<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2020</a></td>
<td class="nump">15,271,755<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(126,710)<span></span>
</td>
<td class="num">(126,710)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">$ 15,272<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">158,793,127<span></span>
</td>
<td class="num">(158,929,820)<span></span>
</td>
<td class="num">(119,421)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Jun. 30, 2020</a></td>
<td class="nump">15,271,755<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 29,272<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">158,781,127<span></span>
</td>
<td class="num">(159,170,307)<span></span>
</td>
<td class="num">$ (359,908)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(267,394)<span></span>
</td>
<td class="num">$ (267,394)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 29,272<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">158,781,127<span></span>
</td>
<td class="num">(159,437,701)<span></span>
</td>
<td class="num">$ (627,302)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 29,272<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">158,781,127<span></span>
</td>
<td class="num">(159,315,386)<span></span>
</td>
<td class="num">$ (504,987)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Mar. 31, 2021</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss for the Period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122,315)<span></span>
</td>
<td class="num">(122,315)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 29,272<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 158,781,127<span></span>
</td>
<td class="num">$ (159,437,701)<span></span>
</td>
<td class="num">$ (627,302)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Jun. 30, 2021</a></td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_CommonStockIssuedToPayAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to pay accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_CommonStockIssuedToPayAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_CommonStockIssuedToPayAccountsPayableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Issued in Exchange for Product Payment, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_CommonStockIssuedToPayAccountsPayableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026660472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization & Description of Business<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Organization & Description of Business</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 1 – Organization & Description of Business</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company was incorporated in the State of Nevada on December 10, 1999 as Silver River Ventures, Inc. On February 24, 2006, the Company completed the acquisition of BioForce Nanosciences Holdings Inc. (“BioForce”), a Delaware corporation, and changed the corporate name at that time. On May 6, 2020, the Company purchased 100,000 shares of Element Acquisition Corporation for $1,000 which then became a wholly owned subsidiary. The Company on October 15, 2020 changed the name of its wholly-owned subsidiary Element Acquisition Corporation, a Wyoming corporation, to BioForce Nanosciences Holdings, Inc, a Wyoming corporation. The Company’s mission is to become a leading provider of vitamin, mineral and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660030277928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Basis of Presentation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The accompanying condensed consolidated balance sheet has been derived from the December 31, 2020 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2021 and 2020, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2021, are not necessarily indicative of the results of operations expected for the year ending December 31, 2021. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Principles of Consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Bioforce Nanosciences Holdings, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Earnings (Loss) per Share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-bottom:0pt; "/> <div> <div style="width:100%; clear:both;">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; ">-8-</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/> </div><div style="page-break-after:always;"/> </div>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:24pt; margin-bottom:0pt; "><span style="font-weight:bold; ">BIOFORCE NANOSCIENCES HOLDINGS, INC., AND SUBSIDIARY</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:center; margin-top:0pt; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTES TO THE CONDENSED CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS</span></p> <hr style="border-top:2.5pt solid #000000; width:100%; margin-left:0pt; text-align:left; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 2 – Summary of Significant Accounting Policies - continued</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Stock-Based Compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, <span style="font-style:italic; ">Compensation—Stock Compensation,</span> which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Fair Value of Financial Instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Revenue Recognition</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company implemented ASC 606, <span style="font-style:italic; ">Revenue from Contracts with Customers</span>. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026507416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recently Issued Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 3 – Recently Issued Accounting Standards</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements, including the new lease standard. The Company does not have any leases and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026773736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_GoingConcernAbstract', window );"><strong>Going Concern [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 4 – Going Concern</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company’s consolidated financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has reported recurring losses from operations and has net current liabilities and an accumulated deficit. These conditions raise substantial doubt as to the Company’s ability to continue as a going concern.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">While the Company is attempting to continue operations and generate revenues, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes that the actions presently being taken to further implement the Company’s business plan; to expand sales with a dynamic marketing campaign and generate revenues provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenues and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate revenues. During the three and six months ended June 30, 2021 due to lack of revenues the officers of the Company paid for all expenses through loans to the Company. This allowed the Company to continue as a going concern. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_GoingConcernAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_GoingConcernAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660114185992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-bottom:0pt; "/>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:0pt; margin-bottom:-12pt !important; margin-bottom:0pt; "><span style="font-weight:bold; ">NOTE 5 – Related Party Transactions</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:18pt; margin-bottom:0pt; ">The Company’s Director, Secretary and Acting CFO, Richard Kaiser, is the operator of Yes International, a full-service investor relations firm. He handles duties of the Company regarding his officer capacities as the Secretary and Acting CFO, but also provides investor relations services through Yes International for the Company at no charge.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the six months ended June 30, 2021 and 2020, two board of directors paid expenses of the Company in the amount of $47,492 and $13,772, respectively. Due to related parties was $114,658 and $67,166 at June 30, 2021 and December 31, 2020, respectively. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026551720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stock</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 6 – Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Preferred Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Preferred stock consists of 100,000,000 shares authorized at $0.001 par value. 10,000,000 of these preferred shares have been separately allocated to Series A Preferred. Preferred stock can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock. At December 31, 2020 and 2019 there were -0- Series A Preferred shares issued and outstanding. On June 30, 2020, the Company issued <span style="-sec-ix-hidden:Fact_213">two</span> million shares of Series A preferred stock as compensation for their two board members. The preferred shares were valued at $158 million based on the market price of the Company’s common stock of $0.79 on the measurement date, given such preferred stock can be converted into 100 shares of common stock and has dividend and voting rights as though converted into common stock. On December 4, 2020, the two board of directors returned these 2,000,000 shares to be retired. In exchange the Company issued 14,000,000 common shares.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Common Stock</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Common stock consists of 900,000,000 shares authorized at $0.001 par value. On November 25, 2019, the board of directors approved a 5 to 1 reverse split. At June 30, 2021 and December 31, 2020 there were 29,271,755 shares issued and outstanding, respectively. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">During the year ended December 31, 2020, the Company issued 1,167 shares of common stock in exchange for product payment that was recorded in stock payable in the amount of $1,339 at December 31, 2019. The fair value of the shares issued was based on the market price of the Company’s common stock on the measurement date. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026782888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:9pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">NOTE 7 – Risks and Uncertainties</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "><span style="font-weight:bold; ">Coronavirus Impact (COVID-19)</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Due to the recent outbreak of the coronavirus reported in many countries worldwide, local and federal governments have issued travel advisories, canceled large scale public events and closed schools. In addition, companies have begun to cancel conferences and travel plans and require employees to work from home. Global financial markets have also experienced extreme volatility and disruptions to capital and credit markets.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We are unable to predict the impact of the coronavirus on our operations at this time. Adverse events such as health-related concerns about working in our offices, the inability to travel, potential impact on our business partners and customers, and other matters affecting the general work and business environment could harm our business and delay the implementation of our business strategy. The adverse events may also adversely impact our ability to raise capital or to continue as a going concern. We continue to monitor the recent outbreak of the coronavirus on our operations.</p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:24pt; margin-bottom:0pt; ">  </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026666600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Basis of Presentation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The accompanying condensed consolidated balance sheet has been derived from the December 31, 2020 audited financial statements and the unaudited condensed consolidated financial statements as of June 30, 2021 and 2020, have been prepared in accordance with generally accepted accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements, and should be read in conjunction with the audited financial statements and related footnotes included in our Annual report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”). It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for fair condensed consolidated financial statements presentation. Operating results for the three and six months ended June 30, 2021, are not necessarily indicative of the results of operations expected for the year ending December 31, 2021. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Principles of Consolidation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The consolidated financial statements include the accounts of Bioforce Nanosciences Holdings, Inc., and its wholly owned subsidiary, Bioforce Nanosciences Holdings, Inc., a Wyoming corporation, (the “Company”). All significant inter-company balances have been eliminated in consolidation. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings (Loss) per Share</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Earnings (Loss) per Share</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">Earnings (loss) per share of common stock are computed in accordance with FASB ASC 260 “Earnings per Share”. Basic earnings (loss) per share are computed by dividing income or loss available to common shareholders by the weighted-average number of common shares outstanding for each period. Diluted earnings per share are calculated by adjusting the weighted average number of shares outstanding assuming conversion of all potentially dilutive stock options, warrants and convertible securities, if dilutive. Common stock equivalents that are anti-dilutive are excluded from both diluted weighted average number of common shares outstanding and diluted earnings (loss) per share. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:18pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Stock-Based Compensation</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">We account for employee and non-employee stock-based compensation in accordance with the guidance of FASB ASC Topic 718, <span style="font-style:italic; ">Compensation—Stock Compensation,</span> which requires all share-based payments, including grants of stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Fair Value of Financial Instruments</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts payable and accrued liabilities approximate fair value given their short-term nature or effective interest rates. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:12pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Revenue Recognition</span></p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company implemented ASC 606, <span style="font-style:italic; ">Revenue from Contracts with Customers</span>. These included the development of new policies based on the five-step model provided in the new revenue standard, ongoing contract review requirements, and gathering of information provided for disclosures. </p>
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:12pt; margin-bottom:0pt; ">The Company recognizes revenue and cost of goods sold from product sales or services rendered when control of the promised goods are transferred to our clients in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods and services. To achieve this core principle, we apply the following five steps: identify the contract with the client, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to performance obligations in the contract and recognize revenues when or as the Company satisfies a performance obligation. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660030291752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization & Description of Business (Details)<br></strong></div></th>
<th class="th">
<div>May 06, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDescriptionAbstract', window );"><strong>Business Combination, Description [Abstract]</strong></a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares', window );">Number of shares purchased | shares</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment to acquire subsidiary | $</a></td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660026390232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">$ 114,658<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 67,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember', window );">Two board of directors [Member]</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses</a></td>
<td class="nump">47,492<span></span>
</td>
<td class="nump">$ 13,772<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related parties</a></td>
<td class="nump">$ 114,658<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 67,166<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
function toggleNextSibling (e) {
if (e.nextSibling.style.display=='none') {
e.nextSibling.style.display='block';
} else { e.nextSibling.style.display='none'; }
}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139660028672344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 04, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, par value (in Dollars per Share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, shares authorized (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, shares issued (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, shares outstanding (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
<td class="nump">29,271,755<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Shares issued in exchange for product payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,167<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from exchange for product payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,339<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Preferred Shares Issued for Services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 158,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock per share</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember', window );">Two board of directors [Member]</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Preferred Shares Issued for Services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 158,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Preferred Shares Issued for Services, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bfnh_NumberOfReturnedAndCancelledShares', window );">Number of returned and cancelled shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, shares authorized (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, issued (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, outstanding (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bfnh_NumberOfReturnedAndCancelledShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Returned And Cancelled Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bfnh_NumberOfReturnedAndCancelledShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bfnh_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bfnh_TwoBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>31
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0 ( &MU_5('04UB@0 +$ 0 9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M " !K=?U2B<_C>^\ K @ $0 &1O8U!R;W!S+V-O<F4N>&ULS9+/
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M_K'Q6;!KX====%]02P,$% @ :W7]4IE<G",0!@ G"< !, !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>	+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !K=?U2SD^"T_0$ !J% & 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
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MQ9IFS*$5%FV'5:QC[*UOD#J8^1]?OC2\:TYER([;QB]O1<C)/(V>N:H%PT7
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M85]B:YY6N8.V*_^+<CO/_R+>9$NKOGYL4/S]^3ON(UF5(VC+' 'U4OX=;LH
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MAQ/30+F]./X74$L#!!0 ( &MU_5(.ZW3K(@0 #,. 8 >&PO=V]R
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M\SORS+9. M$6<F N^,0-,3!5\0EW!W#/ 9L#4+*51MA7( IRS0PUCVEBSEH
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M% @ :W7]4I3%4Q)L @ =P8 !@ !X;"]W;W)K<VAE971S+W-H965T
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M " !K=?U2+7DL(B$$ !X$ & 'AL+W=O<FMS:&5E=',O<VAE970T
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MSVH_7!OU&!J1KRII0<.!Y(:B*>4QTY5C@X+).]O&)WW\6J!. U0KX".\0<2
MV"<)[%H)ON6=!(7+OH=[OZ9HO$L7E*L4 !]^"JW,;$,@;T&Q.R B7N8?1A G
M.ZDM6P>%NXMC;=L^]MTKH:Z1V-4A@S=SAK<XFY9]0ZA328B=]]P5]7BG4L[5
ML59SYH\A00%IG5\.JV'AJC :&+8:CE>1Q3SKI%+*UWD+*]"2[3)YK)_+U;)-
M[N?-865]@!^&6+,>J+8Z[]Q.],>>_)'P=9P)E- 5N+(:/IPB/[:YQXEDV[R/
M6S )76$^W% 24:X \'[%F'R=* ?EGPV]_P%02P,$% @ :W7]4KF^YNWI
M! 'A( !@ !X;"]W;W)K<VAE971S+W-H965T-2YX;6RM6%MSZC80_BL:
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MA*-3?4N&4,3A?,8Q<HP&_]B16^#:OP/'=F -GO'EZK8!CEO0ZFI[;A.MB&_
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M9 M!M_I]?DF%H*F^W& 48:8$Y/T5I>)SH1P4GX0&_P)02P,$% @ :W7]
M4DIA<VT]!0 +!D !@ !X;"]W;W)K<VAE971S+W-H965T-BYX;6RU66MO
MJT80_2LKJU);Z3JPR_O*L93XH>LV<:PX:3]4_4!@':, Z\(ZOO??=\&$UP[8
M:=(O,=AGAC-GQL,Q&1U8\I)N*>7H>Q3&Z>5@R_GNJZ*DWI9&;GK!=C06GVQ8
M$KE<G";/2KI+J.OG05&H$%4UE<@-XL%XE+^W2L8CMN=A$--5@M)]%+G)CVL:
MLL/E _>WK@/GK<\>T,9CW;N,UU3_KA;)>),*;/X043C-& Q2NCF<G"%O\Z)
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M9[O\4?(3XYQ%^>&6NCY-,H#X?,,8?SO)GDZ7_R 9_PM02P,$% @ :W7]
M4C;E6-2_ P 5 @ !@ !X;"]W;W)K<VAE971S+W-H965T-RYX;6RU5MMN
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M5>X6/L#P1V+Q#U!+ P04 " !K=?U2.I<"1N4( "L%0 & 'AL+W=O
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M %!+ P04 " !K=?U2R-/D=<T" !5!@ & 'AL+W=O<FMS:&5E=',O
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M?(+^GR3]"U!+ P04 " !K=?U2HI17LS4$ 3"@ &0 'AL+W=O<FMS
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M ZS7SL7]"P<8[X'+?P%02P,$% @ :W7]4MC!+(TE P ^@8 !D !X
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MTXH>)[3L0/NE,?[.X ##<[?Z#5!+ P04 " !K=?U2DJ1!M<,# "<"
M&0 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R55MMNVS@0_96!MFA?7-T<
MQW%J&W NBW:!ID'3W7U8[ ,MC2TB%*F0E!7OU^^0NL1I$@-]L$Q2<\Z<&0XY
MFC=*WYL"T<)C*:19!(6UU7D4F:S DIE052CIS4;IDEF:ZFUD*HTL]Z!21&D<
MGT8EXS)8SOW:K5[.56T%EWBKP=1ER?3^ H5J%D$2] O?^;:P;B%:SBNVQ3NT
M?U:WFF;1P)+S$J7A2H+&S2)8)><7)\[>&_S%L3$'8W"1K)6Z=Y,O^2*(G2 4
MF%G'P.AOAY<HA",B&0\=9S"X=,##<<_^NX^=8EDS@Y=*_,US6RR"LP!RW+!:
MV.^J^8Q=/!/'EREA_!.:UG8\#2"KC55E!R8%)9?M/WOL\G .(O? *0=(/6Z
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M_@]02P,$% @ :W7]4N**HM'R P GP@ !D !X;"]W;W)K<VAE971S
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MG\-^XTT;GZ#,>&0Y+E%MF!1! />E0;$,FV!@_$^R^0M02P,$% @ :W7]
M4H>5L1S:" 8A@ !D !X;"]W;W)K<VAE971S+W-H965T,30N>&ULG5EM
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M^$Y7.,T#"6C_6^'VOU!+ P04 " !K=?U2E HRFB8" ""! &0 'AL
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MW75\%UA5^RY+E<6>]<L2/Q*@70*>%TK9?> :=_CL)/\!4$L#!!0 ( &MU
M_5(8_CY!F@( (8' 9 >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;+55
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ME[==OYU(5ID^N&92=54SS-5%"5P'J/T-8W(WT0GZJS?Y#5!+ P04 " !K
M=?U2A ?<. 0$ !"$0 &0 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6RU
M6%V3VC84_2L:3Q\V,^G:,AA#!IC)0K+=3-/9"4W[D.F#L"^@6=NBD@R;_OI*
MLM<?BS&BG? EGW/\;FZ\M$UTR/C3V('(-%SFF1BYNRDW+]S71'M("7BENTA
M4U<VC*=$JB'?NF+/@<0&E":N[WDC-R4T<^93<^Z1SZ<LEPG-X)$CD:<IX=_O
M(&''F8.=EQ-?Z'8G]0EW/MV3+:Q ?MT_<C5R*Y:8II )RC+$83-SWN-W][ZO
M 2;B#PI'T3A&.I4U8T]Z\!#/'$\K@@0BJ2F(^CG I)$,RD=?Y>D3G5/#6P>
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M8%Z\L!<#R?;F?7'-I'K[-(<[(#%P':"N;QB3+P/]"EK];3+_%U!+ P04
M" !K=?U2^?(N<PL# "+$ #0 'AL+W-T>6QE<RYX;6S=6&UOFS 0_BN(
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MWP_SWU!+ P04 " !K=?U2EXJ[', 3 @ "P %]R96QS+RYR96QS
MG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2
MW!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N
M&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HC
ME5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,E
MC'%BM/XU@LD/['X 4$L#!!0 ( &MU_5+,T#A6<0( %L, / >&PO
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MX_)UNO @+P.0EV>$/*GD( Y."?DA0<Y#$ .NX5<ZBV5<' .\HZ6U2>2<L,T
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M9^/C7'__$U!+ P04 " !K=?U2Z8E.MP\! :"P &@ 'AL+U]R96QS
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MYO%;FJ^?QN?A6W:F.(/X%3[\ E!+ P04 " !K=?U2AX2XJE@! !7#
M$P %M#;VYT96YT7U1Y<&5S72YX;6S-E\M.PS 017\ERK9*7!<H#[7= %OH
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M^*+[GYA] E!+ 0(4 Q0 ( &MU_5('04UB@0 +$ 0
M " 0 !D;V-0<F]P<R]A<' N>&UL4$L! A0#% @ :W7]4HG/XWOO
M *P( !$ ( !KP &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#% @ :W7]4IE<G",0!@ G"< !, ( !S0$ 'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4 " !K=?U2SD^"T_0$ !J%
M& @($." >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#% @ :W7]4@[K=.LB! ,PX !@ ("!. T 'AL
M+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0 ( &MU_5*4Q5,2; (
M '<& 8 " @9 1 !X;"]W;W)K<VAE971S+W-H965T,RYX
M;6Q02P$"% ,4 " !K=?U2+7DL(B$$ !X$ & @($R
M% >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#% @ :W7]4KF^
MYNWI! 'A( !@ ("!B1@ 'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;%!+ 0(4 Q0 ( &MU_5)*87-M/04 "P9 8
M " @:@= !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4 " !K
M=?U2-N58U+\# !4" & @($;(P >&PO=V]R:W-H965T
M<R]S:&5E=#<N>&UL4$L! A0#% @ :W7]4CJ7 D;E" K!4 !@
M ("!$"< 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0
M ( &MU_5+(T^1US0( %4& 8 " @2LP !X;"]W;W)K
M<VAE971S+W-H965T.2YX;6Q02P$"% ,4 " !K=?U2HI17LS4$ 3"@
M&0 @($N,P >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+
M 0(4 Q0 ( &MU_5+8P2R-)0, /H& 9 " @9HW !X
M;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#% @ :W7]4I*D0;7#
M P G @ !D ("!]CH 'AL+W=O<FMS:&5E=',O<VAE970Q
M,BYX;6Q02P$"% ,4 " !K=?U2XHJBT?(# "?" &0
M@('P/@ >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0 ( &MU
M_5*'E;$<V@@ &(8 9 " @1E# !X;"]W;W)K<VAE971S
M+W-H965T,30N>&UL4$L! A0#% @ :W7]4I0*,IHF @ @@0 !D
M ("!*DP 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
M " !K=?U2&/X^09H" "&!P &0 @(&'3@ >&PO=V]R
M:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0 ( &MU_5*$!]PX! 0 $(1
M 9 " @5A1 !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
M4$L! A0#% @ :W7]4OGR+G,+ P BQ T ( !DU4
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4 " !K=?U2EXJ[', 3 @ "P
M @ ')6 7W)E;',O+G)E;'-02P$"% ,4 " !K=?U2S- X
M5G$" !;# #P @ &R60 >&PO=V]R:V)O;VLN>&UL4$L!
M A0#% @ :W7]4NF)3K</ 0 &@L !H ( !4%P 'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#% @ :W7]4H>$N*I8
M 0 5PP !, ( !EUT %M#;VYT96YT7U1Y<&5S72YX;6Q0
52P4& !D &0"F!@ (%\
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */
/* DefRef Styles */
..report table.authRefData{
background-color: #def;
border: 2px solid #2F4497;
font-size: 1em;
position: absolute;
}
..report table.authRefData a {
display: block;
font-weight: bold;
}
..report table.authRefData p {
margin-top: 0px;
}
..report table.authRefData .hide {
background-color: #2F4497;
padding: 1px 3px 0px 0px;
text-align: right;
}
..report table.authRefData .hide a:hover {
background-color: #2F4497;
}
..report table.authRefData .body {
height: 150px;
overflow: auto;
width: 400px;
}
..report table.authRefData table{
font-size: 1em;
}
/* Report Styles */
..pl a, .pl a:visited {
color: black;
text-decoration: none;
}
/* table */
..report {
background-color: white;
border: 2px solid #acf;
clear: both;
color: black;
font: normal 8pt Helvetica, Arial, san-serif;
margin-bottom: 2em;
}
..report hr {
border: 1px solid #acf;
}
/* Top labels */
..report th {
background-color: #acf;
color: black;
font-weight: bold;
text-align: center;
}
..report th.void {
background-color: transparent;
color: #000000;
font: bold 10pt Helvetica, Arial, san-serif;
text-align: left;
}
..report .pl {
text-align: left;
vertical-align: top;
white-space: normal;
width: 200px;
white-space: normal; /* word-wrap: break-word; */
}
..report td.pl a.a {
cursor: pointer;
display: block;
width: 200px;
overflow: hidden;
}
..report td.pl div.a {
width: 200px;
}
..report td.pl a:hover {
background-color: #ffc;
}
/* Header rows... */
..report tr.rh {
background-color: #acf;
color: black;
font-weight: bold;
}
/* Calendars... */
..report .rc {
background-color: #f0f0f0;
}
/* Even rows... */
..report .re, .report .reu {
background-color: #def;
}
..report .reu td {
border-bottom: 1px solid black;
}
/* Odd rows... */
..report .ro, .report .rou {
background-color: white;
}
..report .rou td {
border-bottom: 1px solid black;
}
..report .rou table td, .report .reu table td {
border-bottom: 0px solid black;
}
/* styles for footnote marker */
..report .fn {
white-space: nowrap;
}
/* styles for numeric types */
..report .num, .report .nump {
text-align: right;
white-space: nowrap;
}
..report .nump {
padding-left: 2em;
}
..report .nump {
padding: 0px 0.4em 0px 2em;
}
/* styles for text types */
..report .text {
text-align: left;
white-space: normal;
}
..report .text .big {
margin-bottom: 1em;
width: 17em;
}
..report .text .more {
display: none;
}
..report .text .note {
font-style: italic;
font-weight: bold;
}
..report .text .small {
width: 10em;
}
..report sup {
font-style: italic;
}
..report .outerFootnotes {
font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
<Version>3.21.2</Version>
<ProcessingTime/>
<ReportFormat>html</ReportFormat>
<ContextCount>48</ContextCount>
<ElementCount>165</ElementCount>
<EntityCount>1</EntityCount>
<FootnotesReported>false</FootnotesReported>
<SegmentCount>6</SegmentCount>
<ScenarioCount>0</ScenarioCount>
<TuplesReported>false</TuplesReported>
<UnitCount>3</UnitCount>
<MyReports>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R1.htm</HtmlFileName>
<LongName>00010 - Document - Document and Entity Information</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/DocumentAndEntityInformation</Role>
<ShortName>Document and Entity Information</ShortName>
<MenuCategory>Cover</MenuCategory>
<Position>1</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R2.htm</HtmlFileName>
<LongName>00020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited</Role>
<ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED</ShortName>
<MenuCategory>Statements</MenuCategory>
<Position>2</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R3.htm</HtmlFileName>
<LongName>00030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical)</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical</Role>
<ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical)</ShortName>
<MenuCategory>Statements</MenuCategory>
<Position>3</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R4.htm</HtmlFileName>
<LongName>00040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited</Role>
<ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED</ShortName>
<MenuCategory>Statements</MenuCategory>
<Position>4</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R5.htm</HtmlFileName>
<LongName>00050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited</Role>
<ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED</ShortName>
<MenuCategory>Statements</MenuCategory>
<Position>5</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R6.htm</HtmlFileName>
<LongName>00060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited</Role>
<ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED</ShortName>
<MenuCategory>Statements</MenuCategory>
<Position>6</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R7.htm</HtmlFileName>
<LongName>00070 - Disclosure - Organization & Description of Business</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/OrganizationDescriptionOfBusiness</Role>
<ShortName>Organization & Description of Business</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>7</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R8.htm</HtmlFileName>
<LongName>00080 - Disclosure - Summary of Significant Accounting Policies</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies</Role>
<ShortName>Summary of Significant Accounting Policies</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>8</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R9.htm</HtmlFileName>
<LongName>00090 - Disclosure - Recently Issued Accounting Standards</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/RecentlyIssuedAccountingStandards</Role>
<ShortName>Recently Issued Accounting Standards</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>9</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R10.htm</HtmlFileName>
<LongName>00100 - Disclosure - Going Concern</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/GoingConcern</Role>
<ShortName>Going Concern</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>10</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R11.htm</HtmlFileName>
<LongName>00110 - Disclosure - Related Party Transactions</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/RelatedPartyTransactions</Role>
<ShortName>Related Party Transactions</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>11</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R12.htm</HtmlFileName>
<LongName>00120 - Disclosure - Stock</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/Stock</Role>
<ShortName>Stock</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>12</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R13.htm</HtmlFileName>
<LongName>00130 - Disclosure - Risks and Uncertainties</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/RisksAndUncertainties</Role>
<ShortName>Risks and Uncertainties</ShortName>
<MenuCategory>Notes</MenuCategory>
<Position>13</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R14.htm</HtmlFileName>
<LongName>00150 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
<ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
<MenuCategory>Policies</MenuCategory>
<ParentRole>http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
<Position>14</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R15.htm</HtmlFileName>
<LongName>00160 - Disclosure - Organization & Description of Business (Details)</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails</Role>
<ShortName>Organization & Description of Business (Details)</ShortName>
<MenuCategory>Details</MenuCategory>
<ParentRole>http://bioforcenano.com/role/OrganizationDescriptionOfBusiness</ParentRole>
<Position>15</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R16.htm</HtmlFileName>
<LongName>00170 - Disclosure - Related Party Transactions (Details)</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/RelatedPartyTransactionsDetails</Role>
<ShortName>Related Party Transactions (Details)</ShortName>
<MenuCategory>Details</MenuCategory>
<ParentRole>http://bioforcenano.com/role/RelatedPartyTransactions</ParentRole>
<Position>16</Position>
</Report>
<Report instance="bfnh10q0621.htm">
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<HtmlFileName>R17.htm</HtmlFileName>
<LongName>00180 - Disclosure - Stock (Details)</LongName>
<ReportType>Sheet</ReportType>
<Role>http://bioforcenano.com/role/StockDetails</Role>
<ShortName>Stock (Details)</ShortName>
<MenuCategory>Details</MenuCategory>
<ParentRole>http://bioforcenano.com/role/Stock</ParentRole>
<Position>17</Position>
</Report>
<Report>
<IsDefault>false</IsDefault>
<HasEmbeddedReports>false</HasEmbeddedReports>
<LongName>All Reports</LongName>
<ReportType>Book</ReportType>
<ShortName>All Reports</ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-Q" original="bfnh10q0621.htm">bfnh10q0621.htm</File>
<File>bfnh-20210630.xsd</File>
<File>bfnh-20210630_cal.xml</File>
<File>bfnh-20210630_def.xml</File>
<File>bfnh-20210630_lab.xml</File>
<File>bfnh-20210630_pre.xml</File>
</InputFiles>
<SupplementalFiles>
<File>bfnhlogo2019001.jpg</File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
<BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase>true</HasPresentationLinkbase>
<HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>37
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
"instance": {
"bfnh10q0621.htm": {
"axisCustom": 0,
"axisStandard": 3,
"contextCount": 48,
"dts": {
"calculationLink": {
"local": [
"bfnh-20210630_cal.xml"
]
},
"definitionLink": {
"local": [
"bfnh-20210630_def.xml"
]
},
"inline": {
"local": [
"bfnh10q0621.htm"
]
},
"labelLink": {
"local": [
"bfnh-20210630_lab.xml"
],
"remote": [
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
]
},
"presentationLink": {
"local": [
"bfnh-20210630_pre.xml"
]
},
"referenceLink": {
"remote": [
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
]
},
"schema": {
"local": [
"bfnh-20210630.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
"https://xbrl.sec.gov/country/2021/country-2021.xsd",
"https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
"https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
"https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
"https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
"https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
"https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
"https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd"
]
}
},
"elementCount": 155,
"entityCount": 1,
"hidden": {
"http://fasb.org/us-gaap/2021-01-31": 1,
"http://xbrl.sec.gov/dei/2021": 10,
"total": 11
},
"keyCustom": 6,
"keyStandard": 159,
"memberCustom": 1,
"memberStandard": 5,
"nsprefix": "bfnh",
"nsuri": "http://bioforcenano.com/20210630",
"report": {
"R1": {
"firstAnchor": {
"ancestors": [
"span",
"p",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "document",
"isDefault": "true",
"longName": "00010 - Document - Document and Entity Information",
"role": "http://bioforcenano.com/role/DocumentAndEntityInformation",
"shortName": "Document and Entity Information",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"span",
"p",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "dei:DocumentType",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R10": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00100 - Disclosure - Going Concern",
"role": "http://bioforcenano.com/role/GoingConcern",
"shortName": "Going Concern",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R11": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00110 - Disclosure - Related Party Transactions",
"role": "http://bioforcenano.com/role/RelatedPartyTransactions",
"shortName": "Related Party Transactions",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R12": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00120 - Disclosure - Stock",
"role": "http://bioforcenano.com/role/Stock",
"shortName": "Stock",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R13": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00130 - Disclosure - Risks and Uncertainties",
"role": "http://bioforcenano.com/role/RisksAndUncertainties",
"shortName": "Risks and Uncertainties",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R14": {
"firstAnchor": {
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00150 - Disclosure - Summary of Significant Accounting Policies (Policies)",
"role": "http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
"shortName": "Summary of Significant Accounting Policies (Policies)",
"subGroupType": "policies",
"uniqueAnchor": {
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R15": {
"firstAnchor": {
"ancestors": [
"p",
"us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2020-05-01to2020-05-06",
"decimals": "INF",
"first": true,
"lang": null,
"name": "bfnh:BusinessAcquisitionEquityInterestsPurchasedNumberOfShares",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00160 - Disclosure - Organization & Description of Business (Details)",
"role": "http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails",
"shortName": "Organization & Description of Business (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2020-05-01to2020-05-06",
"decimals": "INF",
"first": true,
"lang": null,
"name": "bfnh:BusinessAcquisitionEquityInterestsPurchasedNumberOfShares",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
}
},
"R16": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2021-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:DueToRelatedPartiesCurrent",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00170 - Disclosure - Related Party Transactions (Details)",
"role": "http://bioforcenano.com/role/RelatedPartyTransactionsDetails",
"shortName": "Related Party Transactions (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30_custom_TwoBoardOfDirectorsMember",
"decimals": "0",
"lang": null,
"name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R17": {
"firstAnchor": {
"ancestors": [
"us-gaap:CommonStockParOrStatedValuePerShare",
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2020-12-31",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unitRef": "USDPShares",
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00180 - Disclosure - Stock (Details)",
"role": "http://bioforcenano.com/role/StockDetails",
"shortName": "Stock (Details)",
"subGroupType": "details",
"uniqueAnchor": {
"ancestors": [
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2020-01-01to2020-12-31",
"decimals": "INF",
"lang": null,
"name": "us-gaap:ConversionOfStockSharesIssued1",
"reportCount": 1,
"unique": true,
"unitRef": "Shares",
"xsiNil": "false"
}
},
"R2": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2021-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED",
"role": "http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2021-06-30",
"decimals": "0",
"lang": null,
"name": "us-gaap:PrepaidExpenseCurrent",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R3": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2021-06-30",
"decimals": "INF",
"first": true,
"lang": null,
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"reportCount": 1,
"unitRef": "USDPShares",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical)",
"role": "http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED (Parenthetical)",
"subGroupType": "parenthetical",
"uniqueAnchor": null
},
"R4": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-04-01to2021-06-30",
"decimals": null,
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "true"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED",
"role": "http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-04-01to2021-06-30",
"decimals": null,
"first": true,
"lang": null,
"name": "us-gaap:Revenues",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "true"
}
},
"R5": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:NetIncomeLoss",
"reportCount": 1,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED",
"role": "http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"lang": null,
"name": "bfnh:CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "true"
}
},
"R6": {
"firstAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
},
"groupType": "statement",
"isDefault": "false",
"longName": "00060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED",
"role": "http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited",
"shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - UNAUDITED",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"p",
"td",
"tr",
"tbody",
"table",
"div",
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember",
"decimals": "0",
"first": true,
"lang": null,
"name": "us-gaap:StockholdersEquity",
"reportCount": 1,
"unique": true,
"unitRef": "USD",
"xsiNil": "false"
}
},
"R7": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00070 - Disclosure - Organization & Description of Business",
"role": "http://bioforcenano.com/role/OrganizationDescriptionOfBusiness",
"shortName": "Organization & Description of Business",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R8": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00080 - Disclosure - Summary of Significant Accounting Policies",
"role": "http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies",
"shortName": "Summary of Significant Accounting Policies",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
},
"R9": {
"firstAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
},
"groupType": "disclosure",
"isDefault": "false",
"longName": "00090 - Disclosure - Recently Issued Accounting Standards",
"role": "http://bioforcenano.com/role/RecentlyIssuedAccountingStandards",
"shortName": "Recently Issued Accounting Standards",
"subGroupType": "",
"uniqueAnchor": {
"ancestors": [
"div",
"body",
"html"
],
"baseRef": "bfnh10q0621.htm",
"contextRef": "From2021-01-01to2021-06-30",
"decimals": null,
"first": true,
"lang": "en-US",
"name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"reportCount": 1,
"unique": true,
"unitRef": null,
"xsiNil": "false"
}
}
},
"segmentCount": 6,
"tag": {
"bfnh_BusinessAcquisitionEquityInterestsPurchasedNumberOfShares": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares purchased.",
"label": "Number of shares purchased"
}
}
},
"localname": "BusinessAcquisitionEquityInterestsPurchasedNumberOfShares",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails"
],
"xbrltype": "sharesItemType"
},
"bfnh_CapitalContributionDirectors": {
"auth_ref": [],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Capital Contribution - Directors.",
"label": "Capital Contributions - Directors"
}
}
},
"localname": "CapitalContributionDirectors",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"bfnh_CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation": {
"auth_ref": [],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 8.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Common and Preferred Stock Issued for Current Year Board of Directors Compensation.",
"label": "Common and Preferred Stock Issued for Current Year Board of Directors Compensation"
}
}
},
"localname": "CommonAndPreferredStockIssuedForCurrentYearBoardOfDirectorsCompensation",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"bfnh_CommonStockIssuedToPayAccountsPayable": {
"auth_ref": [],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Common stock issued to pay accounts payable.",
"label": "Common Stock Issued for Product Payment - Stock Payable"
}
}
},
"localname": "CommonStockIssuedToPayAccountsPayable",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"bfnh_CommonStockIssuedToPayAccountsPayableShares": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Common Stock Issued in Exchange for Product Payment, shares.",
"label": "Common Stock Issued for Product Payment - Stock Payable, shares"
}
}
},
"localname": "CommonStockIssuedToPayAccountsPayableShares",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "sharesItemType"
},
"bfnh_CommonStockIssuedToPayAccountsPayableValue": {
"auth_ref": [],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Common Stock Issued to Pay Accounts Payable.",
"label": "Common Stock Issued to Pay Stock Payable"
}
}
},
"localname": "CommonStockIssuedToPayAccountsPayableValue",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"bfnh_DocumentAndEntityInformationAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Document And Entity Information"
}
}
},
"localname": "DocumentAndEntityInformationAbstract",
"nsuri": "http://bioforcenano.com/20210630",
"xbrltype": "stringItemType"
},
"bfnh_GainLossOnLiabilitySettlement": {
"auth_ref": [],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Loss on liability settlement.",
"label": "Loss on Liability Settlement"
}
}
},
"localname": "GainLossOnLiabilitySettlement",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "monetaryItemType"
},
"bfnh_GoingConcernAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Going Concern [Abstract]"
}
}
},
"localname": "GoingConcernAbstract",
"nsuri": "http://bioforcenano.com/20210630",
"xbrltype": "stringItemType"
},
"bfnh_NumberOfReturnedAndCancelledShares": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Number Of Returned And Cancelled Shares.",
"label": "Number of returned and cancelled shares"
}
}
},
"localname": "NumberOfReturnedAndCancelledShares",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"bfnh_StockPayableCurrent": {
"auth_ref": [],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 4.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Stock Payable",
"label": "Stock Payable"
}
}
},
"localname": "StockPayableCurrent",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"bfnh_TwoBoardOfDirectorsMember": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Two board of directors [Member]",
"label": "Two board of directors [Member]"
}
}
},
"localname": "TwoBoardOfDirectorsMember",
"nsuri": "http://bioforcenano.com/20210630",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "domainItemType"
},
"dei_AmendmentFlag": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
"label": "Amendment Flag"
}
}
},
"localname": "AmendmentFlag",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_CityAreaCode": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Area code of city",
"label": "City Area Code"
}
}
},
"localname": "CityAreaCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_CurrentFiscalYearEndDate": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "End date of current fiscal year in the format --MM-DD.",
"label": "Current Fiscal Year End Date"
}
}
},
"localname": "CurrentFiscalYearEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "gMonthDayItemType"
},
"dei_DocumentFiscalPeriodFocus": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
"label": "Document Fiscal Period Focus"
}
}
},
"localname": "DocumentFiscalPeriodFocus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "fiscalPeriodItemType"
},
"dei_DocumentFiscalYearFocus": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
"label": "Document Fiscal Year Focus"
}
}
},
"localname": "DocumentFiscalYearFocus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "gYearItemType"
},
"dei_DocumentPeriodEndDate": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.",
"label": "Document Period End Date"
}
}
},
"localname": "DocumentPeriodEndDate",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "dateItemType"
},
"dei_DocumentQuarterlyReport": {
"auth_ref": [
"r270"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as an quarterly report.",
"label": "Document Quarterly Report"
}
}
},
"localname": "DocumentQuarterlyReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentTransitionReport": {
"auth_ref": [
"r271"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true only for a form used as a transition report.",
"label": "Document Transition Report"
}
}
},
"localname": "DocumentTransitionReport",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_DocumentType": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
"label": "Document Type"
}
}
},
"localname": "DocumentType",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "submissionTypeItemType"
},
"dei_EntityAddressAddressLine1": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 1 such as Attn, Building Name, Street Name",
"label": "Entity Address, Address Line One"
}
}
},
"localname": "EntityAddressAddressLine1",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressAddressLine2": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Address Line 2 such as Street or Suite number",
"label": "Entity Address, Address Line Two"
}
}
},
"localname": "EntityAddressAddressLine2",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressCityOrTown": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the City or Town",
"label": "Entity Address, City or Town"
}
}
},
"localname": "EntityAddressCityOrTown",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressPostalZipCode": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Code for the postal or zip code",
"label": "Entity Address, Postal Zip Code"
}
}
},
"localname": "EntityAddressPostalZipCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityAddressStateOrProvince": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the state or province.",
"label": "Entity Address, State or Province"
}
}
},
"localname": "EntityAddressStateOrProvince",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "stateOrProvinceItemType"
},
"dei_EntityCentralIndexKey": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
"label": "Entity Central Index Key"
}
}
},
"localname": "EntityCentralIndexKey",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "centralIndexKeyItemType"
},
"dei_EntityCommonStockSharesOutstanding": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
"label": "Entity Common Stock, Shares Outstanding"
}
}
},
"localname": "EntityCommonStockSharesOutstanding",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "sharesItemType"
},
"dei_EntityCurrentReportingStatus": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Current Reporting Status"
}
}
},
"localname": "EntityCurrentReportingStatus",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityEmergingGrowthCompany": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate if registrant meets the emerging growth company criteria.",
"label": "Entity Emerging Growth Company"
}
}
},
"localname": "EntityEmergingGrowthCompany",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityFileNumber": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
"label": "Entity File Number"
}
}
},
"localname": "EntityFileNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "fileNumberItemType"
},
"dei_EntityFilerCategory": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
"label": "Entity Filer Category"
}
}
},
"localname": "EntityFilerCategory",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "filerCategoryItemType"
},
"dei_EntityIncorporationStateCountryCode": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Two-character EDGAR code representing the state or country of incorporation.",
"label": "Entity Incorporation State or Country Code"
}
}
},
"localname": "EntityIncorporationStateCountryCode",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "edgarStateCountryItemType"
},
"dei_EntityInteractiveDataCurrent": {
"auth_ref": [
"r274"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
"label": "Entity Interactive Data Current"
}
}
},
"localname": "EntityInteractiveDataCurrent",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "yesNoItemType"
},
"dei_EntityRegistrantName": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
"label": "Entity Registrant Name"
}
}
},
"localname": "EntityRegistrantName",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_EntityShellCompany": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
"label": "Entity Shell Company"
}
}
},
"localname": "EntityShellCompany",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntitySmallBusiness": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
"label": "Entity Small Business"
}
}
},
"localname": "EntitySmallBusiness",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "booleanItemType"
},
"dei_EntityTaxIdentificationNumber": {
"auth_ref": [
"r272"
],
"lang": {
"en-us": {
"role": {
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
"label": "Entity Tax Identification Number"
}
}
},
"localname": "EntityTaxIdentificationNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "employerIdItemType"
},
"dei_LocalPhoneNumber": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Local phone number for entity.",
"label": "Local Phone Number"
}
}
},
"localname": "LocalPhoneNumber",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "normalizedStringItemType"
},
"dei_Security12bTitle": {
"auth_ref": [
"r268"
],
"lang": {
"en-us": {
"role": {
"documentation": "Title of a 12(b) registered security.",
"label": "Title of 12(b) Security"
}
}
},
"localname": "Security12bTitle",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "securityTitleItemType"
},
"dei_SecurityExchangeName": {
"auth_ref": [
"r269"
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of the Exchange on which a security is registered.",
"label": "Name of Exchange on which Security is Registered"
}
}
},
"localname": "SecurityExchangeName",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "edgarExchangeCodeItemType"
},
"dei_TradingSymbol": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Trading symbol of an instrument as listed on an exchange.",
"label": "Trading Symbol"
}
}
},
"localname": "TradingSymbol",
"nsuri": "http://xbrl.sec.gov/dei/2021",
"presentation": [
"http://bioforcenano.com/role/DocumentAndEntityInformation"
],
"xbrltype": "tradingSymbolItemType"
},
"us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Accounting Changes and Error Corrections [Abstract]"
}
}
},
"localname": "AccountingChangesAndErrorCorrectionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountingPoliciesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"localname": "AccountingPoliciesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"auth_ref": [
"r21"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
"label": "Accounts Payable and Accrued Expenses"
}
}
},
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AccruedSalariesCurrentAndNoncurrent": {
"auth_ref": [
"r250",
"r258"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.",
"label": "Accrued Board of Directors Compensation"
}
}
},
"localname": "AccruedSalariesCurrentAndNoncurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalCommonStock": {
"auth_ref": [
"r14"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 3.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
"label": "Additional Paid-In-Capital"
}
}
},
"localname": "AdditionalPaidInCapitalCommonStock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AdditionalPaidInCapitalMember": {
"auth_ref": [
"r63",
"r64",
"r65",
"r186",
"r187",
"r188",
"r203"
],
"lang": {
"en-us": {
"role": {
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
"label": "Additional Paid-In Capital [Member]"
}
}
},
"localname": "AdditionalPaidInCapitalMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Non-Cash Adjustments:"
}
}
},
"localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
"auth_ref": [],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
"label": "Additional paid in capital contributed"
}
}
},
"localname": "AdjustmentsToAdditionalPaidInCapitalOther",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Assets": {
"auth_ref": [
"r60",
"r105",
"r108",
"r114",
"r122",
"r129",
"r130",
"r131",
"r133",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r197",
"r200",
"r207",
"r227",
"r229",
"r248",
"r254"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets",
"totalLabel": "Total Assets"
}
}
},
"localname": "Assets",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "ASSETS"
}
}
},
"localname": "AssetsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_AssetsCurrent": {
"auth_ref": [
"r7",
"r9",
"r27",
"r60",
"r122",
"r129",
"r130",
"r131",
"r133",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r197",
"r200",
"r207",
"r227",
"r229"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_Assets",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
"label": "Assets, Current",
"totalLabel": "Total Current Assets"
}
}
},
"localname": "AssetsCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_AssetsCurrentAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Current Assets"
}
}
},
"localname": "AssetsCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Basis of Presentation"
}
}
},
"localname": "BasisOfAccountingPolicyPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_BusinessCombinationDescriptionAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Business Combination, Description [Abstract]"
}
}
},
"localname": "BusinessCombinationDescriptionAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
"auth_ref": [
"r4",
"r62",
"r102"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
"label": "Organization & Description of Business"
}
}
},
"localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/OrganizationDescriptionOfBusiness"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashAndCashEquivalentsAtCarryingValue": {
"auth_ref": [
"r5",
"r19",
"r49"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
"label": "Cash",
"periodEndLabel": "Cash - End of Period",
"periodStartLabel": "Cash - Beginning of Period"
}
}
},
"localname": "CashAndCashEquivalentsAtCarryingValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
"auth_ref": [
"r10",
"r50"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
"label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
"verboseLabel": "Cash"
}
}
},
"localname": "CashAndCashEquivalentsPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
"auth_ref": [
"r43",
"r211"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
"label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
"totalLabel": "Net Change in Cash"
}
}
},
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Supplemental Disclosures of Non Cash Investing and Financing Activities:"
}
}
},
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_ClassOfStockDomain": {
"auth_ref": [
"r58",
"r60",
"r82",
"r83",
"r84",
"r86",
"r88",
"r92",
"r93",
"r94",
"r122",
"r129",
"r134",
"r135",
"r136",
"r140",
"r141",
"r145",
"r146",
"r150",
"r154",
"r207",
"r273"
],
"lang": {
"en-us": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
}
}
},
"localname": "ClassOfStockDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ClassOfStockLineItems": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Class of Stock [Line Items]"
}
}
},
"localname": "ClassOfStockLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_CommitmentsAndContingencies": {
"auth_ref": [
"r24",
"r128",
"r251",
"r257"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
"label": "Commitments and Contingencies (Note 8)"
}
}
},
"localname": "CommitmentsAndContingencies",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CommonStockMember": {
"auth_ref": [
"r63",
"r64",
"r203"
],
"lang": {
"en-us": {
"role": {
"documentation": "Stock that is subordinate to all other stock of the issuer.",
"label": "Common Stock [Member]"
}
}
},
"localname": "CommonStockMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "Face amount or stated value per share of common stock.",
"label": "Common Stock, par value (in Dollars per Share)"
}
}
},
"localname": "CommonStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_CommonStockSharesAuthorized": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
"label": "Common Stock, shares authorized (in Shares)"
}
}
},
"localname": "CommonStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesIssued": {
"auth_ref": [
"r13"
],
"lang": {
"en-us": {
"role": {
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
"label": "Common Stock, shares issued (in Shares)"
}
}
},
"localname": "CommonStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockSharesOutstanding": {
"auth_ref": [
"r13",
"r161"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
"label": "Common Stock, shares outstanding (in Shares)",
"periodEndLabel": "Ending balance, shares",
"periodStartLabel": "Beginning balance, shares"
}
}
},
"localname": "CommonStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CommonStockValue": {
"auth_ref": [
"r13",
"r229"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Common Stock - $0.001 Par; 900,000,000 Shares Authorized, 29,271,755 Issued and Outstanding, Respectively"
}
}
},
"localname": "CommonStockValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": {
"auth_ref": [
"r35"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.",
"label": "Board of Directors Compensation"
}
}
},
"localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ConcentrationRiskDisclosureTextBlock": {
"auth_ref": [
"r102"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
"label": "Risks and Uncertainties"
}
}
},
"localname": "ConcentrationRiskDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RisksAndUncertainties"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ConsolidationPolicyTextBlock": {
"auth_ref": [
"r56",
"r199"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
"label": "Principles of Consolidation"
}
}
},
"localname": "ConsolidationPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_ConversionOfStockSharesIssued1": {
"auth_ref": [
"r52",
"r53",
"r54"
],
"lang": {
"en-us": {
"role": {
"documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
"label": "Shares issued in exchange for product payment"
}
}
},
"localname": "ConversionOfStockSharesIssued1",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_CostOfRevenue": {
"auth_ref": [
"r37",
"r60",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r207"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_GrossProfit",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
"label": "Cost of Sales"
}
}
},
"localname": "CostOfRevenue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_DueToRelatedPartiesCurrent": {
"auth_ref": [
"r20",
"r61",
"r132",
"r134",
"r135",
"r139",
"r140",
"r141",
"r222"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
"label": "Due to Related Parties",
"verboseLabel": "Due to related parties"
}
}
},
"localname": "DueToRelatedPartiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_EarningsPerShareBasicAndDiluted": {
"auth_ref": [
"r87"
],
"lang": {
"en-us": {
"role": {
"documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
"label": "Net Loss for the Period Per Common Shares - Basic and Diluted"
}
}
},
"localname": "EarningsPerShareBasicAndDiluted",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "perShareItemType"
},
"us-gaap_EarningsPerSharePolicyTextBlock": {
"auth_ref": [
"r89",
"r90"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
"label": "Earnings (Loss) per Share"
}
}
},
"localname": "EarningsPerSharePolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_EquityComponentDomain": {
"auth_ref": [
"r0",
"r30",
"r31",
"r32",
"r63",
"r64",
"r65",
"r69",
"r76",
"r78",
"r91",
"r123",
"r161",
"r168",
"r186",
"r187",
"r188",
"r191",
"r192",
"r203",
"r212",
"r213",
"r214",
"r215",
"r216",
"r217",
"r260",
"r261",
"r262",
"r275"
],
"lang": {
"en-us": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
}
}
},
"localname": "EquityComponentDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_FairValueOfFinancialInstrumentsPolicy": {
"auth_ref": [
"r205",
"r206"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
"label": "Fair Value of Financial Instruments"
}
}
},
"localname": "FairValueOfFinancialInstrumentsPolicy",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_GeneralAndAdministrativeExpense": {
"auth_ref": [
"r38"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
"label": "General and Administrative"
}
}
},
"localname": "GeneralAndAdministrativeExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_GrossProfit": {
"auth_ref": [
"r36",
"r60",
"r105",
"r107",
"r110",
"r113",
"r115",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r207"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
"label": "Gross Profit",
"totalLabel": "Gross Profit"
}
}
},
"localname": "GrossProfit",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncomeStatementAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"localname": "IncomeStatementAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_IncomeTaxesPaidNet": {
"auth_ref": [
"r51"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
"label": "Income Taxes"
}
}
},
"localname": "IncomeTaxesPaidNet",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"auth_ref": [
"r46"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 5.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
"label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
"verboseLabel": "Accounts Payable and Accrued Expenses"
}
}
},
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccountsReceivable": {
"auth_ref": [
"r46"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 3.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
"label": "Increase (Decrease) in Accounts Receivable",
"negatedLabel": "Accounts Receivable"
}
}
},
"localname": "IncreaseDecreaseInAccountsReceivable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInAccruedSalaries": {
"auth_ref": [
"r46"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 7.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the period in accrued salaries.",
"label": "Increase (Decrease) in Accrued Salaries",
"verboseLabel": "Accrued Board of Directors Compensation"
}
}
},
"localname": "IncreaseDecreaseInAccruedSalaries",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Changes in Assets and Liabilities:"
}
}
},
"localname": "IncreaseDecreaseInOperatingCapitalAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_IncreaseDecreaseInPrepaidExpense": {
"auth_ref": [
"r46"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 4.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
"label": "Increase (Decrease) in Prepaid Expense",
"negatedLabel": "Prepaid Expenses"
}
}
},
"localname": "IncreaseDecreaseInPrepaidExpense",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_InterestPaidNet": {
"auth_ref": [
"r42",
"r44",
"r51"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
"label": "Interest"
}
}
},
"localname": "InterestPaidNet",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
"auth_ref": [
"r47"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
"label": "Common Stock Issued for Product Payment"
}
}
},
"localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_Liabilities": {
"auth_ref": [
"r22",
"r60",
"r109",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r198",
"r200",
"r201",
"r207",
"r227",
"r228"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
"label": "Liabilities",
"totalLabel": "Total Liabilities"
}
}
},
"localname": "Liabilities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"auth_ref": [
"r18",
"r60",
"r122",
"r207",
"r229",
"r249",
"r256"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
"label": "Liabilities and Equity",
"totalLabel": "Total Liabilities and Stockholders' Deficit"
}
}
},
"localname": "LiabilitiesAndStockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
}
}
},
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_LiabilitiesCurrent": {
"auth_ref": [
"r23",
"r60",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r198",
"r200",
"r201",
"r207",
"r227",
"r228",
"r229"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_Liabilities",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
"label": "Liabilities, Current",
"totalLabel": "Total Current Liabilities"
}
}
},
"localname": "LiabilitiesCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_LiabilitiesCurrentAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Current Liabilities"
}
}
},
"localname": "LiabilitiesCurrentAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivities": {
"auth_ref": [
"r43"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 3.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
"label": "Net Cash Provided by (Used in) Financing Activities",
"totalLabel": "Net Cash Flows Provided by Financing Activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Cash Flows from Financing Activities"
}
}
},
"localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"auth_ref": [
"r43"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
"label": "Cash Flows from Investing Activities"
}
}
},
"localname": "NetCashProvidedByUsedInInvestingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"auth_ref": [
"r43",
"r45",
"r48"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0
}
},
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
"label": "Net Cash Provided by (Used in) Operating Activities",
"totalLabel": "Net Cash Flows Used In Operating Activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivities",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Cash Flows from Operating Activities"
}
}
},
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_NetIncomeLoss": {
"auth_ref": [
"r2",
"r28",
"r29",
"r32",
"r34",
"r48",
"r60",
"r68",
"r72",
"r73",
"r74",
"r75",
"r77",
"r78",
"r85",
"r105",
"r107",
"r110",
"r113",
"r115",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r204",
"r207",
"r252",
"r259"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
},
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": null,
"parentTag": null,
"root": true,
"weight": null
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
"label": "Net Loss for the Period",
"totalLabel": "Net Loss for the Period"
}
}
},
"localname": "NetIncomeLoss",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
"auth_ref": [
"r1",
"r66",
"r67",
"r70",
"r71",
"r79",
"r80",
"r81",
"r120",
"r121",
"r124",
"r125",
"r178",
"r179",
"r180",
"r181",
"r189",
"r193",
"r194",
"r195",
"r202",
"r208",
"r209",
"r210",
"r218",
"r233",
"r234",
"r235",
"r263",
"r264",
"r265",
"r266",
"r267",
"r276"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
"label": "Recently Issued Accounting Standards"
}
}
},
"localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RecentlyIssuedAccountingStandards"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_OperatingExpenses": {
"auth_ref": [],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetIncomeLoss",
"weight": -1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
"label": "Operating Expenses [Default Label]",
"totalLabel": "Total Expenses"
}
}
},
"localname": "OperatingExpenses",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_OperatingExpensesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Operating Expenses"
}
}
},
"localname": "OperatingExpensesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_PaymentsToAcquireBusinessesGross": {
"auth_ref": [
"r39",
"r196"
],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
"label": "Payment to acquire subsidiary"
}
}
},
"localname": "PaymentsToAcquireBusinessesGross",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/OrganizationDescriptionOfBusinessDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PreferredStockMember": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
"label": "Preferred Stock [Member]"
}
}
},
"localname": "PreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"auth_ref": [
"r12",
"r145"
],
"lang": {
"en-us": {
"role": {
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
"label": "Preferred Stock, par value"
}
}
},
"localname": "PreferredStockParOrStatedValuePerShare",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_PreferredStockSharesAuthorized": {
"auth_ref": [
"r12"
],
"lang": {
"en-us": {
"role": {
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
"label": "Preferred Stock, shares authorized (in Shares)"
}
}
},
"localname": "PreferredStockSharesAuthorized",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesIssued": {
"auth_ref": [
"r12",
"r145"
],
"lang": {
"en-us": {
"role": {
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
"label": "Preferred Stock, issued (in Shares)"
}
}
},
"localname": "PreferredStockSharesIssued",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockSharesOutstanding": {
"auth_ref": [
"r12"
],
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
"label": "Preferred Stock, outstanding (in Shares)"
}
}
},
"localname": "PreferredStockSharesOutstanding",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_PreferredStockValue": {
"auth_ref": [
"r12",
"r229"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
"label": "Preferred Stock - $0.001 Par; 90,000,000 Shares Authorized, -0- Issued"
}
}
},
"localname": "PreferredStockValue",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_PrepaidExpenseCurrent": {
"auth_ref": [
"r6",
"r8",
"r126",
"r127"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
"label": "Prepaid Expenses"
}
}
},
"localname": "PrepaidExpenseCurrent",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromContributedCapital": {
"auth_ref": [
"r40"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 2.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
"label": "Capital Contributions from Directors"
}
}
},
"localname": "ProceedsFromContributedCapital",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromOtherEquity": {
"auth_ref": [
"r40"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of cash inflow from the issuance of equity classified as other.",
"label": "Proceeds from exchange for product payment"
}
}
},
"localname": "ProceedsFromOtherEquity",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ProceedsFromRelatedPartyDebt": {
"auth_ref": [
"r41"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
"label": "Proceeds from Related Parties"
}
}
},
"localname": "ProceedsFromRelatedPartyDebt",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyDomain": {
"auth_ref": [
"r183",
"r221",
"r222"
],
"lang": {
"en-us": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"localname": "RelatedPartyDomain",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
"auth_ref": [
"r221"
],
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
"label": "Expenses"
}
}
},
"localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RelatedPartyTransactionLineItems": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Related Party Transaction [Line Items]"
}
}
},
"localname": "RelatedPartyTransactionLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"localname": "RelatedPartyTransactionsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"auth_ref": [
"r183",
"r221",
"r224",
"r236",
"r237",
"r238",
"r239",
"r240",
"r241",
"r242",
"r243",
"r244",
"r245",
"r246",
"r247"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
"label": "Related Party Transactions By Related Party [Axis]",
"verboseLabel": "Related Party [Axis]"
}
}
},
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"auth_ref": [
"r219",
"r220",
"r222",
"r225",
"r226"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Related Party Transactions"
}
}
},
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactions"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"auth_ref": [
"r15",
"r168",
"r190",
"r229",
"r255",
"r263",
"r267"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 4.0,
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated Deficit"
}
}
},
"localname": "RetainedEarningsAccumulatedDeficit",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RetainedEarningsMember": {
"auth_ref": [
"r0",
"r63",
"r64",
"r65",
"r69",
"r76",
"r78",
"r123",
"r186",
"r187",
"r188",
"r191",
"r192",
"r203",
"r260",
"r262"
],
"lang": {
"en-us": {
"role": {
"documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
"label": "Accumulated Deficit [Member]"
}
}
},
"localname": "RetainedEarningsMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "domainItemType"
},
"us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
"auth_ref": [
"r57",
"r170",
"r171",
"r172",
"r173",
"r174",
"r175",
"r176",
"r177",
"r182"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for revenue from contract with customer.",
"label": "Revenue Recognition"
}
}
},
"localname": "RevenueFromContractWithCustomerPolicyTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_Revenues": {
"auth_ref": [
"r33",
"r60",
"r103",
"r104",
"r106",
"r111",
"r112",
"r116",
"r117",
"r118",
"r122",
"r129",
"r130",
"r131",
"r134",
"r135",
"r136",
"r137",
"r138",
"r140",
"r141",
"r207",
"r253"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited": {
"order": 1.0,
"parentTag": "us-gaap_GrossProfit",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
"label": "Sales"
}
}
},
"localname": "Revenues",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_RisksAndUncertaintiesAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Risks and Uncertainties [Abstract]"
}
}
},
"localname": "RisksAndUncertaintiesAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"auth_ref": [
"r223",
"r224"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
"label": "Schedule of Related Party Transactions, by Related Party [Table]"
}
}
},
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/RelatedPartyTransactionsDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_ScheduleOfStockByClassTable": {
"auth_ref": [
"r25",
"r58",
"r92",
"r93",
"r142",
"r143",
"r144",
"r145",
"r146",
"r147",
"r148",
"r150",
"r154",
"r159",
"r162",
"r163",
"r164",
"r165",
"r166",
"r167",
"r168"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
"label": "Schedule of Stock by Class [Table]"
}
}
},
"localname": "ScheduleOfStockByClassTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_SeriesAPreferredStockMember": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
"label": "Series A Preferred Stock [Member]"
}
}
},
"localname": "SeriesAPreferredStockMember",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "domainItemType"
},
"us-gaap_ShareBasedCompensation": {
"auth_ref": [
"r46"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited": {
"order": 6.0,
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0
}
},
"crdr": "debit",
"lang": {
"en-us": {
"role": {
"documentation": "Amount of noncash expense for share-based payment arrangement.",
"label": "Preferred Stock Issued for Current Year Board of Directors Compensation"
}
}
},
"localname": "ShareBasedCompensation",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
"auth_ref": [
"r184",
"r185"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
"label": "Stock-Based Compensation"
}
}
},
"localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SharesIssuedPricePerShare": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Per share or per unit amount of equity securities issued.",
"label": "Common stock per share"
}
}
},
"localname": "SharesIssuedPricePerShare",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "perShareItemType"
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"auth_ref": [
"r55",
"r62"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
"label": "Summary of Significant Accounting Policies"
}
}
},
"localname": "SignificantAccountingPoliciesTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_StatementClassOfStockAxis": {
"auth_ref": [
"r11",
"r12",
"r13",
"r58",
"r60",
"r82",
"r83",
"r84",
"r86",
"r88",
"r92",
"r93",
"r94",
"r122",
"r129",
"r134",
"r135",
"r136",
"r140",
"r141",
"r145",
"r146",
"r150",
"r154",
"r161",
"r207",
"r273"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by the different classes of stock of the entity.",
"label": "Class of Stock [Axis]"
}
}
},
"localname": "StatementClassOfStockAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementEquityComponentsAxis": {
"auth_ref": [
"r0",
"r26",
"r30",
"r31",
"r32",
"r63",
"r64",
"r65",
"r69",
"r76",
"r78",
"r91",
"r123",
"r161",
"r168",
"r186",
"r187",
"r188",
"r191",
"r192",
"r203",
"r212",
"r213",
"r214",
"r215",
"r216",
"r217",
"r260",
"r261",
"r262",
"r275"
],
"lang": {
"en-us": {
"role": {
"documentation": "Information by component of equity.",
"label": "Equity Components [Axis]"
}
}
},
"localname": "StatementEquityComponentsAxis",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementLineItems": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
"label": "Statement [Line Items]"
}
}
},
"localname": "StatementLineItems",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfCashFlowsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"localname": "StatementOfCashFlowsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"auth_ref": [],
"localname": "StatementOfFinancialPositionAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"auth_ref": [],
"localname": "StatementOfStockholdersEquityAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StatementTable": {
"auth_ref": [
"r63",
"r64",
"r65",
"r91",
"r232"
],
"lang": {
"en-us": {
"role": {
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
"label": "Statement [Table]"
}
}
},
"localname": "StatementTable",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-UnauditedParenthetical",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
"label": "Preferred Shares Issued for Services, shares"
}
}
},
"localname": "StockIssuedDuringPeriodSharesIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
"auth_ref": [
"r12",
"r13",
"r161",
"r168"
],
"lang": {
"en-us": {
"role": {
"documentation": "Number of new stock issued during the period.",
"label": "Number of shares issued"
}
}
},
"localname": "StockIssuedDuringPeriodSharesNewIssues",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "sharesItemType"
},
"us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
"auth_ref": [],
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
"label": "Preferred Shares Issued for Services"
}
}
},
"localname": "StockIssuedDuringPeriodValueIssuedForServices",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited",
"http://bioforcenano.com/role/StockDetails"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquity": {
"auth_ref": [
"r13",
"r16",
"r17",
"r60",
"r119",
"r122",
"r207",
"r229"
],
"calculation": {
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited": {
"order": 3.0,
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0
}
},
"crdr": "credit",
"lang": {
"en-us": {
"role": {
"documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
"label": "Stockholders' Equity Attributable to Parent",
"periodEndLabel": "Ending balance",
"periodStartLabel": "Beginning balance",
"totalLabel": "Total Stockholders' Deficit"
}
}
},
"localname": "StockholdersEquity",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited",
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfStockholdersDeficit-Unaudited"
],
"xbrltype": "monetaryItemType"
},
"us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Stockholders' Deficit"
}
}
},
"localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedBalanceSheets-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityNoteAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Stockholders' Equity Note [Abstract]"
}
}
},
"localname": "StockholdersEquityNoteAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"auth_ref": [
"r59",
"r146",
"r149",
"r150",
"r151",
"r152",
"r153",
"r154",
"r155",
"r156",
"r157",
"r158",
"r160",
"r168",
"r169"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
"label": "Stock"
}
}
},
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/Stock"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubsequentEventsAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Subsequent Events [Abstract]"
}
}
},
"localname": "SubsequentEventsAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"xbrltype": "stringItemType"
},
"us-gaap_SubsequentEventsTextBlock": {
"auth_ref": [
"r230",
"r231"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
"label": "Subsequent Events"
}
}
},
"localname": "SubsequentEventsTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SubsequentEvents"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
"auth_ref": [
"r3"
],
"lang": {
"en-us": {
"role": {
"documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
"label": "Going Concern"
}
}
},
"localname": "SubstantialDoubtAboutGoingConcernTextBlock",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/GoingConcern"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"label": "Cash Paid During the Period for:"
}
}
},
"localname": "SupplementalCashFlowInformationAbstract",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfCashFlows-Unaudited"
],
"xbrltype": "stringItemType"
},
"us-gaap_UseOfEstimates": {
"auth_ref": [
"r95",
"r96",
"r97",
"r98",
"r99",
"r100",
"r101"
],
"lang": {
"en-us": {
"role": {
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
"label": "Use of Estimates"
}
}
},
"localname": "UseOfEstimates",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"xbrltype": "textBlockItemType"
},
"us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
"auth_ref": [],
"lang": {
"en-us": {
"role": {
"documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
"label": "Weighted Average Number of Common Shares - Basic and Diluted"
}
}
},
"localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
"nsuri": "http://fasb.org/us-gaap/2021-01-31",
"presentation": [
"http://bioforcenano.com/role/CondensedConsolidatedStatementsOfOperations-Unaudited"
],
"xbrltype": "sharesItemType"
}
},
"unitCount": 3
}
},
"std_ref": {
"r0": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "105",
"URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
},
"r1": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "105",
"URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
},
"r10": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r100": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
},
"r101": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
},
"r102": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "275",
"URI": "http://asc.fasb.org/topic&trid=2134479"
},
"r103": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r104": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r105": {
"Name": "Accounting Standards Codification",
"Paragraph": "22",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
},
"r106": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r107": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r108": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r109": {
"Name": "Accounting Standards Codification",
"Paragraph": "30",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
},
"r11": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(27))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r110": {
"Name": "Accounting Standards Codification",
"Paragraph": "31",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
},
"r111": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r112": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r113": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r114": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r115": {
"Name": "Accounting Standards Codification",
"Paragraph": "32",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
},
"r116": {
"Name": "Accounting Standards Codification",
"Paragraph": "40",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
},
"r117": {
"Name": "Accounting Standards Codification",
"Paragraph": "41",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
},
"r118": {
"Name": "Accounting Standards Codification",
"Paragraph": "42",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "280",
"URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
},
"r119": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 4.E)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
},
"r12": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(28))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r120": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "20",
"Subparagraph": "(d)(1)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
},
"r121": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "20",
"Subparagraph": "(d)(2)",
"Topic": "310",
"URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
},
"r122": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "323",
"URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
},
"r123": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r124": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(1)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r125": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(2)",
"Topic": "326",
"URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
},
"r126": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "05",
"SubTopic": "10",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
},
"r127": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "340",
"URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
},
"r128": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "450",
"URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
},
"r129": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r13": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(29))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r130": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r131": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r132": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r133": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iii))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r134": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r135": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-01(a)(5))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
},
"r136": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r137": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r138": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r139": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r14": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r140": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r141": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.13-02(a)(5))",
"Topic": "470",
"URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
},
"r142": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(CFRR 211.02)",
"Topic": "480",
"URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
},
"r143": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
},
"r144": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
},
"r145": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r146": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r147": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r148": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r149": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r15": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r150": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(h)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r151": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(i)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r152": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
},
"r153": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
},
"r154": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
},
"r155": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
},
"r156": {
"Name": "Accounting Standards Codification",
"Paragraph": "16",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
},
"r157": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
},
"r158": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
},
"r159": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
},
"r16": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(30))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r160": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
},
"r161": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
},
"r162": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
},
"r163": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
},
"r164": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
},
"r165": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
},
"r166": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
},
"r167": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
},
"r168": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.3-04)",
"Topic": "505",
"URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
},
"r169": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "505",
"URI": "http://asc.fasb.org/topic&trid=2208762"
},
"r17": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(31))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r170": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
},
"r171": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
},
"r172": {
"Name": "Accounting Standards Codification",
"Paragraph": "18",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
},
"r173": {
"Name": "Accounting Standards Codification",
"Paragraph": "19",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
},
"r174": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
},
"r175": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
},
"r176": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
},
"r177": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
},
"r178": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(2)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
},
"r179": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(i)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
},
"r18": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02(32))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r180": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(i)(2)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
},
"r181": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(j)",
"Topic": "606",
"URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
},
"r182": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "606",
"URI": "http://asc.fasb.org/topic&trid=49130388"
},
"r183": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Subparagraph": "(n)",
"Topic": "715",
"URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
},
"r184": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
},
"r185": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b),(f)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
},
"r186": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r187": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r188": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r189": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(1)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r19": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.1)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r190": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(g)(2)",
"Topic": "718",
"URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
},
"r191": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(2)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r192": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(d)(3)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r193": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(1)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r194": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(2)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r195": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(3)",
"Topic": "740",
"URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
},
"r196": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Subparagraph": "(b)(1)",
"Topic": "805",
"URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
},
"r197": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r198": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
},
"r199": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
},
"r2": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "20",
"Topic": "205",
"URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
},
"r20": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19(a))",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r200": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(bb)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r201": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "810",
"URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
},
"r202": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)(1)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
},
"r203": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)(3)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
},
"r204": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)",
"Topic": "815",
"URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
},
"r205": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "60",
"SubTopic": "10",
"Topic": "820",
"URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
},
"r206": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
},
"r207": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(f)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
},
"r208": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(1)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
},
"r209": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(2)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
},
"r21": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19,20)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r210": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(3)",
"Topic": "825",
"URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
},
"r211": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "230",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
},
"r212": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
},
"r213": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(a)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r214": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(b)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r215": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(c)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r216": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "30",
"Subparagraph": "(d)",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
},
"r217": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "30",
"Topic": "830",
"URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
},
"r218": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(e)(1)",
"Topic": "848",
"URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
},
"r219": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r22": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.19-26)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r220": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r221": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r222": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r223": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
},
"r224": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
},
"r225": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "850",
"URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
},
"r226": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "850",
"URI": "http://asc.fasb.org/topic&trid=2122745"
},
"r227": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r228": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
},
"r229": {
"Name": "Accounting Standards Codification",
"Paragraph": "10",
"Publisher": "FASB",
"Section": "55",
"SubTopic": "10",
"Topic": "852",
"URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
},
"r23": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.21)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r230": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "855",
"URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
},
"r231": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "855",
"URI": "http://asc.fasb.org/topic&trid=2122774"
},
"r232": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.L)",
"Topic": "924",
"URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
},
"r233": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "20",
"Subparagraph": "(f)(1)",
"Topic": "926",
"URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r234": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "20",
"Subparagraph": "(f)(2)",
"Topic": "926",
"URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r235": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "20",
"Subparagraph": "(f)(3)",
"Topic": "926",
"URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
},
"r236": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
},
"r237": {
"Name": "Accounting Standards Codification",
"Paragraph": "15",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
},
"r238": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
},
"r239": {
"Name": "Accounting Standards Codification",
"Paragraph": "20",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
},
"r24": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.25)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r240": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
},
"r241": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
},
"r242": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
},
"r243": {
"Name": "Accounting Standards Codification",
"Paragraph": "33",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
},
"r244": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(a)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
},
"r245": {
"Name": "Accounting Standards Codification",
"Paragraph": "35A",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(b)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
},
"r246": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(1)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
},
"r247": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "235",
"Subparagraph": "(c)(2)",
"Topic": "932",
"URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
},
"r248": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(11))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r249": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03(23))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r25": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.28,29)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r250": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03.15(5))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r251": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.9-03.17)",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
},
"r252": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.9-04(22))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
},
"r253": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "235",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Topic": "942",
"URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
},
"r254": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r255": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r256": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r257": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03.(a),19)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r258": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "210",
"Subparagraph": "(SX 210.7-03.15(a))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
},
"r259": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "220",
"Subparagraph": "(SX 210.7-04(18))",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
},
"r26": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.29-31)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r260": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(e)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r261": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(1)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r262": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(f)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r263": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(i)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r264": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(ii)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r265": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(iii)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r266": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(g)(2)(iv)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r267": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "40",
"Subparagraph": "(h)(2)",
"Topic": "944",
"URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
},
"r268": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b"
},
"r269": {
"Name": "Exchange Act",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "d1-1"
},
"r27": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-02.9)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
},
"r270": {
"Name": "Form 10-Q",
"Number": "240",
"Publisher": "SEC",
"Section": "308",
"Subsection": "a"
},
"r271": {
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Publisher": "SEC",
"Section": "13",
"Subsection": "a-1"
},
"r272": {
"Name": "Regulation 12B",
"Number": "240",
"Publisher": "SEC",
"Section": "12",
"Subsection": "b-2"
},
"r273": {
"Name": "Regulation S-K (SK)",
"Number": "229",
"Paragraph": "(a)",
"Publisher": "SEC",
"Section": "1402"
},
"r274": {
"Name": "Regulation S-T",
"Number": "232",
"Publisher": "SEC",
"Section": "405"
},
"r275": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(a)(3)(iii)(03)",
"Topic": "848"
},
"r276": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "65",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "848"
},
"r28": {
"Name": "Accounting Standards Codification",
"Paragraph": "1A",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
},
"r29": {
"Name": "Accounting Standards Codification",
"Paragraph": "1B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
},
"r3": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"SubTopic": "40",
"Topic": "205",
"URI": "http://asc.fasb.org/subtopic&trid=51888271"
},
"r30": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
},
"r31": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
},
"r32": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
},
"r33": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(1))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r34": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(20))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r35": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03(b)(4))",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r36": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.1,2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r37": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.2)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r38": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.5-03.4)",
"Topic": "220",
"URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
},
"r39": {
"Name": "Accounting Standards Codification",
"Paragraph": "13",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
},
"r4": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "205",
"URI": "http://asc.fasb.org/topic&trid=2122149"
},
"r40": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
},
"r41": {
"Name": "Accounting Standards Codification",
"Paragraph": "14",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
},
"r42": {
"Name": "Accounting Standards Codification",
"Paragraph": "17",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
},
"r43": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
},
"r44": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
},
"r45": {
"Name": "Accounting Standards Codification",
"Paragraph": "25",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
},
"r46": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r47": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r48": {
"Name": "Accounting Standards Codification",
"Paragraph": "28",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
},
"r49": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
},
"r5": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r50": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
},
"r51": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
},
"r52": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
},
"r53": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
},
"r54": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "230",
"URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
},
"r55": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
},
"r56": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
},
"r57": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(e)",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
},
"r58": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(d))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r59": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(e)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r6": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(g)",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r60": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r61": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SX 210.4-08(k)(1))",
"Topic": "235",
"URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
},
"r62": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "235",
"URI": "http://asc.fasb.org/topic&trid=2122369"
},
"r63": {
"Name": "Accounting Standards Codification",
"Paragraph": "23",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
},
"r64": {
"Name": "Accounting Standards Codification",
"Paragraph": "24",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
},
"r65": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
},
"r66": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r67": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(1)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r68": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(2)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r69": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(3)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r7": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
},
"r70": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)(4)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r71": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)(1)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
},
"r72": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r73": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
},
"r74": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
},
"r75": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
},
"r76": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
},
"r77": {
"Name": "Accounting Standards Codification",
"Paragraph": "8",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
},
"r78": {
"Name": "Accounting Standards Codification",
"Paragraph": "9",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
},
"r79": {
"Name": "Accounting Standards Codification",
"Paragraph": "5",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Subparagraph": "(SAB Topic 11.M.Q2)",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
},
"r8": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
},
"r80": {
"Name": "Accounting Standards Codification",
"Paragraph": "6",
"Publisher": "FASB",
"Section": "S99",
"SubTopic": "10",
"Topic": "250",
"URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
},
"r81": {
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"Topic": "250",
"URI": "http://asc.fasb.org/topic&trid=2122394"
},
"r82": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
},
"r83": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
},
"r84": {
"Name": "Accounting Standards Codification",
"Paragraph": "55",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
},
"r85": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
},
"r86": {
"Name": "Accounting Standards Codification",
"Paragraph": "60B",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Subparagraph": "(d)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
},
"r87": {
"Name": "Accounting Standards Codification",
"Paragraph": "7",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
},
"r88": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(a)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r89": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
},
"r9": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "210",
"URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
},
"r90": {
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "260",
"URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
},
"r91": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
},
"r92": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "45",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
},
"r93": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
},
"r94": {
"Name": "Accounting Standards Codification",
"Paragraph": "3",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "272",
"URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
},
"r95": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(b)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r96": {
"Name": "Accounting Standards Codification",
"Paragraph": "1",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Subparagraph": "(c)",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
},
"r97": {
"Name": "Accounting Standards Codification",
"Paragraph": "11",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
},
"r98": {
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
},
"r99": {
"Name": "Accounting Standards Codification",
"Paragraph": "4",
"Publisher": "FASB",
"Section": "50",
"SubTopic": "10",
"Topic": "275",
"URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
}
},
"version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>38
<FILENAME>0001091818-21-000099-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001091818-21-000099-xbrl.zip
M4$L#!!0 ( &MU_5)NQ ;FL0< $$Z 1 8F9N:"TR,#(Q,#8S,"YX
M<V3M6]UWXK@5?]^_0N6AG3XX0+*3;M*0/03(#J=,R FDW3[M$;8,.F-+'DF>
MA/[UO9(M8X,Q-MGN9GMXBC[N]T]7'^;FYL?7,$#?B)"4LUZK>]9I(<)<[E&V
M[+6>Y_?.#ZT?;[^[D>Z*A!AAI01=Q(K<<Q$.B8_C0/5:,?L:XX#ZE'C '9"0
M,%4@R$V#.B9[K952T76[_?+R<O9R<<;%LGW>Z73;/W^>S(RFE/#:Y3%38ITQ
MO"Y$<":)>[;DW]KI)+">=S.&6 AP8!]'.EM@\0@MIX:) B%Y=5?EE'JF0!I0
M]J7@I2%/_;QHZ^D%EB0S00E'K2,BRWE@NJVGM8J.T^DZ&T521:+<)CU3L"F6
MSA+C**/VL5P8\>F$(=;2+_(L1;/R/&:FA$E;X6V%-/7\LIU,%DA5*>G'A%3E
M26E%2"F3"C,W"^GK#@3I0NM>75VUS:PE99BZLCR(9JH012G4;C1@L"00A,7A
M>9ESYQU8,8HP21<!<309$5A!!DKG7&=@IFE?]+.I@E:%Q9*H!QP2&6&79&P+
MRGTN7,(PXV<N#PU3Y_(BT[3PV:H&]>UW"-W\R7'0SW=/$S3D;JPS'0T$P8IX
MZ(6J%8(,1B-O29 O>(@>+] 0*XQF:ZE(*)'C&!F8,:Z,P[JK!Z*(,I\G/>AK
M=*YMDCP1'QF\KK7+O9:D811HG,W82A"_U](>.-;07UP<G(%GED3P@%2L'#W=
M!A8W#HQ-DXU>*P$+=T?(SG)J1X)'1"@*L&0)WOZU?/*(W]0G8*&,OE^7 KQH
MZA*PD.!]>A,)TM0;8)&00?_S5:>ES,$-I!O/3^/]N6[,LIG=9]Z(*:K68\A-
M$1HS6XAZO58EA=5MM6^6X6T'#OD.<C9[1ZZ)F8<282@G[::]+6-+>BR)-V6W
MIKT=SY0Y):E@W,K^VGS%#"ME2P<M!&\"9L"9!Z<&\: A>4 ]O>_>X4"?>[,5
M(4HZSPS''E7ZJJ6!:L11#=RY!FX&P24I<H/IPW#T,!L-=6LVG8R'_3ET[OJ3
M_L-@A&:?1J/Y#.B>'_K/PS%,G; \$LM'#+=6M2**@G/-@2VR5Z-\\6:4T8>"
MOK^>4#^$>A9N.?6G4785K)/*!UFKT?Z^)MJS.?SY/'H I*?W:/HX>NK/QT!P
MRNYC<1Y@N;H/^$MSF,LXJU'^>!3*@_[L$[J?3/]U0OEHE&>*NU]6//"(D$.P
MS:6J,=[5,JJ1OSP*^=E\.OC'I^ED.'J:_04-1_?CP7A^6@1[%L%4+#&C_S%V
M#HET!8UT<^K?Q9(R(F6"\V&R:BC_9N[-5+H!E[$@T,E+1'_&8?1WE!.,N(^L
MZ!->.;QF<1ABL8;$HDM&(9\PO&-<\RV1LN4CI* +;ZD$M)JTU<C]L(-<*E9#
ME!.,-I*1%7U"+H?<$X$1%:S'4L;$VT0+-CCF8>&EH!TFJ\;K:@<O*Q$E(O-
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M[@^PW=@E]414+!CQX"XQT#Q! '>)[:5:A_CW6Y,W[>3:??M?4$L#!!0 (
M &MU_5)E=,&L,08 &5( 5 8F9N:"TR,#(Q,#8S,%]C86PN>&UL[5S=
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MAL"9T'CHH#K.?3 )Y0B<CJ73HO$Q.G-5 R1<EPWY2$%@RZ$COY\[K97$O>I
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MX=XB9 2]YF:,P$Z&,;ZL0Q(=.PT>* _[O])Z)@P'5.-N$FDG.'>]R=A">1
M9<:C.A!N.6 6DH9FL0'ACH01H<']=*13EUGP9<^Q"L$=:AL@=E$V8H^4]"FC
M,06%/MB+A?]]*!C*IK0OQK,<\'*GEY)G1!31.-VP=5P)'F,488&-0N9EESTS
MJ^"1IFAEIIE]5K$AN:PI;^Z5UL.VH;5E&<5L \B84#'0#/&QJAAK^+Y(,!=T
MR(ST&:!?XHA,("B,7Q%.%0/68&\O9"=+@-?B]_ H*7_(CGI]%MPW!3R7@Y5
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M-ZM_N?/A7U!+ P04 " !K=?U2 /S^38H* +J %0 &)F;F@M,C R
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MU:;: V7_Y?[4O[,?*(9_+[!KL=GK"MD.=.@>T!)_XBY*WB,71-:BZT<"/!]
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M&0 [&N_ K]BN@M$@248-24D7.7MD5@A9-JRL=-(7%2AS5P&01,"R/(#NPS2
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MC7_I<L%-X*.O_P=02P,$% @ :W7]4K9L2G U'0 K8H! !4 !B9FYH
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M/@(:K@J$R->]CW$8)+_ )$YGJSNH 000A:;F)#(W8=%10I*6D")R9 2T44L
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M36M_ ="5=#CCXYQ5>_3$\5S+\J8-KE$M0N!'E&%\A[*E\IBM3>DD!MD5M8\
M]E=0_ME-/'$O^6P#E./W(3RY+K<(SCE9?P8T7[*^+JJYC!'SV1ZW9!KT$=+0
M^G0[5NF"(6HTK&]W"]Q<Z:P$NGFI<@S+X??'+(MHZ!NBISB$]UFB$6XQ;]+!
MEGF,WH/MIO>79/=Q,'<CMX=O;4[<,"7=+*$WS:-UG,:TB]'<MTIHU62NX+:-
M5K4V@_FTY"BK"G1X/,"DIG,X,ZZN7US.PJ:SKYOE(D]L_AFU9+IUL4306AJ
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M9SD#8WDR-RWR58;BWV%D!,(!LUOP<711@JXZK0T:)O":+-_*EMYX!T21MU0
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M[C)\*[;GJ4K=6]+2#U^1?Y"?BP##'_X?4$L#!!0 ( &MU_5)=6VJN1!4
M #A< 0 5 8F9N:"TR,#(Q,#8S,%]P<F4N>&UL[5U;=]LXDGZ?7Z'U/"N^
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MED#_QHC=NK984^,"=G)%3"8H'P< 1R?-<A3;]:;<G?B$%U"4)V$R0[DH @Z
MW25!0RPTL,M1E)39'Y+6D #0]+E9FGI",SO0SD'3 FK6GS.9C@V+ 12<[::G
M/(D6 9TC>,QD M;M!>!_OAO\_\<7<W3,G.4C7E"6-WLLDM@'5E(H BZV%$'
MD<LG(A4!,Y02V0>*TC@ .+K<#4?AZTT]8<Y^?A_8V4 0,U5L]2$EMP1!W_W
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M+64^2SEH0-AJ>,T?>=$,.PZ4I+6'S>=FW78()3LY=" TFLN=0FK]<$%GS@
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M$)!<U0.]/>HA)WBR129!%)K('30#V2S2'@@:$X?(>DQBU$^6=I.CO[<$SF/
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M)I::YB3PF5YMX7T=W*;VH# 81
K/VWG, N'>?,:_#B[(:TL"+:MX<RH0+
M6"I4(]:C//[ZM@B+&MP_+RB$#UA9M)U"@-3"V.9W J1$I>CE#1ZKK_LI$-6
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M4?WUIW4@KYRW9@?P-S %EMM:5^&SO$3>L4<2EE*8%]82R,!(:ZM CZ1E?$I
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M2_!?6XVG;XV8Q&U9?" 4GQ6<UOUR*%48(XY__W]02P,$% @ :W7]4G4_
MFI4N3P "1 & \ !B9FYH,3!Q,#8R,2YH=&WMO7MSXS;2+_S_4_5\!ZPW
MFTJJ) \IR9)ES\PIC2TGRDYDK^799-]3IU(P"5G<4*26%]O:3_]V Z1NIJ[6
M!:"PM9G12+PT&K]N] 7=^/A_7OLN>69!Z/C>IQ/SU#@AS+-\V_&>/IW$89&&
MEN.<_)_/__L_'WL17 J7>^&GDUX4#2X^?'AY>3E]*9_ZP=,'LUZO?WC%:T[$
M11?.U&6OCX'++RP91OF#XX41]2R67HN_VN,;)B^N?A _CA[[.N^Y)C[7=3SV
M^Y?[K^/+H^SKQY=^B +JA5T_Z-,(V(!/.BL:I6*I.O&08LBLJ0?!OT^?_.>E
MSSDOELWT.7$4S&5*_0/\.N)'Z&0Q&2XS/_S^Z]>.U6-]6LSBHKN ZT#HGX\T
M'%^/7\R?3/PUO?2QZ_5&5SXZ/HS28A[U_%/+[\/32Z91+1NC<8;%)TH'HQNZ
M-'SD#TY^X#<4#7."-3:;F?Z4O_ #OWPT%Z%?*9FU1> 25YP : GY^)=BD>#L
MD&O?BOO,B\A5P&C$;/+B1#T"W"1-^XF1;N#WR5V97-.(DLXPC%@_),6B>$B/
M49M_@L^1$[GL\Y?6[<WM_563M!OMV\Y5J]F^:G;(S[=?KUOMGSH%TFI?G7[\
M(*Y-;NPS>++E>Q$0\>DD8J_1!R$O.)(B^T_L/'\ZN1*_%Q^& W;R0;S]P^CU
M'Q]]>TC":.BR3R?D)'VR[3RG7]I..'#I\()XOL?2"^ 2Y_4"G\*"T5?)EXYM
M,V_B2_$UW'T34 MQ3#S:9UP9X-1=="+?^K,5AC&SK^, ],0="QS?[O1HP$+Q
M_8T?=%CP[%@L/!$#?HWN6??3R0WP&.;2*!I5F/W(3S^7C3^L.(S\_A\/+_X7
MGP;V;??:"9@5^4'X*^L_,I",V'/$4\2K3HACPQ.!QC]*9OF$"+G[= *R>N'%
M?=N/;&8Y?0K\33Z WFJU;TY(:%'DE''R&>""__OX87K$6=QH W8"QTJ8 :"\
M:'HPN\,KF*R NBW/9J]_9\/,\7*H)^,UQ7@GJ8=_?08JS+)I5,[/4V*2%ZY&
MRU4<!$#(C8-C^Q>C0=.S <AL(W+,D\_%HED"X=R(EE3.QL3<P#?92%A&2@GG
MJ+0-.@1*-Z>D?/+Y'Z6-Z&@ $38GQ*5/&[V[<O*Y"_!E[V+#/V(:1"QPA_=L
MX ?1)H2<?(Z"^'U4/. 2Z:"0;4S&N[@AA+8#VL#]$H>P<(>;P,&LOX,5@H0F
M?/T$VO.GP'^)>E=^?T"]C;2'L05V])CKOH,$<RD)_)<W2PV2%; N ]4%2\4T
MQ=R6N0BYH0.D$&Z-7-# "GQ4WJO8./R.7H#C0/.EF%HIIZ^AG?X<P3+[Z21T
M^@,75LN/'V9>.SN$3&K%,$(_#MZ,PKE(N,FYU0AONWS)X\KU9.I2?C'CTS'S
M/?_%L?&WKL,"PHECF;;H5>OO,TO)Q(VSK_LPYWWPM@%7EIET<),S^CP>!G])
M\NW;-V0\";].N#+++%SB.:>^=:XSV--G-(P#]CDQ\"[@*GQ8^O7L2_!I*TQ'
M"FC%IR,9QC:G8SYV_TBLP3] :_1]C]N$B9UV6#;RQX;L"=>:-S\E:L4&DEX'
MKF,YD:"9V Y<+US@L9D+YA,^I0EV.9AYH!W!H/:BL/'JA">?T\O>C/_CA\Q7
MO"7SPSPZ913,^6*CD2 Q$@ZC$QJVS2T\,+JI8[>\*SIP(NH>)2H6\D("A!Q&
M5VB$J(.0P^B0>Q91\,[L)@T\\)+"HX1&-A,DP,1AM(;&A,R8V)>>,,K:_Y#;
MZDSF:,](N..QF8#9QPN&+!8<+1ZTC:F.C7D8A&A[0F9[8J^84#WXNS=FZ9"?
M_,;7?LQP'=!1=[$] $+T8BOY8KL_3.1@L3V &G_5F+_=O=X,.NYV#62#F,_
MS-*6JKR6ZH&0H"U592S5 R%$6ZH26ZK[P00FLW2:2>[U(YVC/2-!KQ_*K!\'
M0HA>/R1>/_:+"<6=M3TQ:W;O5P<>R,+&400\KEP: A?X$*<E: $7)!"C719_
M)/6=;RD;U7]<A/P2?-C[BC_>&/\:>])C;Q<NP&3AT=U<_-G.,TQ/%G5X/Z]Z
MHY'_EA?3X%U>O)02N_BIR6NOF>?W'6^%%R^1FLFWSG\H7I'!AU5$;D$QH8KK
M)" OB+#(^O-X4!SUH^\S;F*B+GMFPV3Z[387UW&MO3E3:Z\^MXWUN6WLA=M
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M#2 #W R!>V 68ROC-O#MR!]1/<(OV!'+T#GN]+_(X8B/Q.P'@<Z85XI<>$Y
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MI6FG'EXV3L\KX@E7/I*#QB5\XKLU>83HFT=CV\%/-R.;<]2>*LQZ 1!#22_
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MG40!_/BVP551@U6#=6VP5HU,L!H38#4T6&4A]-C!:L[3K.;Q:-;MYU T5'<
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M>[-%;6<M/C5>CQFOI7><M[U%O!Y9T+_E67Z?D0?ZJMLN*3)EQQIY++WGR&X
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MFB)/TY6GL2QRYB49S++#NP;.; WSQ.6I[$LBAI(,IC%X+MF7<=RM.93<2RJ
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M=WH 1A]M2*GYQ#"C"R8Y," /K'B8\#HGT7:!?HNJ/M"A^$EWB#8M:L)RSB0
MH5R=)QI<$FR3G97JE3^H9_7\8)788.OVYO;^JDG:C?9MYZK5;%\U.^3GVZ_7
MK?9/G0)IM:]."Z31OB:=;U\ZK>M6X_Y?2>!PZ;/3ZW8SD6N=5K&4UO;M XS[
MX98\_-PD5[?MZV:[T[S&3YW;KZWKQ@/\XUN[\>VZA9]N6L"NJU;C*^D\P$^_
M-ML/G4VX\K$7I)<FVZIP&*73L[=[JB;E,!DB0ODB&]\G'^#A0OFTXS[PTII4
ME/5-MT!]B4.P&L+PFH56X Q0IS4\^PL-'="U=P$+84XH?OL S_[B@H8](7 I
M'< SHB!F)Y_W+]"'66B+9@GF\"].?^ '$?7>A4MBDN__^EHRS/(EN0V>J.?\
MES.9?$_[@TLR,1G$[Y)TCG8K?;-K";+!/)\K?P\]1J[\/A T)"\T)(YG^0&P
MAI^)['B\1+ #T&$X@C9[IC8E,)QK9G'#E)A&@9CU>IW O1W'!>N$W#OXYS\!
M<7& -+<\ZY3<>N2&/0:\D7"I@GD.HUK@3T_?;L'?+L/7XK?4@J4_=$:\<_P;
M/[ 8:5//#RV'>1;PYV>8"S22Q2M^$'-Q=9E>+/Y]??EC@5"@V*4O-& D'1\\
M&;[W;&+UJ/>4O'8T>"Y?A$;P+?X!W.=C^)4.295G:8QIZ@=Q ,\)\2#I^790
M+5.\C:)QEHJW^%Q-Q?NQZ_5&LMT8LT3812W4LRR,PKOTY:!28%)NNVE&82LI
M!E!M!=!T;]W@4)PL"=/3=%D?YIM,D B<&?&9%YM^MX QY^LR)M5[=W2(+PX?
M?/[J@*7,8N%/P39V@WXVL\?^TG.L'B+ (X_,XEB![WS7'1+_!?PW$L:/H6,[
M@/=3,BED,/!;*_*Y[)P))$TAD.,.6.I$8?+ XNP#E[$;X?[;T.^#:$RC/?*7
M"!(7UCFW3PU#B%;],B1])PSY;(;X>."%SWD!!BD^D0P"_]F!]1.'].Q$H-V
M#OB#!=3ET@<V*_SJQ5&0!'Q@H(.!&"#0,_!?T!'@ESXR4"Q@\\'7.&')P>WP
M5GA)WX_PM3U&W:CGP!-=I\NX8N7@PVE[9J#0P"!T[!@0@,J-ND##$R,!LC\\
MY3Y .M7)ZKQ@M:YGB_,*JW4'%+73!2_.BQJ6A6=D JONP*R ^0@/M4+C0E&?
MNTZ0U1;$TGA![,3]/H(5)GYBO&0\8)*.>,KPFLOME6LNWMA&P@J:X?10_'E(
M;J,ELC&[^:B0N9/6W0%,B_EC>.#+N"44AE FGLT\7"/A$[>BN0 _)KL@PAYC
M$8%U# 0=U"J(/8BL3;HPT5PSCFR.LIGH31K;#CZAZWCP! =U!YHJ7'5PC8&W
MQ5YZV9SW9]_->3NU+8,_4:S\/0K*A%,Y"-@ 5D%N*^%@ YN/Y<6)>N2)<34'
M2P+\P@;X+CI&_R 6\L!31=F79B87M\\3CFWP#A%#2X7=&SL_-1HW(T,':[K
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M#'PG"?#@SIBQ9 3,9<^XZ 1?[)H,O'#960RZ@ _/OON,R;H+'!<*#PQC;/
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M,@1 &U@:5L\!/L!%:*_X 1M'Y@OX"M"<K@BX=7W7]5]X%$T$J-@@O =A^_M
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M_ CT^+FR,NAYK\JT >5]0@AN+L0LM>N"KMQF4\K27#,MG96TMB=RN&W5FM@
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MGV3CAJA;L7AQ<ASQ#;>I/%@38QF5FSA8LL"/ '-PD."+W[@VB^.S0H$<R;B
MJ( NL_FQ 4_8[L*;*+E)R[X"^ <V+WYV0C_@W<\L'GS PG_<B"44!1G$CRZV
MI7L>-5]$R&.\Q^KYOAOR8$&Z!;] 1*=39YS5>8IY78-X-F]Q"88BWXK/RW($
M%;CU/>TQS8NF1SU7>&@"!OBGJ*KI^7BVR$^N_XC;R$9E14*9)._D.]1POU7
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M]_/_#U!+ P04 " !K=?U2]([E5EIG !K:@ $P &)F;FAL;V=O,C Q
M.3 P,2YJ<&>4NW54'-O2/CRXN[N[NP9WA\$MP=W=">[N&MPAN+N[NP6W ,$=
MON2<>^[[WO7>WQ_?GIZU>G5U[:IZ=EG/GOY8^?@!0):1D)8 @(" (Q_?P ?
MZP!1 "@(R)_C7P,, NS/@ 0'!X. @H2"^O.%AH&#@8:&A8:"@D6 A86#_SV@
M8!"1$. 1_YS_F>0/^Q^NWP<\-!0T_/_O\=$'0($&S(!T@(&@ $!10,!00#X&
M 0 $ (Q!]U_SU@0" @H:#!0<%^D_%^$\! _H,, @X!!@H)];$&@ <# 8 B
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M8]1$6&".$"<+YX$0M?+A(AKXC0 Y%[:92+Z9JF2_>@-HI;#/YE CB!Y/<OB
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MII+Y3BH7K[OXJ-K5F.08R/X&OBUF3E6S,"X;"^HZ[_NJ1#'^\#1:DPG'U %
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M7^H]J#>3>PVAOG:[=K63)[)_\5G;?OCSGP6E/_L0H*!@L-!P$%!@?[8B0$'
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M?FMKIY,U:@<_;B$!M^"O_ \*0^U:^^+J( B,%_W1")&)'7"7KVXIQ#NW3'>
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M+??$A)@J$CF)W]9X>U[A4_?&"KZB\8TDFJ2I 7R]OPR^"5OV23<L6RX8\
M1;"=&=&\E:*9M7A[K-I-X^<-_8Z=A;2[CLA8^[Y<>2=O5P9=;A^FNR0Q^ZSA
M+Q.GQ!#J(,UW58UV;P?#(TQ[D83Y\#2VO;%QA2VF^#WR]LR>P3:XS_LH/^>(
MMI7-*B-]#L3Z@WNCL<@BX*9F4VPLDS83YGDWK7Y</<HM%UV'=[ARI:(OW\ZM
MV-;EZ88 :6]Y'"# -1#M$TQU:7>.IWPQ*C"NHK97,R>H1^V-T0AAKYMHBOK'
MVM4KBVF#*"PXQ!5R7!2<+YHFIP%=PH3D3>!;(YG0K3[L;R_TDK8..9R^#%AB
MUY'I+LYG->?PZ?;L'CU3F[T>\N%,DR=L-O)I.^I6$&%:T4ZM@WB!-=)RY\-F
M96A#]#[)-K9OI/@O%#,-, S%[/PX%T'D@ZZ+6UM<D;9'[FAMW#_'HK,*(VS8
M*93+@-7JYQ2KZ?BH K$(^(.D/?#V:HMRNICB;<>_3+C.)X=FXY&DP@^/*(0C
MSFA0Z>Y33;F9()%8\VV*8;ME%E9G:IKHQ,!=M,/FO\7BA0FP,!KWXW:.Z<-C
MO2"1"A6#K]4(4\+56NJ]F:WA_9BT#PB*7YB%JI".Z2YOYL!SNL*QW?,SH$CO
M'+<ET^.^6P!)J;UL"I<M<-\=FN5#;X,!<G%6(^HP+F52%*-5X'2A0^_-P7L,
MAAB/);>!^[*AVMVKB4UCL$=AIW),RM95I6)S>5'<$=E+J$ID2,@WK&C2IO"F
M$D:?;U&O7:0RT$7Y.5DK4E&58,@T-+CJ+'9"'H^=4-21PC6KY^NY(#FU9W*#
M4#1QJQ[M.S: U*(Q?9;7WMG.C79JWEH6ZK]:F<5C<J'>;2D>^P"4:S#@=O9B
M\A!31;6@4FU+NSB*EU+06H2L]Z:FX#D>#2L;[!?;PG_O=]1O,^',AC_&R1%3
MK= _LD$4^D(EM@.Y=VXZNS.E>K8X*VK=*15L'\R(EZ#E$^(L ;O-@^Z@WY;H
MVJ@0:-Z0&+$@L15=XGQ]3KJ4YJI^6JB;!QC[3D,LB5!M8D?TX.N,9<[5.3V5
ME%5BD\& \J0C0CK,-2M2GJX&-%-_>!/QZ6"/)J-,>R"3T]=I6?N6&(T"IXNA
M*VFO=D"[F^YP6B'>AV^<[-7.'0]0LD?@DME9+,^?H#*P_5I(+JVT-S33'JK)
M:.,.-$OJY\X_8+1_P@HWIM,ERU(R+;@ 8$<<? !&5;*@VV/:T;,)U6^G)26N
MKG\<CCWBB[>Z89G:%V"F4L>8L=%2?E+-+&A8&SL>'..5R)E7@&Z+X)^7&PNO
M!U^?50]W@Z-;JM +AOFQPQC0]C*XX%^>1HJTK=.0S<I:CWG\0H5]0WJBC%Q[
MO_"BTV*2-A9@-*-/^^:NT7OM1D8IMB)_C.T0CF!.V,LLHBN-(5#.YR22"M=P
MEJ9+9%,GAGEW)J:V'LR"RQ*FX'_FN(IZV/(E:[ T;L?65SS#:)^&U#@5E],(
M*2H_0*9H?W%>VN-]NKF-NW[/W"2LM.#;KK4#\B*:/K;-25XRD1.+&Y^%03"J
MAG@7ZE.-NH@N"JV1?+$9_I<!8)6JY:9Y*\L'H+D15U1VIHU=7";D=8'&U<I:
M@TP\I3@MTO,ZXK:\F(.GHGJ?L%LOPB@FN%]J%BRL8E17*J[KM&WU0&=YARD(
M89^8959:Q$W@RW)],VPJY#J!B:Q]KW@#N9S]9P9;/^<94H8A,3Y['9->411V
M@M9@#77JEL4Z_C.Y2(DCFRG[Y@3AIFH9!Y[2=!A[F93%%T?I-LIT-VS4 C+^
ME-1!W?W("+758G%B:5=/Q:8>+K9?8J##C'P<;ZH34EZ9B79MW4GXJ11+*?Q^
M6P+2M#6F&+!R#3L.$A.WTJ@<L-P[>+Y,R2B6>EVFNP(XQD3 :$;6!JUUQH I
MD98BV^":KU6_J#8%VT4B LA7G&%2N&D7YS8QDCV-?C4(;5&G1R(DMYQE5\/*
M)EH%,)<(3U&+T85PTYXN!@O;1!HMX0&)<&A6+5=;R3X E4K2]N<5619\2>_S
M(DG7H]$,59AQ3NXA(=+UHQKIKEZ?FOJ)LS%"(<!AAH5<\ZIY'/37K UM,>7K
M[L_R3\8E5P'&KX8#LJC/Y7BH!/-=_8#U&#_D>&:UJE5=XR'*/-W)Y*A#8SU&
MT)8GR[7!.M8QE\A(15P24A/P88QE.=N$84O9<H6H>$;X@E)$2SV)]$;K174S
M\G5RS2IU*FY]"TCPGZF\$,@P0"3:Y3<Q26W-Z,_._#!WJJH<^!KK(6M2BK:&
MPOI?V4&H%*8A]8,</+2:K/H1(V*M/1E3?J82^\Q*0B5EJ%+0>]'.NDD5_7*V
MLF#=6TT$X><T:*IRG.U>R0BF2,T>Y('UL"]SK;"IJIK7$>ZG9LT;LP-7TS=*
MJZ[);[9X,5;IS*I4[CEH6$_G@)JM*^:@LD?%ZQXS 0:S6Q.3;4)E"G#[8+3"
MB:7HY+"QBJ9RZ"W%&,QD:GBY7L>P%GJ5@HKSCUZUL(>?EV(^61^;LO=^Y8I@
MA M7RR*5E*AQU:J@-XJ'/4'#6(R9C%0V6+=6H8_EM^BCE..,;H(JH86A35B0
MHK&3/*?#8IN_R:?E>VGU>VM^WW)4YZOD/N+!=L_ >$9-(&C]:I"EFEJ96J51
MXHXQU+-8-(%=S*-1\P'X(?@Q *!%!OFS004&#@H*]O=[MB %!(6865D8@.'
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MZA6,006[6>=>4!LOUQ>'#$KU=."T>+=1JU@%/!^87H/L$&L<2#;4I&A?ZCX
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MJ]$US8A.5H<+3EZ"[.RJ:@)_*1;2O2^:L*P]BI:1Q)@0PP<-39)+V]<6S
MA^B6#@:1T2=:)YJJI6B-VJ]L0U(NGM;^T\=M7/EFB@-+0!A!2)-8O<#3=!&
MG/VO"@/0(Y7^!5V1E-Z5Q;DF[ET+);0&8]8G@TR$'4RNT%'T3T6.EQ*'!/7!
M=!DX&K";6'QB/$VZCBR7%,T=M<1(&ZL 8KF576S ETLQBB#86]$"1Q^"UET.
M#GF*(]M@U7US'>>%BHI4QF]M%*I:-I\E>"4(]^F;#0_&@X(C@9:$#PG"3\=4
M#-L3>12_XOJ8-0.S.K$P+=*9S:.V7*/3VF2>&U0Z1!#Z50;&)RA4QHZ6"V:^
MB)]VJ&H??_=W2]FIC^]^31_%1 @-QGW659$C$$F%:.ZI0(+<6X+4UESD0:2J
MU28.:;R$[E1ZW36KF;S=E+!:OFRYE0WHM#/;;9O&RK@\JCC;,AG,&&L-%5G0
M;3E]P-L4]K?E662J@4MEM.(\<U*=&X&"\^;PATV>1:D=;9LSN'=,7<Q,1:&X
M(HW#L(L9W""<5=& TJ7'?U$=UGRZH*RED/FD>X(P3>%2,/RF7YK9/S>OYTM6
M/1\W+XELX?DI]3[DQSXR3Z![;[3 AO0-G*LX],/&VB%I WX,5S]'&\J9_!,=
M5 'RU=E2?[N_N7* /)QYNFFNF7ZG.\N#.6X9O94^XC'H=GJRH,F:X#<XI3-Z
MT9W3N>M#R]2EKU6+;KL'R6HZRQH"&:@EL2+Z#(IA5=CEQ?Q;7[ VJTIH*:M#
MZ@%2'=NW(>P"!'X+:EO=MT9L7UNBU74.]')1ELV+I$\=V!@1%'T7/P @;SU^
M;P)?"Q1<O;^]HT!VF69HKJ=B'7"X>C@4-KP+P!NET9V:"(2F6F#C#ZG_C(D-
MT .F\,L$&MQ$K2%/M@ J<MH?1]*OM&]PVY!=+51A:F-)T@'XJ^ 8IUZ"*,NV
MP:;O,PZY:Q-M[ZR]/>^'AB&_C* PJW*@L1JPT<'%P6QFE_,J^](S.9B^09PC
MRH#^(%OOT0W47SQ$RFOS06)<%R%R^SKP(/2B4[+IE,J4UZTQ#USVD3^%+#B)
MM'IDC5W,"/5AX%K>Y3V?ZPGM=M"9250SYO>*8D^SWM%/X&:?Z]Q=KIKET$C7
MF.F#98>LK(FQ"YOV'RZ8/=\)7)J#(M?ZJ<A_@S\,.FQV/I.K//9;X&19'WS
MI9KO&ZH-AN(9!=PB>]VG@5RUZ?K#EV9T] *Q)<'[N ] 0S*)?/S/Q_^OBJN
MJIM[\N'A%'?GX>XNI;B[%"GN[JX/?[@7+5JD%"U2*%#<W8L4=RE.BR_=;[__
M[N:<G"2__&;N3#*9DWOON9/0*K_53QS=5O/HBHFX2Y@=9.C/^8.C1;I]RD3Z
MO'B_\*V=MK+"_C- @=&Q(UJ<=D=N&'Z&(*6Y3O0]G$^:AJN-F/?:<*)B;_$R
M>*3EG,SKUHH.29U7>^=AI)55M:KL'&9MQ4P\X#VA*W/]]E,2_K(0T?_3E3X#
M%#AL;%)E?[ZQPY[B0(\]Z?_]WY8^ QGN+T]D>=0]1B>&[_OE6^JVI]^69%-P
M;4HRL,R9S(82;$PCW8Z\PL@A-3#+:9[[TH+JTV_)I6+S?4=9VH2;S8+D9IW5
M=?#\.MR? ?G[_#O5E6=@.FC3N/T^4N&7_4CT-6G9Y,7Q+0/.)7R@*I1SGK*P
M[O,9^!C7S;#L?/$R<!GJ6NL782AS^ON-6^+*XP@\WJ_-7_>BU/5V:RR2RQY3
MB]=E=P/6_<'N^S[[V=&[\.RU7@;UW.1Z@\+-@0,<)Y_^1[V-^N8/ ](<+3]C
MZ['?3F_:OY88W!I-]'HN-U103GE^* TV7;8@GX#D2PXH+XN$!EZ@S]N4T&LY
M>+MT_?Q7@\EA42RJ3:90VJS_=^=6]^/FZ]O5OQHT*C2T\!'R?Q][>B.+JS%\
MFP9%TD&,T!8+6;9?+R'JC_BV%]?H)U1;31_JVI[^[$'TGG7+EQRIWRELJS;\
M8Z%VEG7R\\7-?,N!FO&;(.IZIWK"3.^M/U](4%'F"UZO7R67I#)46_U<X? .
ME&6\$FD5U7^5R40KZ:]Z\"G#^<67P SR#N'%/XF[2VP$W/'1!(!2P=@C4M.U
M"[&'?[/)K[L$S7U?KX &IO4"GHI[1BM#:AJJ9*[7'?P_6VX,_!Y.K3>%O>(V
M*N2(1V;^T(WE\#DL-B1(3(IL<BU)P>JKI\]^*K;>H<I[>\"UW^-X 1\+,^O_
MPH(L,^LWZ$5Y$H%^ZIO(+FPQ^G-;C9$?@/I/7#SW;96I/\$;VI%AX32\4'FO
M6-8-;'K"]ZFQ^E%K,2P6ZUUVSAS>QK[&+V8WBDO?]5+.X8V53I.'H,W$7@LS
MF:0G@&@:D&:GLLE,+Z?<OBSBPT\NZU72N7/<Z'L8^9$18&61=_*:UV_CAZFH
M<O:0E5:7A7^/1,E@,VCV?3M!@WOV)K7B+OQ;ALL\ZQ*5VC>O+QBD$1_S68!Z
M&7O0>)-8K=<7@^OKX.1+NSCI5^26(QEL'&9TK8@\:7QU1&Y;*621]=5W(HBO
MN!(5AAJ^H-8KD O$X"$$"MI,&]F>*Q1^5U[&9BQ*"A^<DUDL1GL0RD"SC-GA
M,=/C*CX4/\2"JTO&1YXIK'#023'!9W%5+.FI6#9!\^;1)JQ8%:5G$<-G]+K4
M4>JD1O6"U^1IAPS_W$!>5\?:;A;WUY=BYLO68:/34!/CX=Q\FJN$-<+C14_Y
MPFB#UW?) 6L@'%W.3LF344 25?NYTM'H4TX+HXH)5XUO\K5/F&[%$2*GK'Y8
M/H=#V_%HA++1:@Z>E>TH3YU;. A"0)[TRK83J&?4>IN4)S_&#\,^GS;=N57"
ML_3U TWL(4$)3YM,A5F"'9+O5XMFNP_SLAN>+1K\B;)]\6[9?^*HMY)GZS6I
ME>DNJB24:,\7?#Y/Y6&$#*"\0<L4J[?11F":^S5MLC^E.8PU?)XKZ9E]5OV&
MRJZCB05V@;V5%WFR(;DU9:4K,3UN&X95R?0(<P^H-(435^X;$!(W1VC]\FB:
MHF/0>"H4*Q E8H50F:1F4N?@4L@TYTJD.Y=L&6?@]ZX-^YBJUJ[Z4B,E]WIP
M?,9:3Q4VXK5&>),=,VOA8??^]EIMY'X,LP)6U!*2O5[Q,5%BFTA!-TJ4R3N,
M+@M(U^HM*B\)5U9Z70ZG%ZA$4W_>J"69LBHLM+UX1"O 25+E-99.RK%3;QGK
M[I<=1ST^$O<QR1%CSS3\.3BWJ$ O1P_S)$(_:LI,LRO3G^^R=*=E*H&';OA(
M\:)1L_X+:7 I ]:"G*$C&FH-J]CDIGP+2C(O0(9R3BBET:]4>YOV51IM)!(2
MXZA6,P#OC/3^VZ[("0.1YP?UP4NT3;M>M@.]@IFL_1^CS5.ZV^>\N/4%VB1\
M(GB5-2//@*D'$61EU(]#3/\><J0.0^I0^$ERE_-5W8&A51-GT@WO$GJ41S=/
M@MOB)Q^^; KT+,EU+YFEJ8+X\.IK+'VPX^1]FK%/2M<N7 %/65+L+MM]"D^'
M+@ME,_(W3D(CRZ.DMV>"P+!S,=O%F>>7R.$?Q,/K[9'FBA6#KTFW\.UM$!SP
MI*L"I)+&'CG&'IEX4%T:(@R/GR@+5DDC\_IOQ0V@.>/3 ZI3\<41/FHS.<)E
M1,/$^-EMW781RI[G7B99Y4>I=,+P,4Y2AK/QU X_^[4F$%8=-I)J:3^5#<_.
MM4%N*G04TIE+%-*G7W8FK4^&]B_'18T2CT\:?\$ZF'"L;@6I> C)*L$N'+YX
M1E,Q\T))OC_QILMP^GS'??"_=9Z OVO!,#.<I!%9+P4D#?; _UO[(>.!@\"#
M^Q1JW-CYOZ!57EV5$FT>#)VV<T#!OV".V-PK'.8MBLKPQ\V'_XA;KQU[]^=[
MJ,]?FGC\"Q(WT ?DX*AY)U_QDZV[<_QM&P!<RPY4C8&T*X[CCH!GH/]OP9 D
M&#"0+Z=/386(]M*M=?C(-Y_5R;4% $LARZC18 @ D-@!&*;]^%B-=Q! \![
M,1N"# "U "(*@CUEBC L(>@X4-I7I@(ND "'EA.C/HK $S <$)@X"#(-"D
M$"H&A )P20! !=D& #C(/P;^!?]N+B_7\O\#0OX%VR% "M+?AK ! %ON!:1Y
M$>>"P&'"T+R (.#OW5#@KWE: WPCTDO(/!7'/.O=6#L_V;^7Y#WA8WT+U/L
M?\"_+T4.[A\PZ5^FE#S-B_X4.0 0IPF5IP'D@11Y, CFY80F19XF">:O.]CR
M8,P74!P.@@0'B(-!<C0IX@!('ORB!"0.0,0!;+$7$3@0#/C%6H@\&)"C"7WA
MR .A<D *,DV2/!RV^/\)@?]?"80)ZR5@_AG3^/]#&J:N(<F%F& QM;JNJ8TS
M#LA_5@UB,KA)YU@!^N_KBFAMI>E,$=3\QS8P1/IMZE MHE(/$!Q13E#*H,BZ
M&-6;R*Y&]22(-5@C6).)R34&"DU-L="OWU-I#&VC/;RD>.4FG=?<1H0:$WW5
M?J;<=%^)QU!?2NSWCTFP?KNG2E,9<O_I1)NCW+F"7HPUZ^<*7]4F"#W'$WK-
MG27.6,5$#O"LY<>FZ=Q")6X/L:K"18H/[1=;(J/[;$/T+O6 *LDO.":EV<WG
M1C*%N%Z)]YJ('S>M?O?P^4^:/RB ])2WC+.I9Q49XS3"R.IMCQ#SWY/4S?)X
MYC2[?2G.LF0Y-UZIWLM+K=(XP=$>R_PE)'.Z3DR>VVFCG7.[<@D>.V;":3_K
MVE<4Q !EAP<@WJK(N>1Z1Q1<W9#_=IGR%*;F]U$?:+!?]"3G)@J9%<[C6Z!F
MS3VL)BS3</).J;DS5S#*9V"<0G@0:Y>N&GF([_\6("$9/RZ#O$XI:QZX8V5@
M;1_JSO9P<3_6LW1%URGH?QWSNQTV2_URA+V1WG[UG::.S1?]E8/*AQ*_SG[Z
M72'LB&< O?NCGUM\S64;9NW81J;BET3ME8,^Z5IR+9V:XUW+=V5L2.?F8FL(
M=C +F:ADJ$Y[I<?"8@HR\T1VE2)2J/VW45MUWX*LW/9CQE-O#<0+J*P6RN1J
M>@8RRSZV*8>G"1F+)C%.4%UT->#OP5% N-PN*M\*8T;#-KTU]1/['1XZ-^*X
M'I&=FD?XOM"3ZA N8+07=A*+J74ESY0_YB*:G2V78\*:JU>L^81;A6<'=K,L
M*\A[[^DK:>/L]J^N\]NJE!S!$-0G ?&6I1Y-(86FULCY(KO.:!D!5Z;B<,5>
M7&.L6GBF 7IHTENNINM(K$$TXTP1M1/>*[X<.AOCIC?10Y=$DF'%F=>);Z["
MG1ZR9(*D>X;:$1)M(?K:[&J,OT.\XSXSE"2BRY5^SM$Y9Q!JRS%U'X0UHOW(
M%I9H^\X_/7VVZT^FN4[%EC,9=TA-=+B:G[AV!7CD4P)M;A"^M&,</P?$71SG
M8ZD25FLDK22J@IX-VPAH_I 8F[W*:0:34&M"?1$=B^Y.43!1'FG[U9AW1B_)
M$=HK1,*?XN\RI6&:L@-&X9H5>Z48&Q8^2AV$9ORQGDTJ1\]ZQ_SQ1_-TI8$6
M85ALKH[&-R(H1S^RL>.C-PF>VBGYFCY,L$!JM8OV/4L[NXNIP2.;AH3%WLP3
M."JD8P43*EQS<#%:+A0$KJ/':6"$QFMAU/6.S=:V>G+2/&Z,8N^XK+@ESG*[
M@]K/<8"AJV> 6ZZ1=$W/XU!*IND!=90VV[QI0\S;V+ZX ?(#B0?=?ZM-T"]<
M&VT8'&,R2"H=$N=B]@O>_$BS.@FZ8.X5^IV]4OJQ?TM>._AXI#U0-S-F/RL$
M2Y@O()4DI/E7<]77,_P3",_:3TEU(FDLC[QCO&E93RP=U)Z'.H*QK[RE2CEW
MDY'K'NRVX9CI,U@% S\#50A6U0,^5M14L7-E9BW+BAH?(OS2X=3^^@QX4)2(
M[FADK<+SK.SN!3>+MCBA6;UU@N.L^;;\F,]YL!VL:7X\70(C>RP^4T$GZ?8(
M3OYX-Y.I.''<8C18-7S]NO3FL;Y/V19-*<KLZ8>/)?4[WW,A(<2UFUXCDDHE
MF9@GXV6J,-)E: ,8;\;Y!,J2%O3C<2SX(OA_DR#H[S)J&.#_)D%,\$L:%%,K
M[*J;XM@X@_QG:1FF#!SM-UXU673JT,^8XSC8W]-@!K^GC(),ART=\BI_(*[2
M6I!66LD6\(/PY"TF^62MJBO1C);65V"G#>[(:/<I>+Q/,)F$VGH"CQH_06'[
MIN\5?\8QVR_C[8_:<E\7*O7.4H9IG^-IB9F0T;-BX?U:FZ6.H,CRLND7".AU
M-VK^<\0\M+NTE=OTTR_(NI9X5H6!^SWM;"U^,-G6YO( Q2$<GDHK9%LTHNNH
MH6-EE7<V+.G)[/3[FX'*WQQ6VA@7>7'#ZG-?6)-*XK\WBH$5C#<SZ$PJ/\O*
MU9B="SC,VGSN(JJO)'2NN4MS58%[/8G(@CT"660R.##HX(CD=#6.]GD"_9XX
MQS3RV[L$P;;7;_H7)Q[B-N;&H9^L#3X#V-OLT%E_5?$W3DY6DL] ;,9Z=<=L
MI><]?=OXZ[$;L2,%/_6)XXB?,ZJ+)!Q94:A$:M'?[F(1RW7<YS>YSSQA.*;7
MQU^#T45%*PWCUD^FB>=^L?R1YN>>;5\/'0"4B#Z3ONJ[ERI[)XI8OU^W:Y22
MK+*'E>\"?N\?+]-]'\#YN:L'J7!MI:=#7_VMVF3ZU"+2J) K\\%B+UZZR_3O
M,#_:U%T1"3)>. (UAXXR4JOU(+/ZI8E#5G2K0KK[,09W9LZ37[UV"8_^2CF(
M,+WB#D<[4!WF4!@- ;->9TU>\+?2 4$<VP^65I+0D@:/]/=)?'>YJ7S>%#=4
M^%4ST7'Z HJ\B@O6;;*YEXNL4T%3^84NO=^.2+(F6D/FW!9>38;YX?3PC*FJ
MEK5\.M3J$*!#;H[F%A2[Y,[;DR5P=$<A0R=L]D-$+"0@;S"RHZG]$G&5 <IV
MP@![0YBPON3-W/2;+>$P#'PL0?;<^Q-9J55K-"Y*CT'^(Q<U-^<V1.'>N&&1
M.;*HI'I\I_E#VD/R>RWL>X/$45?*=LX_::0$<25/5NK4JUI@ _RM+)7,Z*C]
MB 1=#UE+PF%"1MHX,<4**T LGLV03S9U<U7+&Y@M.HFG.DDAX[ SW,1K,JA"
M16IIWK2&JW5","%^+Z$(7AWH'7JEI7D.9/((_\Y RPI3OP,W'MK=EWP*'QUY
MSP%QTC=W42Z:I\*?H)F(P"&'J5)2=(470<\Q:R4X?J*BDC@QKE1 XMWP.:/D
M(A#Q[_O\=>*RB*8C,,J>$!J_H!L;3J0Y[TU["])C_JAH)E7#7TF+>8!/@>F3
M*3L,0G<]Y5_S[%K2SO"A3>@87^!\R,#MYK2L86# 9&A?[WR-EY]945W7O0EC
MT/49,M?9=E/.;-.I]2WFX(SI$NF=BZ05@MRUJ>F"K?8N2=0YW7?ACW!-)D@,
MOP\>N'V.6CYRLC_\QN-1&<C2%R^<;=L.8R!D&28$QVBTV'O(""]^[GQMTB:W
M676)P]+,VY+NG%U3FP>)$F6L0_O."-4_'370VOP>VL8^YK@6ELF@DP+%^Q0D
M29R>DQCZ236G"$^ /&[J^KS9+<OML4^VPLU'T7*AO[G\7,I 9\6=$#[PC;>X
MXR8XOOPM:=3/<OF<Q6@7X8&!GPT&C9@$PH_+H;A?V:VI'E?P"$X1OA]3W$K^
M,QWUWWGKGU^WOQ4@8+" _TQ'G7$D%XIUU6VH39W_9SH*<R9^+/)'IGI))SM&
M;@2?)OXPK/;ZP'<,H8X55AION6=@#]R%K64@U%/;C/6P7FCQE#* %L?]M F5
M@"?=[PGU]O-AL"<V0T[M*3QBEC6%69UG.>AS;)J2QBG-G+N"X8.EM-"$_=Z@
ML(%&. E!K5<#U;>Q+/ERH!4SB(S:IV#G6,:C*9ZGDZ!CB?N*&CF)_)%&JJ>Q
MDE1N#]),O81^;;>('_(;EAWM2;R'5XB*GA=1:01,;NA*>V13XY<B\:Z()?=P
M7U?4?!%^& "QI'KAIUH3=T=UWH3"_[JZH,-X!PNS$@-T4Y<Q'2"F'R=5<4=P
M4).N^Q8Q/&Y.V/AA-E_ 977)N?!]Y/L8]*Y3NAK[]&,!TTRA7R?J.LTW@"&T
MM8+* !S9;8FCUS3ZQJ7F#2W5ZJ%OMS[$O&^1$@=6K_F3 )G!HLVM.:<^(XEV
M4 AGB#3\@B.2*%M='B=Z%\!;7EC&F!..+69C8F+$T>REA3930& ;Y!KL-(^0
M<#:D1&UK^\6<%Q\OP]&A$099*(1'D-9%,8 [_#QTFV*>-/A'B!T/+-F9WH9O
M//4S,#!N6[\?3UKC<-+C2!EU#6Q2\//3@J70:H)SI=.Q@& N[T1MA(E^??0&
MM^&6UAT<RZIB<7\/N:E1_LF*,.2O_5]=<]9?;5O,-_;X\;?)#+23A#H,::]6
MC#K3N\'91Q-G']+V89:H*R[!S4.+BCGMV/#F/T()EWB@$JD3%@7UAI0!U:]Y
MZS2J/ ,<, CS G+L8*'4:*?P*N^/9ZD8=Z1O)WAFE6S7QE8DB?.FF _:?R=7
MSPU!T& E?OF[@H(E@3(XRNV*K3U=+)38S0'Y,%8F[=,/9T+O(K*-=1"CP*N0
M\U!*EI@;=!$LG#*F].(%!0]$R.(ZG5'2>R2?6=MADRY0M$3@ADRL&U FT.5^
M%*9Z.^@G<:045@^/V@:<B%0%"^0U,]YDC?[H(.2>I,JY)POBV*V$'HDN>FZ1
M*MT?-*V1HT=/"+AY&-TRN_7?P.RA4CJ4+-V>/P._&04IQ'USI&]%PE=M)L?R
M$CR[HDQ53J1OZAA.SO"00BWGU4)Z%DR48$UQTVR61.A944"AMC3TG*\"MF;M
M15?%-CU@Z<W0 IO/C*QNQQ0@2$MO4"^S0T/9?FK,DY6=)Q2U6K)M+XQRGG%'
M_?@XTP/][B:\- FT1HDMW0PBJ<EJ(5R2!5BK<U'!3^M'J*'29WW"YJ1L."E8
MK4,1!V5?.-?)YRXN]EB'B(';-V!9DFT=ZU0^39XB)"WA#2" 1B3[T;7PA#XO
M]6E[<)-:Q/Z&MIRY2+%V^;7V]0B\V0LXWNTN$&7MOQ0OH[F(O\A:T@QR17<<
M!)WTXC[-Q[#+(AT19"+QV!"8](UL2JDB#31-^_B-"U31,BCW1$U?I_T(44+>
M#9\[SW[DJ(Q%A+W?8>-8*&41=0QR(Z:Q3.@5D4]J?G6'C_)FG[/J06VA:WHX
ML["I5WWJ1P<;NVN(OJ]'N_F3HC!9^\?U'L,B-;7HZE-![R0>>M.N/9QW0R%?
M/ 89FVWS/FAAG] N^.#A=E(></TX-W+W'5&Y[B $S_@*2IOTFLN]=_8A>^C%
M"/W<2%*M2U^8F;/Y&7N58PDDM<[T0[8KJ_ JA27#.:2@V#-1H#PS2.B[0%<#
MP1\8$>KA&2@B1LR>JUA#ZAXI])-V(08SF+G-$,?(I: U>(]AB'RN%;&?3MP)
M1O)BW:<*K0?+:.$9<!]=.L/?-Q;9(89S@*M)C8YE#*:U2PKCF&X&(0(>F2%'
M5'0A+;YPE=X?T.)$>.-9_/JV7=;7,/^ 6_=>Q> MO<U4K"9IH].=,I60,I]9
MTQ72F^QICJY$DI/$@?/%3D!)4J&?%5<5:#]^',,K!'D0%5<&)J+S!B]$6>MY
MP?6\[]2:\'#>(RJ ,M7;+0;D]->'*^]P00R":Y7$J((X;*MGR62"XKOT9!%L
M%!EY5E)^V3_0E (1*&G,/#2O0MVH]!BQJD_%V+1)?S+5K3P@)^9E3%VXCR/5
M88<Y@*LW*L6F#:9I/""LO=-P7@^0>T&F .UKTHSB7+I"/,KC/P-"1.!DQ+O.
MM6Z0]D6D=%;OUURK45.S5I&01LQ6_ZLMC@A&Q!&H^2#_/(M/CD92/:_$8>I4
M[THSS3>N9F3M^<5CW3I35"2C/8R#,NTE;_B(E2O$'<3F. 2\J!3A_@/(!O%:
M3EH>'2A/<.SW.&[#Y_1XR>0QY.'?YV':Z][I:2L#J9&8B+8?.9FZ7J5S"D W
M?#!]K^CN^SA'[*NV2(DT=)B\PV1F<HO[21\"=U0K6_?&!8HB7V5BIV=@) A'
MEK.6-_:0,/*7[:3SE-*N7HKU&7/S]<*EEW$*Q.\+C!&%]J;#O!(#)/$&E!'"
MP153'G2,P[NYL=E'?&6Z)UV9=GZ!B8+S7P]/)_;/K)-4S1^M4]%/I7A7$6,N
M-'T^/GWI]>M%>#2C$-FA=GZR2)\=&UU.PW]P)K9Z(BU<Z5_8V^++->_NOR@%
M)QH2*\F-*B3FQG&)6%H-L+' Q*[C,/H/&]CSA^5:2WYH@,^A+G,G\E;G-I#*
MB\@U53E@#T? :2/+J-0A,H3F%4TV;G2@"YH)M!5,G<-SV0U+ED+E&U!6MHTF
MKF<2^Y7KG>IC^^L]R -ZT<T3N^;UZ3]39[O+;:+G9_3#XJIAE26:7Y.K&@SC
MT0AA5);Q/>9LY\?A+(B+_DF "\DMQ8-A^D% (OL]$E>N\!FHCRS_(7..&@,J
MQU&W#]] U*7_>3!"::B&YOX1[JX[,6887K8U!W1[,[X^_[845W26PZG+8^_W
MR3>/@S/\^3H]25BS<M?(9-+/I1 8]<LXL3#8@09$EN.ND.GQ.C0Y-_ LBD<]
ML;EMC/H@:41AM&0^>"?(;6QG*ND[;\:*;)"V.%^ML4^[;Z^"TL(GX7X\3UY8
MOV#=TP+U& .4JUFCZOQ<&0QIW+LE&926&8<_XD\[:O0#3MP7,+T$^M>/LJD+
M?%6S/H8=E?O;1['Z8SD3GQ@5E%T3PP9^EXI9NR,H%# T%M7AQ9OUV.^X%+[T
MU5N[+MPG<K7O<4@:?@X\[<F4/M:G/;[>F*BO1DIWCP@R=N,\" ICB >5&('8
M9%Q.J6,)F_A949!N)\P)5/,OX=[U*M5+D#EWFKK(6C\#5M*8G#^4K7-FDB$$
M I@0+ZK4-NKAI<*.(Z2K3N8S0GJ! WHE\RWRP#?JV]>C4N\RHAJZ5N .EI^!
MQ=@#Q$K4UBX-V0XAT[LZJ<I?;9C;;GU+69GYNU6&O0-O3PN**60:<X8$-/QP
M<EIC78 WQ7 8'0XG,@''IWC/P$1M].4\WK0 XE?U*%)G4,Z6R/"T/OHBL1"'
M:@9EP97UIU,X'#9XHC/Y><K+'1UV%0[%^TK8=K?SNXE<'XJJR[ J/&2*L/0]
MP:N_#Y"S(<2(FOD#FD! =L]K WX(?JBH+(("="K"/\@MNBWE>M6I]X!L:U)D
MZ'!9HZ+%Y=(U\0WA6REM68C(NBKGOC"RH9I3ST29:H?#-L/WZ#--^5C,F\*>
MXTA";3$%]YZ4"AZ:)0^;UW,R>EKLHX0 /?H',\%%+$1RF8,8D:Y!V+.RO3_Y
MIP$S"6*'X(=-X\6GLR",A3;2U0+U2X+%NT3Z:MO1!G8XSJB-/6W$]=VBKH?@
M>V?U-_5\.;-]U\@41 J."?W;7[J4LYIZDC$;&%EC^.-LCX)/7ZS9S'7/W[[7
M+T9W;4+L(Q:'GN$$14B?1[LM4;=QYSW)/JC^[OBKWI*,YVN%DDB*6YW+>=/Y
M(>O=#<6'CC?=NJ5E/CB"=TJ2+$E:/[:WG:_.BHU#"*1A/X@^ S&NX\&I)W9Q
M/%LUC3"L;E(_??I9WZ4PY0IM"?P9MO:D87!%#7P&-H/;GX%9W]?N/,GFNC5T
M35W(E[K@D%01G5[13H@:AEEFJF="B/C2AO*0\RSYG*:<@**@<D#D>TFQ@AV.
MOH/!P96>9X![$NF6<QG;@P94U()URO]J[&9<$]-<V2J^N=:0.V?1J-U7I=1N
M[]?P$8Y*[GU%' '>7EHVK5JBY.=(ZCAG/N?FZJ2IWGBY:7=_7/JU<^< 51,U
M:]=!(TY[%-'TX?M4$PN'FH7ZOTFBNTR TCK19O^!=0B7]OSKK6V-61[=FI!U
M#/D'A"AIGPE*X;QB,DOG/9;^+'U2H(QQG/4E%D]YN=%J@L9=$+?6M,QQ'"R/
MQEHF[U;=NA)0MXS[VN_]G!*D>UZ'_@TP;A6#S5PX#7DO42N2QRHJBNCCQZ^I
M;P*W#OJCE\"B$H'W7IF82Z5EJ2*D_M9!:^-NP2GE_<)69#GE) W;JT(TY$/
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M&@Z'W/9FV>.I,-^9D70K/T%G29J%]0.%JF/ED!IXG3"RUH384#@-E21$]OM
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M& M^7OPO4$L! A0#% @ :W7]4F[$!N:Q!P 03H !$
M ( ! &)F;F@M,C R,3 V,S N>'-D4$L! A0#% @ :W7]4F5TP:PQ
M!@ 94@ !4 ( !X < &)F;F@M,C R,3 V,S!?8V%L+GAM
M;%!+ 0(4 Q0 ( &MU_5( _/Y-B@H NH 5 " 40.
M !B9FYH+3(P,C$P-C,P7V1E9BYX;6Q02P$"% ,4 " !K=?U2MFQ*<#4=
M "MB@$ %0 @ $!&0 8F9N:"TR,#(Q,#8S,%]L86(N>&UL
M4$L! A0#% @ :W7]4EU;:JY$%0 .%P! !4 ( !:38
M &)F;F@M,C R,3 V,S!?<')E+GAM;%!+ 0(4 Q0 ( &MU_5)U/YJ5+D\
M D0!@ / " >!+ !B9FYH,3!Q,#8R,2YH=&U02P$"% ,4
M " !K=?U2]([E5EIG !K:@ $P @ $[FP 8F9N:&QO
C9V\R,#$Y,# Q+FIP9U!+!08 !P ' ,D! #& @$ !
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>